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Summary
Hypertension is a major risk factor for cardiovascular disease and the main risk 
factor for stroke. Previous research has demonstrated that treatment of 
hypertension significantly reduces cardiovascular risk and the incidence o f 
cardiovascular events. Since the prevalence o f hypertension increases with age, 
so the absolute reduction in risk associated with treatment and its resultant 
benefits are greater in the elderly population. Despite this, a situation known as 
the mle o f halves has been shown to exist. This indicates that half o f the 
hypertensive population are not known, half of those known are not treated and 
half o f those treated are not controlled. Addressing this anomaly requires 
information on all potentially at risk patients and accessing the large amounts of 
data held in general practice computer systems is one o f the best ways of 
generating such infoiination. However, whilst practitioners can access the 
information required to inform management of individual patients, the data 
required to infonn strategic decision making are not as readily available.
The research described in this thesis evaluates the provision o f different levels o f 
feedback, developed from computerised data, on identification, treatment and 
control o f hypertension in the elderly. This was done by means o f a randomised 
controlled trial. Fifty two Scottish general practices were recmited and 
randomised to three groups. A Control group which received no inteiwention, an 
Audit group which received feedback o f  audit data and a Strategic group which 
received audit feedback plus data prioritising patients by absolute risk o f death 
from stroke. Electronic data on demography, morbidity and prescribing were 
extracted from practice computer systems annually from 1999-2001 and used to 
develop feedback. Participants represented both urban and m ral practice and a 
range o f practice size, list size and deprivation level.
The data presented demonstrate that over the period o f study, the proportion o f 
65-79 years olds with a blood pressure recorded increased, with the largest 
improvement seen in the Audit gioup. At the outset, 30-40%  o f the patients 
whose blood pressure was >160 / >90 mm Hg had been identified as being 
hypertensive. This improved in all thi'ee groups, the improvement made in the 
Audit and Control groups being two to three times that made in the Strategic
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group. The majority o f diagnosed hypertensives were initially receiving treatment 
and this increased to more than 90% in all tlii'ee groups. The greatest 
improvement was seen in the Strategic group. Around 40% o f treated patients in 
each group had controlled high blood pressure at the outset o f the study and this 
rose by around 10%. The lowest mean systolic blood pressure was found in the 
Strategic group, whilst the greatest proportions of controlled hypertensive patients 
were found in the Strategic and Control groups. However, after adjusting for 
clustering, patient and practice effects, there was a significant difference in the 
level o f control in the Strategic gi'oup compared with the other two groups. 
Absolute risk was reduced for between 10-20% o f patients in each gi'oup, with the 
largest reduction found in the Strategic group. More than 80% of the patients in 
that gi’oup had their blood pressure record updated compared with only half of the 
patients in the Audit and Control groups. In addition, twice as many patients in 
the Strategic group had their record changed to reflect that they did not smoke and 
fewer patients in that group were newly recorded as smokers. There was no 
significant difference in the numbers o f patients in each group who had a stroke 
during the study period.
Improvements were demonstrated in all aspects of the rule o f halves, a finding 
supported by other studies in this area. Whilst 60% o f all hypertensive patients 
and 40% of treated hypertensives were still not controlled at the end o f the study, 
the results suggest that providing practices with patient specific, strategic 
feedback can impact on identification and management o f hypertension in the 
elderly, producing a consequent increase in blood pressure control. The study 
also demonstrates the utility o f electronic primary care data and highlights the 
importance o f practice organisation in the management o f chronic disease.
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1.1 Chapter overview
This thesis describes a randomised controlled trial designed to evaluate the impact 
of two different types o f feedback, developed from electronic patient records, on 
management o f hypertension in the elderly. This chapter describes the 
backgiound issues, summarising the basis for the study undertaken. First o f all, 
the burden o f hypertension and its role as a risk factor for cardiovascular disease 
is described, with particular reference to age and the benefits o f treating 
hypertension in older people. This is followed by a summary of record keeping in 
primary care, including the uptake o f computerisation and electronic records, as a 
means o f contextualising the extent and accessibility o f electronic clinical data. A 
description o f existing systems o f decision support used in hypertension 
management is then provided, followed by a summary o f the use o f audit and 
feedback as an intervention. The chapter ends with the aims and objectives o f the 
study.
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1.2 Hypertension as a risk factor
There is a vast worldwide literature on hypertension, its risk factors and its 
management. The following section draws on a sample o f some influential work 
to illustrate the disease burden created by hypertension, the implications for 
mortality in older people, the benefits of treatment and finally the current situation 
as regards hypertension management in primary care.
1.2.1 The burden of hypertension
“Hypertension can be defined in terms o f  a blood pressure level above 
which investigation and treatment do more good than harm ’ ’ (Evans 
& R ose 1971)
Hypertension is a major global health issue. It affects approximately one billion 
individuals worldwide and has been estimated to be the third leading cause o f the 
global burden o f disease, accounting for 4.4% o f ill health (Ezzati et al. 2002). A 
recent study by Wolf-Maier et al. compared the prevalence o f hypertension, taken 
from the health suiweys o f The United States, Canada and six European countries, 
including England (Wolf-Maier et al. 2003 a). They found that the prevalence of 
hypertension in Europe, as denoted by a blood pressure o f >140/>90 mm Hg, is 
60% higher than in North America (44% v 28%). The most recent health suiweys 
in England, Wales (Department of Health 1999) and Scotland (Scottish Executive 
Health Department 2000) have shown that at this threshold, around 30% o f the 
population o f the United Kingdom (UK) is hypertensive. Even if  a higher 
thieshold o f >160/>95 mm Hg is used, at least 18% have hypertension.
Hypertension is a major risk factor for cardiovascular disease (CVD), the most 
common cause o f death worldwide, (Murray & Lopez 1997). Indeed, the 
relationship o f blood pressure to CVD and CVD related mortality is one which 
has been found to be continuous and independent o f other risk factors (Glymi et 
al. 1995). Thus, as the level of blood pressure increases, so too does the risk o f 
CVD (Selmer 1992) (Prospective Studies Collaboration 2002).
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In the majority o f cases, high blood pressure has no significant symptoms and as 
such, individuals do not usually present seeking care specifically for this 
condition. Whilst opportunistic screening when a patient attends for symptoms of 
other conditions often detects hypertension, identification at a population rather 
than individual level requires more proactive activity on the part o f health care 
providers.
1.2.2 Hypertension and age
As age increases, so too does the level o f an individual’s blood pressure and 
consequently, the prevalence of hypertension. The recent Scottish and English 
health surveys showed that the prevalence o f high blood pressure increased from 
14-20% for individuals aged 45-54 to 27-40%  for those aged 55-64 and to 4 3 - 
58% for those aged 65-74. Previous work by Staessen et al. showed that the 
prevalence o f systolic hypertension increased from an average o f 8% amongst 
individuals in their 60s to over 25% amongst those in their 80s (Staessen, Amery, 
& Fagard 1990). Similar age related increases have been shown for diastolic 
blood pressure (Selmer 1992). As a consequence o f this age related prevalence, 
older patients with hypertension are more at risk o f CVD than younger patients 
(Kannel et al. 1981).
1.2.3. Hypertension and stroke
The Global Burden o f Disease Study was initiated by the World Bank in 1992 and 
carried out over a five year period in collaboration with the World Health 
Organisation (WHO), with the aim o f developing estimates o f prevalence, 
incidence, disability and mortality by age, sex and geographic region (Murray & 
Lopez 1997). It found that in 1990, cerebrovascular accident, or stroke, was the 
cause o f 4.4 million deaths worldwide, second only to ischaemic heart disease 
(6.3 million deaths). Another suiweillance study, the WHO MONICA project 
(World Health Organization Monitoring Trends and Determinants in 
Cardiovascular Disease), was established in the 1980s to register the occurrence 
o f myocardial infarction and stroke as a means o f analysing changes in risk 
factors over time. This work has shown that there is gi'eat variation in stroke 
incidence rates amongst the 16 European and two Asian countries participating 
(Thorvaldsen et al. 1995). In their recent study in Europe and North America,
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Wolf-Maier et al. showed that the average mortality rate for stroke in Europe was
41.2 per 100,000 (Wolf-Maier et al. 2003a). In Scotland, whilst the rate has been 
falling over the last decade, it is still higher than the European average, at almost 
50 deaths per 100,000 (Information and Statistics Division (ISD) website; 
www.isdscotland.org). The stroke mortality rate in Scotland is also higher than in 
the rest o f UK (Registrar General for Scotland 2000), with rates having been 
shown to be similar for both men and women (Hart, Hole, & Davey-Smith 1999) 
(Isles et al. 1992).
W hilst hypertension is a risk factor for cardiovascular disease in general, it is the 
main risk factor for stroke (Kannel et al. 1970) (MacMahon et al. 1990) (Hart, 
Hole, & Davey-Smith 1999) (Psaty et al. 2001) (Prospective Studies 
Collaboration 2002) and has been estimated as being responsible for almost three 
quarters o f all strokes (Dunbabin & Sandercock 1990). Furthermore, the 
incidence of stroke increases with increasing age. Research on the stroke 
incidence in Auckland, New Zealand showed that the rate increased dramatically, 
from tliree strokes per 10,000 individuals aged 30-40, to 300 per 10,000 
individuals aged 80-90 (Bonita, Beaglehole, & North 1984). The same 
researchers also showed that 88% o f strokes occurred in those aged over 65 
(Bonita 1992). A recent meta-analysis o f data relating to one million individuals 
from 61 observational studies from around the world showed that for those aged 
40-69 years, each increase of 20 mm Hg in systolic blood pressure (SBP) or 10 
mm Hg in diastolic blood pressure (DBP) doubles the risk o f stroke death 
(Prospective Studies Collaboration 2002). Whilst these data are based on first 
occurrence o f stroke, additional research demonstrates that survivors o f a previous 
stroke have a 15-fold increase of a recunence compared with the general 
population (Burn et al. 1994), equivalent to a risk o f 8% per year (Lees, Bath, & 
Naylor 2000).
The majority o f strokes are not fatal, but are rather the cause o f chronic disability 
(Wade 1994). Indeed, stroke is the single largest cause o f disahility in the UK and 
in 1998 the Stroke Association estimated that there were ai'ound 250,000 disabled 
stroke suiwivors (The Stroke Association 1998). As such, stroke is a major source 
o f expenditme in the NHS, estimated at around £2.3 billion per year (Department
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of Health 1996). Identifying effective strategies for stroke prevention is o f major 
importance.
1.2.4 Benefits of treating hypertension in older people
Several major randomised trials have demonstrated that treating high blood 
pressure in older individuals has a substantial impact on morbidity and mortality 
related to stroke.
In the late 1970s, two general practitioners (GPs), Coope and Warrender (Coope 
& Warrender 1986), conducted a trial with 884 men and women aged 60-79 
(mean age 69) who were recmited from 13 general practices in England and 
Wales. Mean blood pressure on entry to the trial was 196/99 mm Hg.
Participants were randomised to active treatment or to a control group and were 
followed up for an average o f 4.4 years. At the end o f the study, average blood 
pressure in the treatment group was 18/11 mm Hg lower than in the control group. 
Cardiovascular deaths were reduced by 22% in the treatment group compared 
with the control group and strokes by 42% (12.5 v 21.4 per 1000 patient years; 
p<0.03).
The European Working Party on High Blood Pressure in the Elderly conducted a 
trial in ten European countries involving 840 participants aged 60 or over (mean 
age 72) who were randomised to receive active treatment or placebo (Ameiy et al. 
1985). All had both systolic and diastolic hypertension, with an average blood 
pressure o f 182/101 mm Hg on entry to the study. Participants were followed up 
for an average o f 4.7 years after which there was an average difference in blood 
pressure between the two groups o f 22/10 mm Hg. Cardiovascular deaths were 
reduced by 27% in the treatment gi'oup and stroke mortality by 32% (11 v 16 per 
1000 patient years; p=0.16). The same group later conducted a trial looking at 
isolated systolic hypertension, the Syst-Eur trial (Staessen et al. 1997), which 
involved 4,695 patients aged 60 or over (mean age 70) followed up for an average 
of two years. Again, participants were randomised to either active treatment or 
placebo and mean blood pressure at the outset o f the trial was 174/85 mm Hg. At 
the end o f the study period, blood pressure in the treatment group was 10.1/4.5 
mm Hg lower than in the placebo gioup and the occurrence o f stroke was reduced 
by 42% (7.9 v 13.7 per 1000 patient years; p=0.003).
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In 1991, the Systolic Hypertension in the Elderly Program (SHEP) Cooperative 
Research Group reported findings from a trial conducted in the United States (US) 
involving 4,736 men and women aged 60 years or older (mean age 72) (SHEP 
Cooperative Research Group 1991). All o f the participants had systolic 
hypertension with a baseline average pressure o f 170/77 mm Hg. They were 
followed up for a period of 60 months, half receiving active treatment and half 
receiving placebo. At the study end, there was an average difference in blood 
pressure o f 11.1/3.4 mm Hg between the treatment and control gi'oups, in favour 
o f the treatment gioup, and a significant reduction in stroke risk. Cardiovascular 
disease was reduced by 32% and strokes by 36% (5.2 v 8.2 per 100 subjects; 
p=<0.000). Subsequent analyses by the group showed that treatment reduced the 
incidence o f both haemorrhagic and ischaemic stroke (Perry et al. 2000).
Aiound the same time, the Medical Research Council (MRC) conducted a trial 
involving 4,396 men and women aged 65-74 (mean age 70) (MRC Working Party 
1992). They were recruited from 226 practices from Scotland, England and 
Wales which were part o f the MRC General Practice Research Framework, 
established in the late 1970s. All participants had either isolated systolic 
hypertension or combined systolic and diastolic hypertension. On entry to the 
study, participants had a mean blood pressure o f 185/91 mm Hg and were 
randomised to receive a diuretic, beta-blocker or placebo. They were then 
followed up for an average o f 5.8 years. Both treatments reduced blood pressure 
below the level in the placebo gioup, the average reduction was 6.3/5.9 mm Hg. 
Patients in the active groups had a 17% reduction in cardiovascular events and a 
25% reduction in strokes compared with the placebo group (8.1 v 10.8 per 1000 
patient years; p=0,04).
In a study from Sweden, Dahlof and colleagues sought to detennine the benefits 
o f treatment on patients aged over 75 (Dahlof et al. 1991). They recmited 1,627 
patients aged 70-84 years (mean age 76) from 116 health centres and randomised 
them to active treatment or placebo. All participants had either diastolic 
hypertension or combined systolic and diastolic hypertension and were followed 
up for an average of 25 months. At the outset o f the study, participants had a 
mean blood pressure o f 195/102 mm Hg. At the study end, there was an average 
difference in blood pressure between the two groups o f 27/10 mm Hg.
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Cardiovascular events were reduced by 40% in the treatment gioup and strokes by 
46% (16.8 V 31.3 per 1000 patient years; p=0.008).
Similar results have been shown in trials conducted with elderly patients hom  
Australia (The Management Committee 1981), China (Liu et ai. 1998) and Japan 
(Kuramoto et al. 1981) and in smaller studies, such as the CASTEL study in Italy 
(Casiglia et al. 1994) and the study by Sprackling et al. in the UK (Sprackling et 
al. 1981).
In recent years, several meta-analyses have combined the results hom  these and 
other studies to give an overall quantification o f the effect o f treating hypertension 
in the elderly. Additional analyses have combined the results o f the trials in 
elderly patients with those o f trials involving both younger and older individuals, 
such as the Hypertension Optimum Treatment HOT study (Hansson et al. 1998) 
and the Heart Outcomes Prevention Evaluation (HOPE) trial (Heart Outcomes 
Prevention Evaluation Study Investigators 2000). All demonstrate that 
antihypertensive drug treatment reduces stroke by at least 20% and perhaps by as 
much as 42% (Blood Pressure Lowering Treatment Trialists' Collaboration 2000) 
(Staessen et al. 2000) (Insua et al. 1994) (Collins et al. 1990). A meta-analysis 
conducted by Gueyffîer et al. analysed the results o f five o f the major trials by 
patient sex and found that the reductions in risk were consistent for both men and 
women (Gueyffier et al. 1997).
In a review published in Journal o f the American Medical Association, Mulrow et 
al. combined the results from 13 trials involving patients aged 60 or over with 12 
trials involving younger and middle aged patients to compare the benefits of 
treatment in the elderly with the benefits found in younger people (Mulrow et al.
1994). They showed that the nmnber needed to treat (NNT) that is, the number of 
individuals who need to be treated with antihypertensive medication for five years 
in order to prevent one adverse cardiovascular outcome, is considerably lower for 
the elderly than for younger patients. For all outcomes except cardiac mortality, 
two to four times as many younger patients needed to be treated. Preventing one 
stroke required treatment o f 46 elderly patients compared with 168 younger 
patients.
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Thus, there is considerable research evidence to demonstrate that reducing blood 
pressure in older patients impacts on the incidence o f stroke and other 
cardiovascular events. The majority o f trials in this area were designed to 
determine the effectiveness o f particular active treatments in reducing blood 
pressure. They did not consider effective ways o f identifying the patients who 
would benefit most from receiving those treatments.
1.2.5 Hypertension identification, treatment and control
In 1968, Julian Tudor Hart carried out blood pressure screening on 100% o f the 
men and 98% o f  the women in his practice in Glyncorrwg in Wales (Hart 1970).
In 1970, Joseph Wilber and Gordon BaiTow conducted a study involving 6,000 
individuals aged 15 or over from a commimity o f 23,000 adults in Atlanta,
Georgia (Wilber & Barrow 1972). Their aim was to determine whether 
widespread community methods could improve control o f hypertension and 
women from the target or adjacent neighbourhoods were trained to cany out 
screening. What these and other community surveys demonstrated was that half 
o f those with high blood pressure were not know, half o f loiown were not treated 
and half o f those treated were not controlled. This situation became known as the 
‘mle o f halves’. Subsequent studies in the UK have shown that although 
improved, the mle o f halves still exists.
Smith et al. used data from the Scottish heart health study on 450 men and women 
aged 40-59 to audit the detection, treatment and control o f adults in Scotland 
(Smith et al. 1990). They found that hypertension was undetected in 53% o f men 
and 46% o f women, detected but untreated in 42% o f men and 33% of women and 
treated but uncontrolled in 50% o f men and 40% o f women. Data fi om the 
Scottish MONICA surveys were used to revisit the m le and showed that whilst 
improvements have been made, the mle still applies. In 1995, only 33% of treated 
hypertensives were controlled (Chen et al. 2003). In the British family heart 
study, canied out in 26 general practices around Scotland, England and Wales, the 
study group found that one third of men and one sixth o f women with previously 
undetected high blood pressure had a diastolic reading o f >90 mm Hg (Family 
Heart Study Group 1994). Only 24% o f those with reported high blood pressure
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were taking medication and almost two thirds o f those who were diagnosed (64%) 
were not adequately controlled.
Fahey and Lancaster analysed the case records o f 2,428 patients aged 65 or more 
registered with 27 practices in Northamptonshire, England (Fahey & Lancaster
1995). They found that whilst the majority o f patients had a blood pressure 
recorded (86%), 49% of those with a hlood pressure o f >160/>90 mm Hg were 
untreated and only 42% o f those diagnosed were adequately controlled. Cranney 
et al. audited the case records o f 6,139 patients aged 65 or more recruited 76 
general practices in Merseyside, England, (Cramiey, Barton, & Walley 1998). 
Almost half o f  the patients were identified as hypertensive (43%), 64% were 
receiving antihypertensive medication, but only 37% o f those being treated were 
controlled.
In a recent study by Hooker et al., the computer systems o f 22 general practices in 
London were used as a means o f determining the rule o f halves (Hooker et al. 
1999). Even using less rigorous assessment criteria, based on the expected 
prevalence o f hypertension in the elderly (identification), presence o f an electronic 
blood pressure recording (treated) and mean SBP and DBF over a one yeai' period 
(control), the researchers still found that only 74% o f hypertensives were 
identified, 67% were treated and 61% were controlled. Duggan et al. reviewed 
the records o f 6,986 patients from 51 practices in the former Northern Region o f 
England (Duggan et al. 2001). Blood pressure status was undetermined in 30% of 
patients, whilst 70% o f those diagnosed as hypertensive were treated and only 
30% of those were controlled. In all, only 14% o f elderly hypertensive patients 
were identified, treated and controlled.
Work elsewhere has demonstrated that the rule o f halves also applies to other 
populations. In a study using the Northern Sweden MONICA cohorts, Weinehall 
et al. showed that 27% o f those with hypertension were treated and only 29% of 
those were controlled (Weinehall et al. 2002). A study on trends in detection, 
treatment and control in the adult population o f Belgium showed that whilst all 
phases improved between 1980 and 1992, 53% o f male and 26% female 
hypertensives were still untreated and only 35% and 16% respectively were 
controlled (De Henauw et al. 1998). In the Unites States, work has shown that
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there have been significant improvements since the first National Health and 
Nutrition Examination Survey in 1960 (Burt et ah 1995) (Chobanian et ah 2003). 
The proportion o f treated hypertensives was 59% in 2000, an increase o f around 
30%. However, even with an increase o f 25% on the 1960 total, the proportion of 
controlled hypertensives was still only 34%. A recent comparison of treatment 
and control in five European countries, Canada and the US, showed that control of 
hypertension in the European population is on average 37% less than in the US 
and 20% less than in Canada (Wolf-Maier et al. 2003b). The rule o f halves has 
also been shown to be relevant to the hypertensive populations in Spain (Compan 
et ah 1998), India (Deepa et ah 2003) and in Afro-Caribbean countries 
(Cruickshanlc et ah 2001).
Thus, despite the benefits arising from the treatment o f hypertension at any age, 
but particularly in elderly patients, the rule o f halves remains an ongoing problem 
worldwide.
1.2.6 Absolute or relative risk?
Studies considering hypertension and the risk o f stroke often vary in their 
description o f risk. The majority report evidence in tenais o f relative risk, despite 
the fact that in clinical practice, absolute risk is as, if  not more, relevant.
Absolute risk relates to the probability o f an event happening in the population 
under study, that is, the incidence o f the event in that population. For example, 
the absolute risk o f death associated with coronary angiography is 0.1% or one 
death per 1000 individuals. Relative risk on the other hand is the ratio of two 
absolute risks, such as the risk o f death in a population with a specific disease 
compared with the risk of death in a population without that disease.
Whilst the relative risk o f death associated with raised blood pressure is greater in 
younger people, since the average blood pressure in that gioup is lower and high 
pressures less common, there is a higher level o f absolute risk o f death associated 
with age. In a commentary in the British Medical Journal in 1981, Geoffrey Rose 
presented age and blood pressure related mortality data for four groups o f men 
based on both relative and absolute risk (Rose 1981). He demonstrates that the 
relative risk o f death does increase as blood pressure increases, regardless o f age,
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but that the incline lessens as age advances. This is likely due to the fact that 
blood pressure increases with age and as such, a systolic pressure o f 160 mm Hg 
is not as uncommon in older people. However, when the same data are presented 
for absolute risk, whilst there is still an increase in risk as blood pressure 
increases, the increase is most pronounced in the older age groups. So, there are 
twelve deaths per 1000 in men aged 30-39 with an SBP o f 160 mm Hg, compared 
with 83 deaths per 1000 in men aged 60-69. In an article published ten years later 
(Rose 1991), Geoffrey Rose reiterates a point made in his earlier piece when he 
writes,
“All policy decisions should be based on absolute measures o f risk;
relative risk is strictly fo r researchers only”
Since the risk o f hypertension related death is greater in elderly patients than in 
younger patients, the risk reductions achieved through treatment and control o f 
high blood pressure are also gi'eater in this group. In view o f this, the study 
reported in this thesis focused on patients’ absolute risk. A summary o f available 
risk prediction tools and the method used in this study are described in chapter 5.
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1.3 Record keeping in primary care
1.3.1 The origins of record keeping
“The traditional medical record  is a vital part o f  the picture that
he [the general practitioner] builds up o f his patient to be able to 
recall with what frequency the patient consults him, whether a child 
has had measles, how many pregnancies a woman has had, and what 
was the outcome... " (Working Party o f the Royal College o f General 
Practitioners 1972)
An influential report on quality assessment in general practice, states that primary 
care records are "more than an aide-memoire to the doctor or nurse”. Good 
quality record keeping is regarded as an "essential aspect o f care ” (Roland, 
Holden, & Campbell 1998) and it has been suggested that poor, incomplete record 
keeping may hide poor practice.
The records used in general practice in the UK today originate from the 1911 
National Insurance Act, which obliged GPs, "to keep such medical records as 
might be required o f them under their conditions o f service ”. As part o f pay 
negotiations the following year, the then Prime Minister, Lloyd George, 
maintained that record keeping was one o f the duties o f a GP. However, the 
system introduced to facilitate this, day sheets which covered six square feet of 
table space, were cumbersome and failed to meet the needs o f both clinical 
practice and preventive medicine (Honigsbaum 1979). Eight years later the 
Rolleston Committee was established to look at the fonn that these records might 
take and the Lloyd George envelope and record card emerged as the standard 
fonnat. This provided the first method o f continuously recording patients’ 
attendance, diagnosis and treatment.
In 1921, regional medical officers were introduced in England to inspect the new 
records and ensure that they were kept. In contrast, the Board o f Health in 
Scotland took a different approach and tried to promote record keeping through its 
research programme, beginning in 1930 (Honigsbaum 1979). Whilst record 
keeping was widely practised, the records themselves were often incomplete.
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Clinical notes tended to be made only for more serions conditions, such as those 
that required certification off work, referral or operations (Digby 1999).
From 1950 onwards, there were proposals to improve the fomiat of patient 
records, although none were widely adopted and the Lloyd George envelope 
continued to be extensively used. In 1967, the Department o f Health supported a 
trial o f A4 records and a year later the Scottish Council o f the Royal College o f 
General Practitioners (RCGP) began a major study o f the A4 record scheme. This 
was put forward as a replacement for the Lloyd George envelope in both 1974 and 
1977, but there were still conflicting views as to its merits and plans to introduce 
it as the standard tliroughout the UK were never fulfilled, hi 1983, however, it 
was offered to any practice in Scotland that wanted to use it.
1.3.2 The advent of electronic records in the UK
Electronic record keeping emerged in parallel with manual systems and first came 
into the UIC health service in the 1950s. Early development o f computers 
focussed on their use for collecting and administering what was already being 
called ‘routine patient data’.
Some o f the earliest work was earned out as part o f the Oxford Record Linkage 
Study and sought to demonstrate whether it was practical or indeed beneficial to 
collate patient health data. Records which had previously been held by various 
health professionals were pulled together into one centralised record (Acheson 
1964) (Acheson & Forbes 1968) (Perry 1972). Systems for complete health 
centres also became operational around this time, with the purpose o f allowing 
GPs and other health professionals to enter and access infoiuiation during 
consultations (Abrams et al. 1968) (Abrams 1972).
By the end o f  the 1960s, a minority of innovative GPs were not only using 
systems for administrative activities, but were also using them for activities more 
related to patient care, such as running screening and immunisation programmes 
(Hodes 1968) or recording morbidity data (Dinwoodie 1969). In Livingston, 
which was at the forefront o f primary care computerisation in Scotland, the 
impact o f an electronic records system on health centre personnel was also being
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tested (Gnier & Heasman 1970). Even at that time, the research team reported 
that the most,
‘‘effective, practical assistance so far provided by the computer is in 
the preventive field  o f the practitioner’s work”,
and that one o f the essential requirements in the development o f the system was,
" ...provision o f adequate methods ofpopulation surveillance... ”
This early work had all depended on remote batch processing o f patient data, 
where data from individual patients encounters was collected, but collectively 
entered in a single session, usually out with surgery hours. In 1970, the first real 
time data systems began to emerge (Preece et al. 1970) (Lippman & Preece 1971), 
allowing practitioners to access and enter data when required, using 
microcomputers situated in practice. Many aspects o f the electronic medical 
records used today originate from this system, including patient history, repeat 
medication and recall for immunisations.
1.3.3 Implementation of electronic records
The Royal College o f General Practitioners has been in favour o f electronic 
patient records since the late 1970s, when its Computer Working Party 
[established in 1978] published a report considering,
the desirability and practicability o f  the use o f  computers for  
general practice clinical records.... ” (Royal College o f General 
Practitioners 1980)
However, it was another decade before computer use became widespread. The 
govermnent’s ‘Micros for GPs’ scheme, launched by the Department o f Trade and 
Industry in 1982 as part o f Information Technology Year, was the first real step 
towai'ds universal general practice computerisation. Under the scheme, 150 
practices in Britain received 50% of the cost o f installing a particular computer 
system, either CAP (UK) or British Medical Data Systems. These systems were 
designed for patient registration, repeat prescribing and screening and recall and
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in return practices agreed to participate in an evaluation o f their use over a tlrree 
year period. Although the scheme attracted criticism at the time, mainly over the 
lack o f choice of available computer systems, more than 1000 practices applied to 
participate (Project Evaluation Group 1985).
In 1987, VAMP (now InPractice Systems) and AAH Meditel, two o f the largest 
computer suppliers in the country, introduced no-cost computer schemes whereby 
practices were offered free multi-user computer systems in return for anonymous 
patient data on morbidity and repeat prescribing. As a result, 19% o f practices in 
England and Wales had become computerised by 1988 rising to 28% by 1989 
(Department o f Health 1993). The situation in Scotland, however, was somewhat 
different.
1.3.4 The situation in Scotland
When the Micros for GPs scheme ended, the 16 participating Scottish practices 
were concerned that the progress and enthusiasm for computerisation that had 
been created would wane. To prevent this, David Ferguson, a Glasgow GP, 
offered a software package that he had designed in 1984, originally as a repeat 
prescribing system, and the General Practice Administration System for Scotland 
project (GPASS) was established. Development o f the system has been 
financially supported by the Scottish Executive Health Department (SEHD) since 
1984 and offered free to any practice with compatible hardware. Encouraged both 
by the success o f the system and by the SEHD incentive, the number o f 
computerised practices in Scotland had risen to 27% by 1988 and to 36% by 1989, 
covering more than one third o f the total patient population (Ryan 1989).
1.3.5 Impact of the 1990 contract
Undoubtedly, the greatest catalyst in the drive towards electronic records in the 
UK came in the shape o f the 1990 General Medical Services contract for general 
practice. The contract placed greater emphasis on health promotion, identification 
o f at risk groups and disease prevention. As a means o f ensuring that practices 
fulfilled these requirements, remuneration was linked to targets. To receive 
maximum payment for activity, practices had to identify all relevant patients. Not 
only did they need to identify gi'oups o f patients by age and sex, they now also
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had to identify them by disease. Categorising and identifying patients in this way 
is quicker and easier on a computer than with paper records. As part o f the 
contract, the Department o f Health offered 50% reimbursement on the acquisition 
and mnning costs o f computer systems. These factors led to an increase in the 
number o f computerised practices from 28% in 1989 to 47% following the 
introduction o f the contract and to 63% in the following year (Department of 
Health 1998).
1.3.6 The classification of eiectronic data
With the emergence o f technology to store patient data electronically, came the 
need to categorise those data in a useful and meaning way.
Attempts to classify disease began in the early 1700s and by the beginning of the 
19th century, the most widely used system was the Synopsis Nosologiae 
Methodicae, published in 1785 by William Cullen (1710-1790) (World Health 
Organisation 1993). Wlien the General Register Office o f  England and Wales 
was established in 1837, William Fan' (1807-1883), the first medical statistician, 
set about improving the Cullen classification. The system continued to develop, 
and with support from various individuals, including Florence Nightingale, it was 
expanded to include diseases resulting in measurable morbidity. Ultimately, the 
classification evolved into International Classification o f Diseases (ICD) 
which has been in routine use since 1945.
The prime function o f ICD was to classify causes o f mortality and the reasons for 
going to hospital and as such, it was considered biased towards secondary care 
and not suited to general practice. Consequently, various community oriented 
classifications were produced in several countries, including the RCGP’s own 
system (College o f General Practitioners 1959). In 1972, a WONCA working 
party (World Organisation o f National Colleges and Academies o f General 
Practitioners/Family Physicians) began developing a common system, the 
International Classification o f Health Problems in Primary Care (ICHPPC), 
which was accepted by all countries during the sixth World Conference on 
General Practice in 1974 (WONCA Working Party 1976).
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When planning the third UK National Morbidity Survey in 1981, the RCGP 
discovered that the updated ICHPPC-2 (WONCA 1979) now contained fewer 
codes than had been used in their 1971 smwey. Since one of the objectives was to 
compare the data over time, a method o f integrating ICHPPC-2 with ICD was 
developed to provide the missing information. Following the survey, the RCGP 
began to fonnalise this new system, eventually resulting in the Classification and 
Analysis o f  General Practice Data, the first classification specifically designed for 
use with electronic records (Royal College o f General Practitioners 1986).
By the late 1980s, when levels o f primary care computerisation were increasing, 
several methods of classifying electronic clinical data were available. In 1987, the 
Joint Computing Group o f the RCGP and the General Medical Services 
Committee of the British Medical Association were given the remit o f considering 
the various systems, with a view to use o f a single system. They recommended 
that the Read Clinical Classification, be adopted as the standard general practice 
morbidity coding system in the UK (GMSC-RCGP joint computing gioup 
technical working party 1988). This is now the most commonly used coding 
system in UK general practice. Each piece o f patient data is stored as an 
alphanumeric code, allowing rapid data access and retrieval. The Read Clinical 
Classification is discussed in detail in chapter 4.
1.3.7 Use and extent of electronic records
Patient records serve a variety o f functions, which vary between general practices 
both in level and degree o f use. The most common uses include documenting the 
patient’s history, prescribing, screening and administration (Richards et al. 1998). 
Computerisation o f records has provided the ability to collate and sort patient data 
and ‘flag’ patient files to highlight particular issues or act as a reminder to 
perform a particular task. In addition, these records can be used to audit current 
practice or for research pmposes. They also form the basis o f a medico-legal 
document for litigation.
In its most recent surveys on computerisation in primary care in England and 
Wales, the Department o f Health found that the majority o f responding general 
practices used electronic records for patient registration (98%), repeat prescribing 
(94%) and for maintaining clinical records (90%). Two thirds o f the practices
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entered clinical data during consultations (66%), whilst 63% used them to flag 
records for follow up tasks (Department of Health 1993). Similar figures were 
reported in a recent Scottish survey (Morris et al. 2003). The majority of 
respondents used electronic records for repeat prescribing (84%), whilst 63% 
recorded clinical information. Almost three quarters (72%) used their records for 
clironic disease management.
The Department o f Health suiwey also showed that receptionists (92%) and 
secretaries (65%) are two of the largest users o f electronic records, unsurprising 
given the high proportion o f practices using records for patient registration data 
and recall. Doctors (80%) and practice nurses (76%) were also high users, but use 
among attached nurses (8%) and health visitors (11%) was uncommon. However, 
findings from the survey by Morris et al (2003) show that use amongst the 
practitioner groups has increased, particularly nurses. Almost all GPs used 
computerised records (94%), 91% of them whilst in the consulting room. Eighty 
five percent o f practices nurses were frequent or occasional users, as were just 
over half o f community nurses (55%) and health visitors (56%).
Thus, electronic records ai e widely used by members o f primary care teams.
Their use both during and out with consultations has resulted in datasets 
containing a wealth o f data relating to patient demogi aphics, morbidity and 
prescribing.
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1.4 Use of computers for disease management
The widespread adoption o f electi'onic patient records in primary care and the 
consequent application o f computers to the consultation enabled the use of 
information technology to move beyond the administrative and towards 
facilitating improvements in the management o f disease. Previous research has 
shown that use o f computers and electronic patient data can lead to improvements 
in the organisation and outcome of care. A previous systematic review, conducted 
by the author as an update to her previous review (Sullivan & Mitchell 1995), 
assessed the impact o f computers on primary care practitioner perfonnance and on 
patient outcomes (Mitchell & Sullivan 2001). The majority o f identified studies 
focussed on immunisation or preventive tasks and demonstrated that practitioner 
performance o f these activities increased by as much as 34% (Rosser et al. 1992) 
(McDonald, Hui, & Tierney 1992) (Singh et al. 1992) (Chambers et al. 1991) and 
47% (McDonald et al. 1984) (Tierney, Hui, & McDonald 1986) (Harris et al.
1990) (Burack et al. 1996) (Garr et al. 1993) respectively when a computer was 
used. Many o f the studies on preventive activities involved the use of electronic 
reminder systems, where the gi'eatest increases occurred when the practitioner was 
prompted as part o f the consultation. However, some studies found that rates fell 
to pre-inteiwention levels (Chambers et al. 1991) or to levels similar to that o f 
control practices (McDowell, Newell, & Rosser 1990) when the reminders were 
stopped.
Studies on prescribing showed that computer use increased prescribing o f generic 
rather than proprietary drugs (Gehlbach et al. 1984), led to reductions in 
prescribing costs (Donald 1989) (Jones et al. 1996), led to time savings (Roland et 
al. 1985) and facilitated improved management tlirough decision support to 
prevent drug interactions (Davidson, Kahn, & Price 1987).
Computers have also been found to have positive effects on disease management, 
primarily tlii'ough the use o f decision support systems incorporating electronic 
protocols, algorithms, electronic alerts and reminders, although improvements 
could also result in increased consultation length. These various methods have 
led to differing levels o f improvement in standards of care for diabetes (Mazzuca 
et al. 1990) (Lobach & Hammond 1994) (Lobach 1996) (Mitchell, McConnachie,
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& Sullivan 2003), in management for patients with HIV (Safran et al. 1996), in 
compliance with management plans for childhood illnesses (Margolis et al. 1992) 
and in the management o f anticoagulation therapy (Fitzmaurice et al. 1996).
Other studies have highlighted the difficulties involved in examining computer 
use by practitioners. In one study o f decision support for lipid management, no 
real differences were demonstrated and in addition, system usage was less than 
expected (Hobbs et al. 1996). In another, the introduction o f a computer 
algoritlim for paediatrics did increase recording and compliance with management 
plans, but physicians found it ‘too tedious to use during routine care’ and the 
study was abandoned after five weeks (Margolis et al. 1992).
As part o f the review, the methodological adequacy of included studies was 
assessed using a scoring technique which had been used in two earlier reviews o f 
computerised clinical decision support systems (Johnston et al. 1994) (Hunt et al. 
1998). The majority o f studies received a relatively high overall rating (median 
6/10; inter-quartile range 4-8), due in the main to their use o f a rigorous trial 
methodology and attempts to minimise between gioup differences. However, 
more than three quarters o f these studies were open to possible bias as a result of 
the unit o f allocation used. Whilst the computer interventions studied were 
applied at the level o f practitioner, study outcomes were generally measured at a 
patient level. Indeed, more than half o f the studies randomised by patient, while a 
further quarter randomised by individual practitioner. By not allocating complete 
clusters such as practices, these studies may have created the potential for 
crossover contamination between groups, as practitioners either treated both 
intervention and control patients or acted as their own controls. In addition, they 
may have underestimated the statistical power required to demonstrate meaningful 
differences. Consequently, the tme effect o f the inteiwentions is difficult to 
detemiine.
Nonetheless, it does appear that positive effects on practitioner performance have 
been demonstrated, particularly in relation to preventive care, prescribing and 
disease management, hi their review, Hunt et al. concluded that 66% o f the 
systems studied had improved patient care (Hunt et al. 1998) and more recent 
studies have continued to demonstrate varied levels o f success. Improvements 
have been shown for cancer screening (Burack et al. 2003), provision o f
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preventive care to communities living in remote areas (Bailie et al. 2003), 
management o f diabetes (Meigs et al. 2003) (Montori et al. 2002), prescribing 
(Tamblyn et al. 2003) and prevention o f drug related morbidity (M om s et al. 
2004). Other studies, however, showed no significant improvements when 
computers were used, for example in the management o f asthma (McGowan et al. 
2001), astlnna and angina (Eccles et al. 2002) and heart disease (Tierney et al. 
2003).
A recent update o f the review by Hunt and colleagues, which incorporated a 
further 37 articles, again found that more than 60% o f the systems studied had 
improved practitioner performance (Garg et al. 2005). The authors also 
demonstrated that the methodological quality o f studies has improved over time; 
36% of trials published before the year 2000 used cluster randomisation, 
compared with 67% after 2000. In addition, they reiterated the findings o f 
previous work (Sullivan & Mitchell 1995) (Hunt et al. 1998) (Mitchell & Sullivan 
2001) by concluding that the effects o f computer use on patient outcomes remains 
understudied. Those studies which did examine patient health often had 
inadequate statistical power to detect clinically significant differences and 
consequently few have demonstrated any patient benefits.
1.4.1 Decision support in the management of hypertension
Several studies have also detennined the impact o f  the use of electronic decision 
support as a means o f improving management o f hypertension.
Electronic protocols have been shown to increase recording o f blood pressure and 
other cardiovascular risk factors. In Sheffield, England, use o f a protocol which 
prompted for entry o f data relating to new events, physical examination, including 
blood pressure, and decisions regarding care was evaluated for use during 
consultations for chionic hypertension (Brownbridge et al. 1986). Wliilst use of 
the protocol led to a statistically significant increase in the number o f physical 
examinations conducted, practitioners found it time consuming and average 
consultation length increased by a third. The researchers concluded that the 
verbal examination required to elicit relevant information from patients was too 
detailed and potentially inappropriate for use in routine consultations. In London, 
use o f an electronic protocol by health promotion nurses and GPs led to a 20%
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increase in blood pressure recording over a five year period compared with the 
control group (93% v 73%, p<0.001) and an increase o f 28% in recording for 
diagnosed hypertensive patients (97% v 69%, p<0.001) (Robson et al. 1989).
There was also a significant increase in recording o f smoking status (73% v 57%,
p<0.001).
Studies evaluating the use of electronic reminders have shown improvements in 
blood pressure recording and follow up. McDowell et al. compared the use of 
passive reminders (electronic reminder to practitioner at time o f appointment) 
with active reminders (computer generated letter and telephone list) in a trial 
involving 8,298 patients from practices in Ottawa, Canada (McDowell, Newell, & 
Rosser 1989a). They found that the computer generated letter had the greatest 
effect and increased recording by 15% more than in the control group, compared 
with 10% for the practitioner reminder and 3% for the telephone reminder 
(p<0.001). In addition, a gi’eater number o f elevated blood pressure readings were 
detected in the practitioner and letter reminder groups compared with the 
telephone and control groups. In Boston, Massachusetts, Barnett et al. (Barnett et 
al. 1983) compared automated surveillance utilising the electronic medical records 
system to generate a practitioner reminder designed to improve follow up of 
newly diagnosed hypertensive patients. At 12 months, follow up was attempted 
or achieved for 84% of patients in the experimental group compared with 25% in 
the control group (p<0.01) and 98% compared with 46% after 24 months 
(p<0.01). There was also a significant difference in the proportion o f patients 
who either had a diastolic blood pressure o f <100 mm Hg or were on treatment 
(70% v52% ,p<0.01).
Previous work has also shown benefits in providing computer generated feedback 
as a means o f improving care. In the main, this has been based on general 
practitioners completing a data collection form after each patient visit. The forms 
are then sent to a remote centre where the data are entered into a computer which 
generates feedback. In a study in Toronto, Canada, McAlister et al. found that 
although not statistically significant, mean DBF o f patients with moderate 
hypertension (DBF >104 mm Hg) in the intervention practices fell below the goal 
o f 90 mm Hg, but this was not the case in the control practices (88.5 mm Hg v
93.3 mm Hg) (McAlister et al. 1986). There was also a greater mean reduction in
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DBF in the intei-vention gi’oup (21.7 mm Hg v 16.7 m Hg, p<0.06). In addition, 
fewer o f the patients whose practitioners had been given feedback had dropped 
out of follow up treatment after tlmee months (37.5% v 42.1%, p<0.03). In a study 
in the Netherlands, van den Hoogen and colleagues found that 31% more 
hypertensive patients were under peimanent suiweillance in the intervention group 
compared with the control group (76% v 45%) (van den Hoogen & van Ree
1990). They also found that the target diastolic pressure o f 95 mm Hg was 
achieved in 14% more patients in the intervention group (70% v 56%). Dickinson 
et al. evaluated the impact o f computer generated feedback against and with a 
practitioner education progiamme (Dickinson et al. 1981). The average number 
of appointments for patients in the feedback gi oup was twice that found in the 
control group (4.2 v 2.2, p<0.05), suggesting that feedback led to gi'eater 
scheduling o f appointments. However, there was no statistically significant 
difference between the groups in relation to change in hlood pressure levels or the 
proportion o f patients controlled.
Finally, several studies have deteitnined the benefits o f computerised decision 
support for hypertension management, but have reported conflicting results, hi 
the late 1970s in Chicago, US, a computerised algorithm was used to generate 
treatment recommendations for patients attending hypertension clinics. This was 
compared with standard treatment by physicians (Coe, Norton, & Oparil 1977). 
The researchers found no significant difference between the groups in relation to 
average reductions in blood pressure (SBF 19.5 mm Hg v 18.3 mm Hg; DBF 13.4 
mm Hg V 14.5 mm Hg) or in prescribing patterns. In the Netherlands, van der Lei 
et al. compared an integi'ated decision support system to audit GF management of 
hypertension, ‘HyperCritic’, with review by a panel o f physicians (van der Lei et 
al. 1991). The reviewers agreed with 260 of 468 (56%) management comments 
that had been made by practitioners; the system agreed with 118 (25%) o f these. 
The main reasons for the discrepancy related to insufficient data in electronic 
medical records and omissions in the HyperCritic database. In Norway, an 
external computer progiamme, which was accessible fi’om the main records 
system and guided practitioners in diagnosis, history and examination, was 
compared with usual care (Hetlevik, Ho linen, & Kruger 1999). Use o f the system 
resulted in a small but significant difference in diastolic pressure in favour o f the 
inteiwention group (1 mm Hg, 95% Cl 0.17, 1.89). In addition, a significant
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difference in baseline systolic pressure which had been in favour o f the control 
group was reduced from 2.7 mm Hg to 1.2 mm Hg. More recently, Montgomery 
at al. investigated the effect o f a decision support system and risk chart, based on 
the New Zealand guidelines for hypertension management (Jackson 2000), on 
absolute cardiovascular risk for diagnosed patients in practices in Avon, England 
(Montgomery et al. 2000b). They found that patients in the decision support 
group were no more likely to have their risk reduced below 10% than patients in 
the chart only or control group (11% v 15% v 12%). Nor did they have greater 
reductions in mean blood pressure levels. The only significant difference was that 
the chart only group had a lower mean SBP when compared with the control 
group (4.6 mm Hg, p=0.02).
1.4.2 Strategic versus individual clinical decision support
Systems for decision support can either be ‘passive’, providing information on 
demand, or ‘active’, presenting recommendations for a particular course o f action 
or preventing further action unless mandatory stages in a process have already 
been completed. Both types o f system are already being used in practice. These 
include the electronic British National Formulary (BNF), which provides 
information on the clinical use of medicines, PRODIGY (Prescribing Rationally 
with Decision support In General practice studY (University o f  Newcastle 2000), 
a system designed to provide scenario based clinical knowledge about common 
conditions and symptoms seen in primary care, and electronic referral letters such 
as those used in the Scotland wide Electronic Clinical Communications 
Implementation programme (Pagliari, Gilmour, & Sullivan 2004).
However, with few exceptions, the decision support systems that have been used 
in the management o f hypertension have concentrated on the provision o f 
individual clinical decision support. That is, systems which aid decisions made 
about individual patients at the time o f their consultation. That being the case, 
they are reliant on patients attending for treatment, or at least on the GP accessing 
the patient’s record for some reason. Additionally, such systems often involve 
software programmes external to the practice records system, requiring manual 
entry o f patient data which is already held elsewhere. Thus, existing systems are 
unlikely to provide comprehensive support in situations such as the rule o f halves
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since they do not readily facilitate care for those who have not yet been identified 
or who may have been lost to follow up.
Conversely, strategic decision support is based out with the individual patient 
consultation. This approach involves using infonnation to review existing care or 
assist in the delivery o f  care at a population level rather than at an individual 
patient level. It is a method o f targeting care to those who need it most, such as 
high risk groups. It is therefore a method which requires information relating to 
all those in need o f care, not just those who are already diagnosed with a condition 
or attending for treatment. General practice computing systems were not designed 
with the clinical effectiveness agenda in mind, but rather the administration and 
collection o f data relevant to individual patient care. Hence, the information 
required to facilitate a population based approach to decision making is not 
readily accessible to the practice team, although it is likely to be stored in the 
practice system.
Query progrannnes have been developed for use in the National Health Service 
(NHS) to allow interrogation of practice databases as a means o f facilitating 
improvements in practice profiles and disease registers. The MIQUEST 
(Morbidity QUery Infonnation Export SynTax) project enables extraction of data 
from different types of computer system using a common query language (Neal, 
Heywood, & Morley 1996). The NHS Information Authority is responsible for 
the software, which is compatible with most o f the major commercial computer 
suppliers. Using local facilitators who liaise and work with practices, the system 
allows improvement of clnonic disease registration and identification o f under 
recording at a practice level and comparative analysis o f practice activity at a 
Primary Care Trust (PCT) level. In Scotland, the majority o f practices use the 
national computer system, GPASS, rather than commercial systems. The Primary 
Care Clinical Infonnatics Unit (PCCIU; formerly the GPASS Data Evaluation 
Project) at the University o f Aberdeen developed software similar to MIQUEST 
for use with GPASS. The Electronic Questionnaire (EQ) extracts data held on the 
practice system; these are then analysed to produce practice specific reports on 
disease prevalence and prescribing. The PCCIU team also initiated the 
Continuous Morbidity Recording project (CMR), in which volunteer practices
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return monthly EQ data. This project is now maintained by ISD Scotland as the 
CMR System for Scotland (www.isdscotland.org).
These interrogation progi'ammes provide an opportunity to utilise existing primary 
care data for strategic purposes. By incoi-porating additional methods, such as 
data linlcage and risk factor scores, it is possible to use these data to generate 
information which may assist practices in targeting and managing high risk 
gi'oups, such as elderly hypertensive patients.
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1.5 Feedback as an intervention
Research on interventions to enhance management o f hypertension has sho’wn that 
even when generated remotely, feedback can provide benefits related to improved 
care. This is described in more detail in section 1.4.1. Previous studies have 
demonstrated reductions in diastolic blood pressure, improved rates o f follow up, 
and reduced drop out rates (McAlister et al. 1986) (van den Hoogen & van Ree
1990) (Dickinson et al. 1981).
The provision o f feedback generated from audit is a commonly used method of 
impacting on clinical practice. It is also one which has met with varying degrees 
o f success. The most comprehensive evidence comes from systematic reviews o f 
the area.
Mugford et al. carried out a review o f 36 studies to determine the impact o f 
feedback o f infonnation on clinical practice (Mugford, Banfleld, & O'Hanlon
1991). They differentiated between ‘passive’ feedback (the unsolicited provision 
o f feedback with no stated requirement for action) and ‘active’ feedback (where 
the practitioner’s interest in a particular aspect o f  practice has been engaged).
They reported that passive feedback, such as presentations at medical conferences 
or mailed drug brochures, tended to have little effect. Conversely, active 
feedback, such as feedback o f cost infoimation or information relating to specific 
preventive care recommendations, whilst changes were small, did lead to some 
improvements. The authors’ conclusion was that feedback has the potential to 
influence practice if  it is part o f an overall strategy and targets those who have 
already agreed to review their practice.
A subsequent review by Davis et al. synthesised 99 studies on the effects of 
continuing medical education strategies on physician performance (Davis et al.
1995). The review incorporated 24 studies on audit with feedback and the authors 
found that ten o f these demonstrated a positive impact on behaviour, whilst 14 
demonstrated a negative impact. In another review published that year, these 
same authors reported that the effectiveness o f feedback across different types of 
clinical behaviour ranged from nil to moderate (Oxman et al. 1995). However, 
they also concluded that,
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“There are no ‘magic bullets 'for improving the quality o f health 
care, but there are a wide range o f interventions available that, if  
used appropriately, could lead to important improvements in 
professional practice and patient outcomes ”
Balas et al. conducted a meta-analysis combining trials that evaluated peer 
comparison feedback, which they defined as ‘physician profiling’ (Balas et al.
1996). They found that ten o f the twelve studies included showed positive effects 
related to the provision o f feedback. The results o f the meta-analysis showed a 
statistically significant, but modest, effect o f peer comparison feedback on various 
clinical procedures, including, screening, prescribing and test ordering.
In a recent update to a previous oveiwiew o f systematic reviews related to 
changing provider behaviour (Bero et al. 1998), Grimshaw et al. demonstrated 
that passive feedback, such as the distribution of guidelines, is generally 
ineffective, regardless o f the importance o f the topic (Grimshaw et al. 2001). 
Interventions involving audit and feedback alone were found to be o f variable 
effectiveness. However, they found that multifaceted interventions, such as a 
combination o f audit and feedback with reminders, were consistently effective at 
promoting changes in practice. Oxman et al. (Oxman et al. 1995) have previously 
defined a reminder as,
“any intervention that prompts the health care provider to perform a 
clinical action. Examples include concurrent or inter-visit reminders 
to professionals about desired actions such as screening or other 
preventive services... ”
Grimshaw and colleagues have recently published an additional review on the 
effectiveness and efficiency o f guideline dissemination and implementation 
strategies (Grimshaw et al. 2004). In this review, unlike many o f the previously 
published reviews, the authors have attempted to account for methodological 
wealmesses in the primary studies included, in order to provide a more accurate 
indication o f the true effects o f the various strategies designed to change provider 
behaviour. O f the 235 studies included in the review, 10 evaluated audit and 
feedback as a single intervention, whilst a further 57 studies evaluated it as part of 
a multifaceted inteiwention. Many o f these studies had unit o f analysis errors, and
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whilst Grimshaw et al. concluded that the evidence related to audit and feedback 
was less robust than the evidence for other interventions, they also stated that 
audit and feedback, whether used alone or in conjunction with other inteiwentions, 
did appear to result in modest effects. In addition, and in contrast to the findings 
o f their previous review, they concluded that multifaceted interventions were 
effective, but did not appear to be more effective than single inteiwentions, nor did 
the effects o f multifaceted interventions increase incrementally with the number 
o f components.
In 1998, Thomson et al. published the results o f a Cochrane review comparing 
audit and feedback with alternative strategies to impact on practice (Thomson et 
al. 1998). Their conclusion was that audit and feedback might be effective. 
However, they also reported that few trials had altered the way in which audit and 
feedback could be done, including the source o f the information, the recipient 
(individual or group), the fonnat or the content. This review has since been 
updated and the authors report that audit and feedback can be effective in 
improving professional practice (Jamtvedt et al. 2004). The size o f that effect 
varies gi'eatly from apparently negative effects to very large positive effects. 
However, despite the update containing 85 studies, only two o f those compared 
feedback o f differing content. Like Grimshaw et al., the authors did not find 
evidence o f a larger effect for multifaceted interventions compared with audit and 
feedback alone.
Thus, whilst previous work has demonstrated a positive impact from providing 
feedback for the management o f hypertension, evidence relating to the type o f 
feedback which has the greatest effect on practice is still relatively scarce. 
However, it would appear that providing multifaceted feedback, containing more 
than routine audit data, is likely to be o f value, although not necessarily more 
effective than audit and feedback alone. Furthermore, linking feedbaek to the 
analysis o f electronic patient data, which is not always accessible to practitioners, 
would appear to be a feasible method with which to impact on decision making 
related to identification, treatment and control o f hypertension in the elderly. 
Indeed, the authors o f a paper on the role o f electronic records in primary care 
suggest that process monitoring and ongoing perfonnance feedback, or ‘quality 
improvement’, can encourage compliance with guidelines (Elson & Connelly
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1995). Thus, the study reported in this thesis sought to apply such a method to 
compare two different types o f feedback, one containing audit data only, the other 
containing audit data plus strategic data on individual patient risk.
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1.6 Aims of the research
The review in this chapter has demonstrated that hypertension in all age groups is 
a major risk factor for cardiovascular disease, and for stroke in particular (Kaimel 
et al. 1970) (MacMahon et al. 1990). As systolic and diastolic pressure increase 
with age, so too does the prevalence of these disorders (Kannel et al. 1981). 
Research has shown that treatment o f hypertension produces significant 
reductions in risk (SHEP Cooperative Research Group 1991) (MRC Working 
Party 1992) and the absolute reductions provided by treatment are gi'eater in 
elderly patients (Dahlof et al. 1991). As a consequence, the numbers of elderly 
hypertensive patients who need to be treated for one year in order to prevent a 
cardiovasculai' event is considerably lower than for the younger age group 
(Mulrow et al. 1994).
The literature suggests that half o f the hypertensive population are not Imown, 
half o f those Imown are not treated and half o f those treated are not controlled 
(Wilber & Baii'ow 1972), a situation known as the rule o f halves. Despite the 
benefits that can be achieved through treating older patients at lower levels of 
blood pressure, the rule o f halves also applies to this group.
The last two decades have seen a major increase in primary eare computerisation 
in the UK (Department o f Health 1993) (Department o f Health 1998). Yet despite 
this, computers are still primarily used for routine functions such as preventive 
tasks and prescribing (Mitchell & Sullivan 2001). Various members o f the 
primary care team use desktop computers to access and enter data during 
consultations and this has provided practices with a large central database of 
patient information. I f  general practices are to address the rale o f halves for 
elderly hypertensive patients, or indeed, other long tenu health problems, one of 
the most effective policies is likely to be tlirough the adoption o f a strategic 
approach to decision making. In this way effort and resources can be targeted at 
high risk gi'oups, who are most likely to benefit from treatment and control. This 
requires information on all patients at high risk, not just those already diagnosed 
or attending the surgery. It includes those lost to the system who may require 
screening, assessment, intervention or follow up. Whilst the data needed to allow
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this are generally held in general practice computer systems, they are not readily 
available.
Practitioners can access the information required to inform the management of 
individual patients attending for treatment. However, extracting richer data, such 
as that required for strategic decision making, is complex and time consuming. 
Consequently, much o f the information which should be available to the practice 
remains ‘hidden’ in the computer.
The research described in this thesis sought to address these issues in the context 
of the need to improve identification, treatment and control o f hypertension in the 
elderly and the availability but inaccessibility o f the electronic patient data which 
would facilitate this.
The aim o f the study described was therefore,
To evaluate, by means o f a randomised controlled trial, whether it was 
possible to improve identification, treatment and control o f  elderly 
hypertensive patients by providing practices with feedback developed from  
electronic patient data.
In this study, two different levels o f feedback were used as a means of 
determining whether a multifaceted intervention providing information at a 
strategic level had any greater impact than more traditional audit and feedback.
Chapter 2 provides a synopsis o f the methods used to carry out this study.
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2.1 Introduction
The purpose of this study was to determine whether feedback had any impact on 
identification, treatment and control o f elderly hypertensive patients. The 
intervention was delivered at a practice level, since practitioners detect and 
provide ongoing care for patients with hypertension. Analysis was conducted at a 
patient level, since that is the best means o f deteiTnining whether the treatment 
provided impacts on control o f blood pressure. This study involved conducting a 
cluster randomised controlled trial.
Practice feedback was developed from data contained in electronic patient records 
and two intervention groups provided with different levels o f feedback were 
compared to a control gioup. Questionnaires suiweys were used to determine the 
organisational structure and levels o f computerisation available in participating 
practices. A casenote review was conducted as a means o f validating the data 
extracted from electronic patient records.
The following chapter details the rationale for the study design, outlines the 
process o f practice recmitment and randomisation and describes the methods used 
in each aspect o f the study. The chapter also outlines the procedures developed 
for collection and processing o f electronic data and the statistical measures 
employed in analysis.
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2.2 Use of cluster randomisation
The intervention used in this study was the provision o f feedback based on data 
extracted from the electronic records o f elderly patients with hypertension. Whilst 
it would have been possible to randomise individual practitioners to receive 
feedback, or to have provided feedback for only a random sample o f hypertensive 
patients within a practice, it was considered that this would result in a flawed 
methodology for three main reasons.
Firstly, patients with hypertension may consult with and be managed by more 
than one GP in their practice. As such, it would be extremely difficult to 
determine whether any changes in blood pressure control were due to the actions 
o f the practitioner receiving feedback or to interventions made by other members 
o f the practice team. Asking individual patients to consult with a single GP and 
asking GPs to consult with only particular patients for the duration of the study 
would not have been feasible, nor is it likely to have been acceptable to practices. 
Secondly, whilst individual GPs would be provided with feedback, it would be 
difficult, if  not impossible, to ensure that they did not discuss that feedback, 
management decisions or the study in general with their colleagues who were not 
receiving feedback. This might raise awareness o f hypertension control within the 
practice as a whole, and create a situation whereby those not randomised to 
receive feedback might also be influenced to improve management. As a 
consequence, it would be difficult to inteipret the results o f the study, since there 
might be similar changes for patients in both the intervention and control groups. 
Finally, if  feedback was based only on particular patients within a practice, it 
would be extremely difficult, and indeed unlikely, for professionals receiving the 
feedback not to apply Imowledge gained through this to the management o f all of 
their patients, not just those on whom feedback was based. Intervention and 
control patients might therefore be subject to the same treatment and as such, 
results might be similar for both. Thus, in order to avoid the potential 
contamination which might arise from randomising by individual, the unit of 
allocation used in this study was the practice.
Randomising by practice is a foiin of cluster randomisation, that is, where clusters 
or groups rather than individuals are randomised. In individually randomised
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trials, it can be assumed that outcomes for the individual are independent of 
outcomes for other participants. However, when using cluster randomisation, it is 
no longer possible to make that assumption. Patients in the same practice may be 
more similar to each other than to patients from other practices, either because o f 
sociodemographic differences, or because they are exposed to the same health 
care providers, practice culture, or methods o f implementing care etc. As such, 
patients in the same practice may respond in similar ways, and may have similar 
outcomes. Thus, it camiot be taken for granted that the outcome for each patient 
is independent o f that for any other patient. This had two major implications for 
the design and analysis o f the study. Firstly, this lack o f independence, or 
clustering, reduces the statistical power o f the study compared with trials which 
randomise individuals. Therefore, standard sample size estimates had to be 
inflated to account for the cluster design. This is described in more detail in 
section 2.4.6. Secondly, whilst randomisation was by practice, analysis was 
conducted at a patient level and it was therefore necessary to account for the 
clustered nature o f the data when analysing the main study outcomes. Failure to 
do so would have increased the likelihood o f generating falsely significant 
findings. The additional statistical teclmiques applied are described in section 
2.11.3.
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2.3 Ethical considerations
This project was designed as a Scotland wide study covering the twelve mainland 
health board areas. As such, ethical approval had to be obtained from the Multi- 
Centre Research Ethics Committee (MREC) for Scotland before any o f the Local 
Research Ethics Committees (LRECs) could be approached. An application was 
submitted to MREC in April 1998 and approval gi anted at the end o f July 1998. 
Applications were then made to the twelve LRECs. All were successful and 
approval was received from the last o f these in November 1998.
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2.4 Sampling strategy
2.4.1 Sampling frame
The GPASS electronic record keeping system was designed in the early 1980s, by 
a general practitioner in Glasgow, as a repeat prescribing system. The Scottish 
Executive Health Department financially supported its subsequent development 
and it has been offered free to any practice with compatible hardware since 1984. 
Scotland is unique within British general practice in that more than 80% of 
practices use this national computer system (personal correspondence, GPASS).
The target population consisted of all general practices using the GPASS record 
system which were located in the twelve mainland health board areas namely, 
Argyll and Clyde, Ayi'shire and Airan, Borders, Dumfries and Galloway, Fife, 
Forth Valley, Grampian, Greater Glasgow, Highland, Lanarkshire, Lothian and 
Tayside. At the time o f study, a total o f 744 GPASS practices were situated in 
these areas (Table 2.1).
2.4.2 Sampling criteria
This study was designed to evaluate the impact o f providing practices with 
decision support, in the form of electronically derived feedback, on identification 
and management o f elderly hypertensive patients. The way in which a practice 
will respond to such infonnation and indeed the fonnat o f the feedback itself may 
be influenced by various factors. It was therefore necessary to account for the 
most important o f these when recmiting practices.
Level o f practice computerisation may deteinaine the sorts o f data collected 
electronically and therefore influence the infonnation that can be derived from 
those data as well as the application o f that information. Likewise, the health 
board area in which a practice is located may influence practice policy on 
utilisation of information and the activities conducted by the primary care team. 
However, it was considered that one o f the most important determinants o f 
practice response relates to personnel, in terms o f the availability o f members of 
the primary care team to respond to feedback.
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Although there are routine data available on reimbursements made to practices for 
employing staff based on the practice profile, it is not possible to determine how 
these monies are actually allocated by a practice. Consequently, it is not possible 
to ascertain whether a practice nurse, practice manager, receptionist or other 
member o f the primary care team is available to a practice without asking the 
practice directly. Therefore, the decision was made to use practice size, 
represented by number o f partners, as the first stratification variable.
A further significant factor in detennining response to strategic feedback is that of 
existing patient need. Previous research illustrates that socioeconomic deprivation 
has a significant impact on patient morbidity and mortality (Black 1980)
(Acheson 1998) (Shaw et al. 1999). Thus, the health caie needs of a patient 
population and the ability of a practice to meet those needs will vary according to 
sociodemographic characteristics. Without direct access to person specific data, it 
is not possible to accurately deteraiine an individual’s social or medical 
circumstances, nor is it possible to infer levels o f practice workload based on 
patient need. Various deprivation indices exist, which aim to classify 
socioeconomic status either on the basis on single markers, such as employment 
status, or on an aggregate score based on multiple indicators. However, the 
majority of these indices attempt to categorise levels o f disadvantage or otherwise 
for individuals living in geographical areas. Although these markers provide an 
accurate description o f socioeconomic circumstances across a postal sector, they 
may not accurately represent each individual within that area. Nor will they 
accurately describe the needs o f those individuals in relation to health care or its 
provision.
The Jarman Undeiprivileged Area index is a multivariate census based measure, 
designed to account for geographic variations in the demand for primary care 
services. It is used as an indicator o f general practice workload. The index was 
derived from a questiomiaire suiwey in which one in ten o f all Britain’s GPs were 
asked to rate the service and sociodemographic factors affecting their workload 
most. Seiwice factors were omitted from the final score as they were thought to be 
sensitive to changes in local and national policy and NHS management. Other 
variables, including the proportion o f over 65s and transport difficulties in visiting 
patients were also excluded, since they were incorporated in the existing GP
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remuneration scheme. The UPAS score is the most commonly used variant o f the 
index and it comprises unemployment, overcrowding, lone parents, children under 
5, elderly living alone, ethnicity, low social class and mobility (Jarman 1983).
This measure, like most deprivation indices, has evoked criticism, primarily 
because the inclusion o f overcrowding and etlinicity under represents rural 
deprivation. Nevertheless, it is used by the Department o f Health as the marker 
against which to provide additional payments to general practitioners for the 
provision o f services to patients from deprived areas. In England the index was 
originally calculated at ward level, while Scotland used Enumeration Districts. 
Here the low social class variable was omitted, as the data were not considered 
robust enough to be included. Levels o f payment derived from this Scottish 
formula were used as the second stratification variable.
2.4.3 Identification of practices
Lists o f practices using the GPASS system were obtained from the Primary Care 
Directorates o f the twelve mainland Scottish health boards between June and 
September 1998. The lists contained demographic details o f each practice, 
including practice size.
Data relating to practice deprivation payments were obtained from ISD Scotland 
in October 1998. At the time o f study, there were tlu*ee levels o f payment, 
calculated at ward level, representing marginal deprivation, medium deprivation 
and high deprivation. The data obtained included the proportion of patients from 
each practice in each o f these payment bands. Data were based on payments 
made to practices as at 1 April 1998.
2.4.4 Stratification of practices
All 744 general practices in the sampling fr ame were stratified according to size 
and deprivation payment level. Number o f partners was derived from the health 
board lists and practices were categorised as belonging to one o f tlrree gi'oups; 1 to 
2 pailners, 3 to 4 partners or 5 or more partners. A single level o f deprivation 
payment was obtained by combining the proportions o f patients in each o f the 
tlrree payment bands [marginal, medium, high] to give an overall figure for each 
practice (Table 2.2).
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2.4.5 Data linkage
The two sets o f data, practice details and deprivation payments, were manually 
entered into separate tables in a Microsoft Access database and were linked using 
practice code, a numeric identifier unique to each practice. The majority o f health 
board lists did not contain these identifiers and health boards had to be re­
contacted and the codes obtained before the two datasets could be linked.
The dataset contained several marginal practices, that is, practices which bordered 
two health board areas and as such, were included on the practice list for each 
board. However, these practices were only noted as being a GPASS user under 
one health board area and were therefore included in the sampling frame for that 
board only.
Deprivation payments were based on numbers o f patients in each practice as at 1 
April 1998. Difficulties arose over practices which had either formed, converged 
or split after this date. Such practices had been allocated new practice codes by 
the health boards and these did not conespond to the codes held by ISD. It was 
therefore not possible to identify deprivation data for these practices. Five 
practices were excluded from the sampling frame for this reason.
A small number o f Scottish practices have no registered patients and therefore no 
data on deprivation payments. These are restricted GPs who are, for example, 
attached to a hospice or a practice for the homeless and confined to treating 
members o f that ‘institution’. One practice was excluded from the sampling 
fi'ame for this reason.
After these exclusions, the remaining eligible practices (n=738) were divided into 
nine strata according to size [1-2 GPs; 3 -4  GPs; >5 GPs] and deprivation 
payment level. As a means o f verifying practice size, numbers o f partners 
provided on the GPASS lists were compared with the numbers given on the full 
health board lists. In one health board, there was disagreement between the 
figures for eight practices. The health board was contacted for clarification, and 
as a result tlu'ee practices had to be moved to a different recruitment stratum. 
Discontinuous deprivation categories were used to avoid overlap between the 
payment strata and accentuate inter-practice differences. Practices with
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deprivation payment levels o f between 1 to 4% (n=120) and 16 to 19% (n=33) 
were therefore excluded (Table 2.3). The 585 remaining practices were 
categorised as having low deprivation [received payment for 0% of patients], 
medium deprivation [payment for 5 to 15% of patients] or high deprivation 
[payment for 20% o f patients or more].
2.4.6 Sample size
Since randomisation was by practice rather than by patient, possible variations in 
patient outcomes between and within practices were accounted for by the 
inclusion o f an inflationary factor in the sample size calculation based on the 
intra-cluster correlation (ICC). The sample size was calculated to detect a 15% 
improvement in the number o f controlled elderly hypertensives from 30% to 45%. 
If individual patients were randomised, a sample size o f 324 patients would have 
80% power to detect this change at a 5% significance level. Fahey and Peters 
(Fahey & Peters 1996) found an ICC for the proportion o f controlled 
hypertensives in UK practices to be o f the order o f 0.06. The calculation for this 
study assumed a worse case intra-practice correlation of 0.1. This suggested that 
we required data on 40 patients from each o f 60 practices.
The numbers o f eligible GPASS practices in each o f the nine sampling strata were 
detemiined. Then, the number o f study practices required from each stratum was 
calculated to reflect the coiresponding proportion o f the total number of eligible 
practices (Table 2.4).
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2.5 Practice recruitment
Practices were randomly selected from each stratum. The first batch of 
recruitment letters was sent in February 1999 and the last in September 1999. In 
total, 179 practices were contacted and after eight iterations o f the recruitment 
process, 54 agreed to participate. These are located in eleven o f the twelve 
mainland health boards and cover a range o f practice sizes [1 to 11 GPs], list sizes 
[744 to 17647] and deprivation payment levels [0 to 54%] (Figure 2a).
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2.6 Practice randomisation
2.6.1 Statistical method
Randomisation to study ami was carried out by an independent statistician using a 
list o f sixty random numbers generated by the S-Plus statistical programme 
(version 4.5). Block randomisation was used, with five sets each containing 12 
allocations. Each set o f allocations consisted o f four allocations to each o f the 
three study arms. These were ordered independently o f each other. The sets were 
then combined to make a full sequence, so that after every 12 allocations, 
distribution was balanced between study groups.
2.6.2 Study groups
Recruited practices were randomised to tlrree groups as follows:
Control group [n=19] -  which received no feedback on performance during the 
period under study. Practices allocated to this group, like those in the intei*vention 
groups, had access to existing guidelines, as well as to those published during the 
study period, such as the Scottish hitercollegiate Guideline Network (SIGN) 
guideline for hypertension in the elderly (Scottish Intercollegiate Guideline 
Network 2001).
Audit group [n=17] -  which received mle of halves feedback on numbers o f 
registered patients aged 65-79 who may require a) screening i.e. have no blood 
pressure measurement recorded b) assessment i.e. have no diagnosis o f 
hypertension but a blood pressure >160 / >90 or c) treatment i.e. have a diagnosis 
o f hypertension, with a blood pressure >160 / >90.
Strategic group [n=18] -  which received the rule o f halves feedback plus a list 
prioritising those patients most at risk o f death from stroke in the next ten years.
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2.7 Development of a risk formula
Absolute risk o f death from stroke was derived by an equation developed using 
data from the Midspan study (Hawthorne et al. 1995). Unlike other risk 
predictors, this formula does not include cholesterol, since it was not thought 
likely that cholesterol levels would be recorded for every patient, nor was it 
possible to collect cholesterol readings electronically. The equation allocates a 
score based on the patient’s age, systolic blood pressure, antihypeilensive drug 
treatment, smoking status, stroke history and diabetes status. A detailed 
description o f the equation and its development is provided in chapter 5.
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2.8 Electronic data collection
Electronic data were collected from practice computer systems using the 
Electronic Questiomiaire (EQ), a data extraction tool that pulls out demographic, 
morbidity and prescribing data, developed by the Primary Care Clinical 
Informatics Unit at Aberdeen University. At the outset o f the study, it was 
anticipated that data would be extracted from practice systems on a quarterly basis 
for a period of 24 months, with feedback being returned to practices within four 
weeks o f the download. However, the full process o f distributing the EQ to 
practices, attempting to ensure complete returns, processing data and analysing 
and formatting it for feedback took months rather than the anticipated weeks. As 
a result only tlu ee batches o f data were extracted during the study (Figure 2b). 
Issues related to data extraction and processing are discussed later (chapters 3 and 
4).
Raw GPASS data, extracted by practice managers, were sent to PCCIU and 
returned to me as a Microsoft Access database consisting o f nine different tables; 
‘Practice List’, ‘Clinicians’, ‘Encounters’, ‘Generates’, ‘Patients’,
‘M easurements’, ‘Clinical Events’, ‘Prescriptions’ and ‘Referrals’. Five o f the 
tables were not utilised in the data analysis process. ‘Practice list’ and 
‘Generates’ contain administrative data relating to data extraction. ‘Clinicians’ 
and ‘Encounters’ contain data relating to system identifiers for individual GPs and 
consultations. ‘R etenais’ contains data relating to refenal specialty and location, 
but were not required for this study. The remaining tables, containing information 
relating to patient registration status and demographics, process measures o f care, 
symptoms and diagnoses and prescribing were then utilised to produce practice 
feedback.
In each table, each patient is distinguished by a unique numeric identifier (ID), a 
combination of practice ID and an individual GPASS patient ID that remains 
constant to that patient. In a process lasting five months, a complex succession of 
more than 30 queries was developed to automate the process o f linking each item 
o f individual patient data using this identifier, thereby allowing more rapid 
generation o f relevant information. Once the appropriate items o f individual 
patient data were collated, the risk formula was applied, giving each patient a
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score for ten year stroke mortality. Data output was transferred to a Feedback 
Report Template held in Microsoft Word and the relevant feedback was returned 
to practices.
Practices were recruited to the study over a 10 month period, between February 
and November 1999. Fifty two practices had been reciaiited by September 1999; 
one was recruited in October 1999 and one in November 1999. Distribution of 
the first Electronic Questiomiaire (Baseline) began in October 1999 and data were 
returned by practices over the next five months, from October 1999 to February 
2000 (Figure 2b). Following batch processing and analysis o f  data, the first 
feedback report was sent to practices at the end o f June 2000, four months after 
data collection.
The second Electronic Questiomiaire (Year 1) was sent to practices in September 
2000, approximately one year after the baseline EQ and tluee months after the 
first feedback report. Data were returned by practices over the next six months, 
from September 2000 to February 2001 (Figure 2b). Feedback was sent to 
practices in September 2001, seven months after data collection.
The third and final Electronic Questionnaire (Year 2) was sent to practices in 
December 2001, again, approximately one year after the previous EQ and three 
months after feedback. Data were returned by practices over the next five months, 
from December 2001 to April 2002 (Figure 2b). Feedback was sent to practices 
in November 2002, seven months after data collection. No further extraction of 
electronic data took place.
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2.9 Feedback intervention
The intervention in both the Audit and Strategic groups was the provision o f a 
feedback report. Practices in both gi'oups received audit feedback, which was 
essentially a rule o f halves report, on all patients aged 65-79 and on patients aged 
65-79 with diagnosed hypertension. This contained the numbers o f patients with 
blood pressure recorded, with no blood pressure recorded, with normal blood 
pressure, with high blood pressure, receiving or not receiving antihypertensive 
drug treatment and with the additional risk factors o f smoking, diabetes or 
previous stroke (Appendix I). In addition, the feedback included average results 
for each o f these categories for all practices in the relevant group. It did not 
contain data at an individual patient level. Patients were regarded as having a 
recorded blood pressure if  a measurement o f systolic and diastolic blood pressure 
was recorded in their electronic record. The threshold for high blood pressure was 
taken as >160 / >90 mm Hg, as indicated for treatment by the then cuirent British 
Hypertension Society guideline (Sever et al. 1993). At the study outset, the 
versions o f GPASS in use by participating practices did not record multiple blood 
pressure readings and each new entry replaced the previous entry in a patient’s 
record. Feedback was therefore based on the most recent blood pressure reading 
only. No time limit was applied. The presence of one or more hypertension 
related Read codes in a patient’s electronic record was taken as denoting a 
diagnosis o f hypertension. Further information on Read codes is provided in 
chapter 4.
In addition, practices in the Strategic group received a patient specific colour 
coded list ranlcing individual patients according to their level o f absolute risk of 
death from stroke; red denoted a stroke risk of greater than 25%, orange 20-25%, 
yellow 15-20% and green 10-15% (Appendix 2). This contained date of last 
blood pressure, systolic and diastolic reading, record o f diagnosis, treatment and 
diabetes status and stroke history. Patients without a blood pressure record were 
excluded from this list. Patients without a record o f smoking status were given 
two absolute risk scores; one based on being a smoker, the other on being a non- 
smoker. Each practice also received a computer disk containing a re- 
identification programme to linlc Patient ID as shown on the feedback report with 
the relevant patient contact details. In order to avoid overloading practices,
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feedback was provided only for patients most at risk, that is, those with a 10% or 
higher chance o f death from stroke in the next 10 years. Practices were told that 
they could have information on all patients if  desired.
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2.10 Questionnaire surveys
2.10.1 Practice organisation and structure
The availability o f resources that would allow practices to respond to the 
feedback, such as surgery hours, consultation length, staff availability, clinics held 
and recall procedures was detennined using a Practice Stmcture Questionnaire 
(Appendix 3). This questionnaire was sent to the liaison person in the practice, 
usually the practice manager, at the study outset and then bi-annually for a period 
o f 24 months. The questiomiaire was based on a similar questiomiaire developed 
by the author for use in a previous study (Mitchell, McConnachie, & Sullivan 
2003). This was then piloted with colleagues in General Practice and Primary 
Care, University o f Glasgow and refined before use.
2.10.2 Practice computerisation
Infonnation relating to levels o f computerisation and extent o f computer use in 
participating practices was collected using a questiomiaire (Appendix 4). This 
incorporated questions to detemiine, among other things, the availability of 
computers in the consulting room, to members o f the practice team, 
responsibilities in terms o f data entry, use o f computer systems and types o f data 
collected. This questionnaire was sent to the liaison person in the practice, mid­
way through the study. A draft questionnaire was developed based on the 
questionnaire used in the Department o f Health’s original smwey o f computing in 
primary care (Department o f Health 1993). This was piloted with colleagues and 
a subsequent nominal group style meeting was held in General Practice and 
Primary Care, University o f Glasgow, to further refine the tool.
2.10.3 Casenote review
To assess the accuracy and validity of the electronic data, the written records of a 
random sample of patients in a subset o f practices were examined retrospectively. 
The review covered a 12 month period prior to the practice’s most recent data 
extraction. Data were collected to allow comparison with those data collected 
electronically and used to detennine the patient’s risk and also to provide
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information relating to the patient’s utilisation o f health services. Data therefore 
included age, sex, visits to primary and secondary care, blood pressure readings, 
hypertensive status, treatment and co-morbid conditions (Appendix 5). It was 
anticipated that 40 patients from each practice would be recmited and over 
sampling was used to account for refusals, non responders and attrition. Patients 
were sampled by level o f risk; those 40 patients at highest risk o f stroke mortality 
along with 40 randomly allocated from the remainder. In practices with less than 
80 at risk patients, all patients were contacted.
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2.11 Statistical considerations
The main purpose o f the analyses o f data extracted from the GP clinical record 
keeping systems and the questiomiaire phases o f this study was to compare 
identification, treatment and management o f elderly patients with hypertension in 
the tlu'ee study gi'oups -  Control, Audit and Strategic -  accounting for practice 
characteristics. Data were analysed using SPSS v9.0 and SAS v8.2 and the 
following statistical methods were used in analysis o f the data.
2.11.1 Chi-squared test
The chi-squared test is used to analyse categorical data. It compares proportions 
relating to different unmatched groups o f subjects, for example, the proportions of 
patients aged 65-79 whose blood pressure is controlled. The simplest test 
compares the proportions o f subjects falling into two descriptive categories, for 
example yes/no; however, the test can also be used on variables which have more 
than two categories. Data are arranged in a contingency table and the actual 
frequencies obseiwed are compared with the frequencies expected, namely, the 
proportion o f the total sample that would be expected to fall into each of the 
categories if  the null hypothesis were true and there were no differences between 
the groups. The larger the gap between the observed and expected frequencies, 
the less likely it is that the null hypothesis is true.
2.11.2 Analysis of variance
Analysis of variance (ANOVA) is used to compare the means o f three or more 
independent gr oups. It detennines whether observed values might belong to the 
same population regardless o f the groups, or whether the obseiwations in at least 
one o f the groups seems to come from a different population, hr order to do this, 
the variability o f values within the gr'oups is compared with the variability of 
values between the gi'oups. If  there is a real difference in population means, that 
is, the null hypothesis is false, the between group estimate o f variance is much 
larger than the variance within the groups.
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2.11.3 Adjusting for the effects of clustering
The unit of randomisation in this study was the practice, not individual patients.
As such, patients in one practice, or cluster, may be more similar to each other 
than to patients from other practices and respond in similar ways, since they are 
exposed to the same health care providers, practice culture, locality etc. As such, 
it cannot be taken for gi'anted that they act independently. Analyses were 
therefore conducted to account for intra practice clustering (Donner 1998).
Due to the complexity o f this type o f analysis, a programme for SAS was written 
and the data analysed by Dr Peter Donnan, Senior Lecturer in Medical Statistics, 
Tayside Centre for General Practice. This teclmique was used for the main study 
outcomes, namely a) final systolic blood pressure adjusting for initial reading and 
b) final level o f blood pressure control (yes / no) adjusting for initial level. Final 
SBP was analysed using a mixed model with the study arm treated as a fixed 
effect and practice as a random effect. The practice level factors of training 
status, practice nurse, hypertension register and recall system were adjusted for. 
The patient level factors adjusted for were initial systolic blood pressure, sex, 
smoking status (current, non, ex and unknown) and Carstairs deprivation category 
(1-7) (Carstairs & Morris 1988). Final control of hypertension was analysed in a 
logistic model using the Generalized Estimating Equation (GEE) approach. The 
practice and patient level factors outlined above were entered into the model along 
with a binary indicator of initial hypertension control.
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2.12 Summary
Application o f the methods used in this study facilitated the collection o f data to 
allow comparison o f identification, treatment and control o f elderly hypertensives 
in the Control, Audit and Strategic groups. Subsequent chapters present more 
detail relating to development issues (chapter 3) and to the methods used to 
handle the vast amounts o f electronic patient data returned by participating 
practices (chapter 4). The method used to predict patient risk is also described 
more fully (chapter 5).
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Table 2.1 -  Sampling frame: GPASS practices by health board area
HEALTH BOARD TOTAL PRACTICES GPASS HB COVERAGE %
Ayrshire & Arran 62 52 83.9
Argyll & Clyde 103 91 88.3
Borders 23 23 100.0
Dumfries & Galloway * 36 27 75.0
Fife 66 32 48.5
Forth Valley 56 50 89.3
Grampian 97 33 34.0
Greater Glasgow 220 183 83.2
Highland 79 46 58.2
Lanarkshire 97 63 64.9
Lothian 126 98 77.8
Tayside 92 46 50.0
TOTALS 1057 744
71
Table 2.2 -  Proportion of eligible GPASS practices by size and total
deprivation payment
TOTAL DEPRIVATION 1-2 GPs 3-4 GPs > 5  GPs
PAYMENT (%) (n=257) (%) (n=268) (%) (n=213) (%)
0 (none) 68 (26.5) 43 (16.0) 24(11.3)
1 - 5 33(12.8) 49 (18.3) 68 (31.9)
6 - 1 0 43(16.7) 52(19.4) 51 (23.9)
11 -  15 20 (7.8) 45 (16.8) 31 (14.6)
1 6 -2 0 11 (4.3) 19(7.1) 13(6.1)
21 - 2 5 18(7.0) 18(6.7) 11 (5.2)
2 6 -3 0 16(6.2) 7 (2.6) 5 (2.3)
31 - 3 5 4(1.6) 7 (2.6) 4(1.9)
3 6 -4 0 17(6.6) 15(5.6) 4(1.9)
41 - 4 5 15(5.8) 7 (2.6) —
4 6 - 5 0 4(1.6) 2 (0.7) —
>50 8 (3.2) 4(1.4) 2(1.0)
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Table 2.3 -  GRASS practices excluded from sampling frame by
deprivation payment
DEPRIVATION NUMBER OF
PAYMENT PRACTICES
1% 42
2% 25
3% 30
4% 23
Percentage of all G PASS 16.3%
16% 13
17% 6
18% 6
19% 8
Percentage of all G PASS 4.5%
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3.1 Introduction
This study centred on the extraction o f electronic patient data from the computer 
systems o f participating general practices. As such, much o f the study related to 
development work, dealing with the initial difficulties involved in establishing a 
new method o f providing practices with feedback. Wliilst the nature and 
complexity o f the study meant that many of these problems were to be expected, 
others were unforeseen. This chapter details the difficulties that were encountered 
during the development process, both at a practice and a project level, and 
describes the approaches used to overcome these.
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3.2 The GPASS computer system
In 1989, when SEHD undertook its first review o f GPASS and subsequently 
assumed direct responsibility for its development and maintenance, almost 400 of 
the 1100 general practices in Scotland at that time were already using this single 
terminal, office based system. The number o f users rose rapidly after the 
introduction o f the 1990 Contract and continued to rise during the early 1990s. At 
the same time, the system progressed to include a multi terminal, consultation 
based version and by 1994 the system was being used by over 800 practices. 
GPASS maintained its position as the most widely used general practice computer 
system in Scotland and when this study began in 1998, 80% were users (Figure 
3a).
The system was originally only available as a single-user system on the DOS 
(Disk Operating System) platform and then also as a multi-user system on the 
UNIX operating platform (‘Old’ GPASS). However, GP users were o f the view 
that developments in the system lagged behind those available in other 
commercially available systems, in particular the lack o f a graphical interface. 
After SEHD commissioned an independent review o f GPASS, the decision was 
made to transfer the system to Windows™ (‘N ew ’ GPASS). This process began 
in 1995 and between 1997 and 1999, when the transfer to the new teclmical 
platform was completed, and when this study was undertaken, four major versions 
o f New GPASS were released.
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3.3 Patient identification
In the early 1970s, Tayside health board developed a system o f unique numeric 
identifiers for each patient in the health board area, known as the Master Patient 
Index System. By the end of the decade it had also been taken up by Argyll and 
Clyde health board and became laiown as the Community Health Index (CHI).
The system was subsequently implemented across Scotland and since the early 
1990s every patient registered with a GP has been issued with a CHI number. The 
CHI is a ten digit identifier comprising the six digits o f the patient’s date o f birth, 
a further two digits denoting sex and an additional two digits allocated at random. 
It is widely available in electronic general practice records as a patient identifier, 
but since it contains data enabling identification o f the patient, it does not meet the 
requirements o f the Data Protection Act, which states that consent is required for 
the use o f any identifiable data relating to a person’s physical or mental health ( 
1998). That being the case, it was not possible to extract CHI numbers for this 
project.
Instead, the only identifier extracted from electronic records to denote each 
individual patient was a unique GPASS number. Consequently, this was the only 
identifier that could be used for practice feedback. The study was based on the 
premise that practices in the Strategic gioup would be able to identify and target 
those patients listed in the at risk feedback report. In addition, patients from all 
tlii'ee gioups had to be identified for recruitment to casenote review. At the outset 
o f the study, we were aware o f the need for anonymity in data extraction. 
However, it later emerged that the ID number allocated to each patient was a 
system number only and as such, was not available to practices as a searchable 
field. Practices therefore had no means o f identifying relevant patients.
The problem was discussed with PCCIU, who agreed to develop an additional 
software programme to enable re-identification. When mn, this programme 
extracted relevant patient contact details from the GPASS system and linked 
these, in a separate report, to the identifier and if  relevant, to the patient’s risk 
score. Before it could be implemented for the study, the programme was site 
tested in two practices to ensure that it operated correctly with both Old and New 
GPASS. The process, from discussion o f requirements until availability of the
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software, lasted nine months. This delay lengthened the inteiwal between 
practices submitting data and receiving initial feedback. In addition, rumiing this 
programme was the only way that practices could identify patients. It was an 
extra, unanticipated task, which practices had not agreed to when they consented 
to take part in the study, and it may have had a detrimental effect both on rates of 
electronic data return and on utilisation o f feedback.
Even after the software had been developed, there was a subsequent problem 
related specifically to practices operating Old GPASS. The re-identification 
programme could not extract addresses from the DOS or UNIX system. Although 
patients’ names and dates o f birth were pulled out, practices had to manually 
append addresses to the report. Again, this created additional workload for 
practices and resulted in direct consequences for recruitment o f patients to the 
casenote review.
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3.4 System changes
The migration o f GPASS to Windows™, which was still ongoing when the study 
began, occurred in stages, with each succeeding generation o f the software 
incorporating further developments. In addition, individual general practices 
develop and respond to innovations at different rates. These factors combined 
meant that versions o f  both Old and New GPASS were in use among participating 
practices at the outset o f the study. As such, the variation existed not only in the 
system itself, but also in the way in which it was employed in practice, since some 
participants were still using single-user office based versions.
Prior to the initial EQ disks being distributed to practices in October 1999, 29 of 
the 52 participating practices were using Old GPASS, four were running the 
software on DOS and 25 on UNIX. The remainder were using one of the four 
releases of New GPASS available at that time. Practices upgraded their systems 
at various stages tliroughout the study and by the end all were using some version 
o f New GPASS. However, the cycle of practice upgrades resulted in various 
challenges for the project.
3.4.1 Software incompatibility
The simplest, most easily remedied problem related to practices which upgraded 
from Old to New GPASS during the study period. The EQ software required to 
extract data from the DOS and UNIX versions o f the system was different to that 
required for Windows'™ based versions. Consequently, any practice which had 
upgraded between data extractions had to be re-sent the correct software. This 
extended the extraction period and generally meant additional work for practices.
3.4.2 Unique identifiers
Several practices upgraded to a newer version of GPASS in the period between 
extracting initial data from their system and being sent their re-identification disk. 
It was noted at that time, that the ID numbers as shown on the feedback report did 
not tally with those generated by the re-identification programme. It then 
emerged that for those practices which had upgraded fi'om Old to New GPASS,
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part o f the upgrade process involved removing the unique identifiers o f all 
patients in the system and sequentially re-allocating these in order to eradicate 
unused identifiers, i.e. numbers left behind when people were deleted from the 
practice list. Thus, initial and succeeding identifiers did not match, making data 
linkage for patients in these practices extremely difficult (chapter 4). This 
problem affected eighteen practices in all. It meant that eight practices in the 
Strategic group could not accurately re-identify those patients detailed in their 
first feedback report. In addition, patients in the remaining ten practices who had 
been randomised for participation in casenote review were not the patients for 
whom contact details were extracted (see section 3.5).
3.4.3 GPASS Release 4
Shortly after the study began, a further generation o f the new GPASS software. 
Version 4, was released. One of the participating practices had upgraded to this 
latest version between consenting to take part in the study and being sent the EQ. 
At that stage, PCCIU was not able to extract data fiom Release 4 as they had not 
received accreditation from GPASS for the use o f third party software with this 
version. Although this problem had been resolved by the time o f the second data 
extraction, it was not possible to collect a complete set o f data fiom that particular 
practice.
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3.5 Patient recruitment
At the outset o f the study, it was anticipated that the casenote review would be 
conducted for a random sample of patients in each o f the participating practices. 
Thus, although only practices in the Strategic group required the identification o f 
patients for possible assessment and/or treatment, all practices required 
identification o f those patients randomly allocated to be invited to take part in the 
casenote review. The problem of the method o f re-identification had been 
resolved, but it continued to create difficulties for patient recruitment.
Firstly, if  a practice did not run the EQ and extract data, it was not possible to 
recmit patients from that practice. Eight o f the 52 participating practices did not 
return electronic data at any time during the study. Secondly, if  a practice 
returned data but did not run the re-identification programme, it was not possible 
to identify patients from that practice. Due to the problems already outlined, the 
project had been significantly delayed and it was crucial that patients were 
identified fi'om the first data extraction in order to ensure completion o f the 
review within the remaining timescale. Thirty seven practices returned data in the 
initial extraction, but despite rigorous follow up, fifteen did not iim the re­
identification programme. It was therefore not possible to recmit from these 
practices.
Twelve o f the remaining 22 practices, which ran the programme, had extracted the 
data from Old GPASS but had upgraded to new GPASS before they received their 
feedback. Although they had identified the patients for contact, there was no 
method of ensuring that the contact details produced were for the coiTect patients, 
since it was likely that ID numbers had been deleted and the remainder reassigned 
as part o f the upgrade.
As a result o f these difficulties, casenote review could only be conducted for 
patients from ten practices.
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3.6 Practice specific difficuities
In addition to the generic problems affecting the development o f the study as a 
whole, there were issues relating to specific practices, which hindered the 
advancement o f the project.
Organisation within the practices varied greatly, and this produced associated 
problems. Four practices (two groups o f two) shared two practice managers, 
which meant that those practice managers had twice as much study related work 
as other participants. In addition, the practices in one o f  these groups shared the 
same GPASS system, thereby creating difficulties in relation to identifying 
patients from each individual practice for feedback and recruitment. Before 
extracting the data, the practice manager for this group had to append a code to 
each doctor from each practice, so that patients could then be differentiated using 
this. Perhaps unsurprisingly, three o f the four practices did not return data.
One practice shared a server with two other practices in their health centre, which 
were not participating in the study. In this instance, the EQ could only be run by 
someone from the health board. The practice required additional instructions, and 
due to their reliance on health board personnel, returned each set o f data after an 
average delay o f  4 months.
One practice had a branch surgery which lay across the health board boundary.
As a result, they had an additional GPASS system at that site. The practice 
manager had to be given two copies o f the EQ, and asked to run one in each 
location. However, data from the two systems then had to be collated during 
processing and analysis since the practice required combined feedback.
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3.7 Technical difficulties
Other problems were simply a result o f the teclmological nature o f the study.
Practice managers would often forget to sign and return the data release fonn, sent 
with each EQ, which allowed access to their data (Appendix 6). This required 
rigorous follow up since without the release fomi, the data could not be processed 
and used in the study.
Wlien the EQ is used, data are extracted from the practice system and stored on 
the same disk as the electronic questionnaire itself. However, a few o f the 
practices held extremely large patient databases, too large to be stored on this 
single disk. This often meant that only partial data were extracted. Practices then 
had to be sent another EQ along with a batch o f blank disk and asked to m n the 
EQ again.
There were also some general system problems. The system in one practice did 
not have enough available memory to enable the extraction o f data to the disk. 
There were also regular difficulties with EQ disks being corrupt or practices 
returning disks that did not contain any data. In these instances, practices had to 
be asked to run the EQ again, contributing to additional work on their part and 
adding further delay to the extraction period.
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3.8 Summary
The developmental nature o f this study generated problems related to the methods 
used to extract electronic patient data from primary care computing systems. 
These difficulties were not insunnountable and whilst they required thought and 
remedial action, they were resolved. As a result, participating practices generated 
vast quantities o f data on several occasions. The methods used to handle and 
analyse those data are described in the following chapter.
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Chapter 4 
DATA HANDLING
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4.1 Introduction
Extracting data from the computer systems o f participating practices was the first 
stage in the feedback development process. Large quantities o f electronic data 
were extracted, not all o f which were relevant to this study. Data were 
subsequently processed, analysed and used to generate a risk score for individual 
patients before reports were sent to practices. This chapter describes the format of 
the data themselves and the systems used to automate the process o f selecting 
only the most recent and relevant data for feedback. The chapter also outlines the 
method used to validate the automated process as a means o f ensuring that only 
appropriate data were selected.
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4.2 Classification of electronic data
The Read Clinical Classification (Read codes) was originally developed in the 
early 1980s by James Read, a GP in Loughborough, Leicestershire, as a means of 
allowing GPs to describe relevant clinical summary and administrative data. 
Following the Joint Computing Working Group’s recommendation, the NHS 
Executive purchased the Read codes in 1990 and established the NHS Centre for 
Coding and Classification to maintain and develop the system for use across the 
NHS (Chisholm 1990).
The original version o f the Read codes contained a hierarchy o f around 40,000 
codes, each consisting o f four alphanumeric characters. The version launched 
following the Department o f Health’s purchase o f the codes in 1990 (Version 2) 
had been adapted for use in hospitals as well as in general practice and 
restructured into a five level hierarchy to allow more detail. The Clinical Terms 
Projects, jointly undertaken by the NHS Executive and the clinical and nursing 
professions, established 55 representative working groups from the specialties 
with the remit o f selecting terms which met their requirements. As a result, a new 
version of the Read codes (Clinical Terms Version 3) was developed and released 
in 1994 (NHS hrfomiation Authority 2000), although there has not been 
widespread uptake o f this version.
There are around 125,000 different clinical tenns in 30 groupings, incorporating 
not only diseases, but all clinical aspects of management including history and 
symptoms, examinations and findings, diagnostic and laboratory procedures, 
preventive, operative and therapeutic procedures, administrative procedures, 
occupation and social information. Thus, each doctor-patient encounter can be 
recorded as a single code or combination o f codes. Each o f the five characters in 
a code is linked to a specific category for which it is an alternative term. The first 
character denotes the grouping and the remaining characters branch out within 
that grouping until the required detail is reached (Figure 4a). The NHS 
Information Authority distributes the Read codes on behalf o f the Department of 
Health and these are updated at six monthly inteiwals.
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Although use of Read codes is not mandatory, it is the most commonly used 
system in the UK and is currently available in around 80% o f general practices 
(NHS Infomiation Authority Website 2004). In Scotland, Read codes are 
recommended by the NHS Executive as the primary system for coding clinical 
data. They are universally used in GPASS practices. In 1998 when this study 
began, GPASS used a partial implementation o f Read Version 2 (Scottish 
Advisory Group on Read 1997). Upgrade to the full Read Version 2 was part o f 
the redevelopment to New GPASS (described in chapter 3).
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4.3 Data extracted from practice systems
4.3.1 Format of electronic data
The EQ extracted electronic data from the GPASS systems o f participating 
practices in ASCII fonnat (American Standard Code for Information Interchange). 
This is a widely used encoding system, developed as a means o f exchanging 
infoimation between computers manufactured by different companies. A string o f 
seven bits (binary digits 1 and 0) are used to represent each character with a 
numeric code ranging from 0 to 127. The first thirty two ASCII codes are used to 
represent control characters, that is, codes which do not carry information but 
control devices such as printers and keyboards. Codes 33 to 126 represent 
printable characters such as letters, digits and punctuation marks. The last code, 
127, represents delete (Table 4.1).
For each batch o f  data extracted, practices sent their encoded files directly to 
PCCIU either on disk or by email. There, the data were processed and imported 
into a Microsoft Access database configured as nine sepai’ate tables. Four o f these 
tables were used to produce feedback. Further detail on the tables excluded is 
provided in chapter 2.
4.3.2 Content of data tables
The four relevant tables contained various pieces o f  patient information.
The Patients table contained information relating to patient registration and 
demographics: Practice ID, Patient ID (combine to make a unique patient 
identifier); date o f birth; age; age-band (in five year bands from 000_004 to 
100+); sex (M -male; F-female); postcode (tmncated to sector level); deprivation 
category (based on Carstairs and M on is: 1-7); Clinician ID (number denoting 
registered doctor); registration status (L-live, D-dead, T-temporary); date 
registered; date deregistered; is deleted (electronic record has been deleted: F -  
false, T-true).
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The Measurements table contained information relating to the process o f care: 
Practice ID; Patient ID; measurement date; systolic blood pressure (BP); diastolic 
BP; height; weight; parity; gravida; Encounter ID.
The Clinical events table contained infoiTnation relating to patients’ symptoms 
and diagnoses: Practice ID; Patient ID; Read code; Number code (numeric 
representation o f Read code); Read code type (D-dated; U-undated); Diagnosis 
date; Modifier (CMR practices only; First, Recurrent, Persistent); Encounter ID.
The Prescriptions table contained information relating to drugs prescribed: 
Practice ID: Patient ID; drug name; dosage; BNF code; start date; end date; script 
type (A-acute, R-repeat); Encounter ID.
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4.4 Automated selection of data for feedback
4.4.1 Data required for feedback
Each o f the three batches o f data extracted provided several million pieces o f
information. Therefore, a process o f automating data selection was developed in
order to ensure rapid identification o f those data required for the generation of
feedback.
• Practice ID and Patient ID  were selected from each o f the four tables since 
they were the only means o f liiildng data for each patient.
• Feedback was provided only for those patients aged 65—79, therefore age was 
selected. However, no data were allocated to this field in the first batch of 
data. Thus, age~band was used instead. Only those patients with an entry o f 
between ‘045-049’ and ‘075-079’ in the age-band field were selected (45-64 
year olds were selected for comparison only; these data were not provided to 
practices).
•  Sex was selected.
• Deprivation category was selected as a marker o f patients’ socioeconomic 
status.
• Registration status was selected in order to ensure that feedback was provided 
for currently registered patients only. Only those patients with an entry o f ‘L ’ 
were selected. De-registered and temporary patients were excluded.
• Measurement date was selected in order to determine patients’ most recently 
recorded blood pressure.
• Systolic BP was selected.
• Diastolic BP was selected.
• Read code was selected as a means of determining those patient who were 
diagnosed with hypertension, hi addition, it was used to identify patients with 
additional risk factors and relevant morbidities required for the risk calculation, 
namely smoking status, diabetes and previous stroke.
• Diagnosis date was selected.
• Drug name was selected in order to identify those patients who had been 
prescribed antihypertensive medications. Data on dosage and BNF code were
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not always present in patients’ prescribing records and therefore could not be 
relied upon.
4.4.2 Methods of data selection
Microsoft Access is a powerful database management program in which all data 
are stored in tables. As such, procedures are either earned out on a single table, 
between tables or produce a table as the result. Tables are linked by establishing a 
‘jo in ’ between common fields, which tells the database how the data in each table 
are related. Records are then included or excluded depending on the type o f join. 
In this study, the common data were Practice ID and Patient ID and these were 
used to linlc the four individual tables (Patients, Measurements, Clinical events, 
Prescriptions).
All o f the procedures are earned out using queries, which question the data held in 
the tables, produce the records that are required and display these in a specified 
order. There are several types o f query, which can be used to view, change and 
analyse data in various ways. The following queries were used to select data for 
feedback.
1. Select queries, which retrieve data from one or more tables and simply display 
the results. A select query can also be used to group records and calculate sums, 
counts, averages and other types o f totals.
2. Crosstab queries, which calculate a sum, average, count or other type o f total 
for grouped data.
3. Action queries, which make changes to or move multiple records in one 
operation. Tln ee types o f action query were used: Delete (deletes records from 
one or more tables), Append (adds records from one table to the end o f another 
table). Make-table (creates a new table from all or part o f the data in one or more 
tables).
4. Find duplicates queries, which determine if  there are duplicate records in a 
table.
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4.4.3 Criteria for data selection
Limits were placed on the queries to ensure that they identified and selected only 
those records that were relevant for feedback. All data selected related to 
currently registered patients aged between 45 and 79 years.
Measurement data
Data on Systolic BP, Diastolic BP and Read code were sorted and selected to 
ensure that only the most recent entry was retrieved. Data with a corresponding 
date were given priority over those without a date if  both were available for a 
patient. However, if  the only available data were undated, these were selected.
No time limits were applied to the data -  the most recent entry was selected, 
regardless o f when it had been recorded.
The thi eshold for high blood pressure was taken as a systolic pressure o f >160 or 
a diastolic pressure or >90. Those with a null entry or an entry o f ‘0’ or ‘-1 ’ were 
labelled as ‘M issing’, those with an entry o f <160/90 were labelled as ‘Normal 
B P’ and those with an entry o f >160/>90 were labelled as ‘Possible HTN’. Data 
for patients labelled ‘M issing’ were included in the rule o f halves feedback but 
not in the prioritised list. Data for patients labelled ‘Noimal B P’ were included in 
rule o f halves feedback and were included in prioritised list only if  they had 
diagnosed hypertension. Data for patients labelled ‘Possible H TN’ were included 
in both the rule o f halves feedback and the prioritised list since they were potential 
hypertensive patients.
Read coded data
At the time o f study, there was no standardisation o f the Read codes used by 
general practices to denote particular conditions. As such, no single code or small 
gi'oup o f codes were routinely used to indicate hypertension, diabetes or stroke. It 
was therefore necessary to include every possible code which might be used by 
individual practices. Codes from the relevant sections o f the Read hierarchy were 
chosen and the inclusions and exclusions were then verified by members o f the 
project steering group and by other GP colleagues in General Practice and 
Primary Care, University o f Glasgow.
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All codes contained in the G2 hierarchy {Hypertensive disease) were included 
with the exception o f G24zl : ‘Hypertension secondaiy to drug’. In addition, the 
code representing ‘History o f hypertension’ and several hypertension related 
codes from the ‘Clu onic disease monitoring’ section o f Preventive procedures and 
from the Other therapeutic procedures m d  Administration hierarchies were 
included. In total, 67 codes were used. Patients were considered to have 
diagnosed hypertension if  they had an entry o f one o f these codes in the Read 
code field o f their electronic record (Appendix 7).
All o f the codes contained in the CIO hierarchy {Diabetes mellitus) were included. 
In addition, the codes representing ‘History o f diabetes’, ‘History o f insulin 
therapy’ and ‘Diabetic diet’ were used. Several diabetes related codes from the 
Nervous system/sensory organ disease, Circulatory system diseases,
Genitourinary system diseases. Skin/subcutaneous tissue diseases and 
Musculoskeletal/connective tissue hierarchies were included, as were relevant 
codes from Examinations/signs, Laboratory procedures. Preventive procedures. 
Other therapeutic procedures and Administration. Codes relating to diabetes and 
pregnancy were excluded. Given the age o f women in the target gi'oup, pregnancy 
was unlikely to have been recent and as such, it would not be possible to 
detemiine whether diabetes had been confined to pregnancy. I f  it had not, this 
should be picked up by the other diabetes codes. In total, 189 codes were used. 
Patients were considered to have diagnosed diabetes if  they had an entry o f one o f 
these codes in the Read code field of their electronic record (Appendix 8).
More than half o f the codes in the G6 hierarchy (Cerebrovascular disease) were 
included to detemiine patients with previous stroke. In addition, the codes 
representing ‘History o f CVA/stroke’ and ‘History o f stroke in last year’ were 
included as were relevant codes from the Preventive procedures hierarchy. A 
total o f 65 codes were used. Patients were considered to have had a previous 
stroke if  they had an entry o f one o f these codes in the Read code field of their 
electronic record (Appendix 9).
Smoking related Read codes were selected from the History/symptoms hierarchy, 
from the Mental disorders hierarchy -  where several codes relating to tobacco 
dependence are located -  and from the ‘Prevention/screening admin’ section of
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the Administration hierarchy. The codes used encompassed current smokers, 
never smokers and ex smokers. A total o f 52 codes were included. Patients were 
considered to have data on smoking status if  they had an entry o f  one of these 
codes in the Read code field of their electronic record (Appendix 10).
Prescribing data
Section 2 {Cardiovascular system) of the then current British National Formulary, 
BNF 36, was searched for antihypertensive drugs. Given the large number o f 
possible inclusions, GP colleagues from General Practice and Primary Care were 
provided with the list and asked to indicate those drugs which they considered 
unlikely to be prescribed for hypertension. They were also asked to suggest drugs 
which were not listed, but which would be prescribed. A total o f 167 dmg names 
were used (Appendix 11). The list was updated in 2000 following validation 
against BNF 39.
4.4.4 Query design
Queries to select relevant data were developed using a bottom up approach 
whereby each was added to the analytic database as it was required. Each new 
query was built on the previous one, producing a series o f individual operations 
which, when run in succession, ultimately produced a single record for each 
patient. This record incorporated all relevant data items fr om each o f the four 
original tables (Appendix 12).
The initial query selected each unique Read coded entry in the Clinical events 
table for each currently registered patient aged 45-79 and added this to a new 
table called Morbidity master. Subsequent queries selected the most recent blood 
pressure measurement for each patient (patients who had no blood pressure 
recorded were also included), identified all registered patients aged 45-79 with a 
hypertension related Read code and linlced the two sets o f data to produce a list o f 
hypertensive patients and their most recent BP reading {Hypertensives), 
Additional queries identified all registered patients aged 45-79 with a diabetes 
related Read code {Morbidity diabetes), with a stroke related Read code 
{Morbidity stroke) or with a smoking related Read code {Morbidity smoldng). A 
further query was developed to identify potential hypertensive patients, that is, 
those with a blood pressure measurement o f >160 / >90 who did not have a
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hypertension related Read code {Possible hypertensives). Due to the vast number 
o f items of prescribing data, five separate queries were developed to identify 
patients receiving antihypertensive medication. These were then combined and 
the most recent entry for each patient selected {Drug therapy).
The final stage in the selection process involved linldng the results o f the various 
queries, Hypertensives, Possible Hypertensives, Morbidity diabetes, Morbidity 
stroke, Morbidity smoking and Drug therapy. This query, which took thi’ee hours 
to run, produced one single list containing all o f the relevant data items for 
diagnosed and potential hypertensives namely, Practice ID, Patient ID, age-hand, 
sex, last systolic BP, last diastolic BP, measurement date, hypertension status 
(diagnosed/undiagnosed), smoking status, stroke status (yes/no), diabetes status 
(yes/no) and antihypertensive medication (yes/no). Additional crosstab queries 
provided information by practice on age and sex, BP recording and BP levels.
4.4.5 Quality assurance
In total, 32 individual queries, which ran in succession, were developed to 
automate the process o f data selection. The original development was carried out 
using the first batch o f data extracted Rom participating practices. Saving the 
queries in this way made it possible to simply link each subsequent batch o f data 
to the analytic database; the queries would then operate on those new data to 
identify and select the relevant items for feedback. Given that, it was essential 
that each query was accurate in relation to the data it selected. Testing and 
validation o f query results was an integral part o f  the development process and 
was conducted tluoughout. Essentially, the process involved copying data from 
the original table or tables to Microsoft Excel. Records for those patients who 
were out with the target age bands and not cuiTently registered were deleted as 
were data relating to irrelevant Read codes or drugs. The remaining data were 
then sorted chronologically and all but the most recent entries for each patient 
were excluded. The results o f the manual tests were then compared with the 
results generated by the relevant query. Each query was developed and 
individually tested in a process lasting five months.
100
4.5 Summary
W hilst the process o f automating the generation o f feedback data was time 
consuming and complex, it undoubtedly led to time savings over the course o f the 
study. It also enabled only relevant data to be extracted from patients’ records, 
those data which were required to populate the risk equation. The risk equation 
used was developed as part o f the study reported here and details o f its derivation 
and content are provided in chapter 5.
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Figure 4a -  Read code hierarchy
A B C D E F G H J K L M N P Q R S T U Z
G.... Circulatory system diseases
GO... G1... G2... G3... G4...
G2... Hypertensive disease
G20.. G21.. G22.. G23.. G24.. ►
G24.. Secondary hypertension
G240. G241. G242. G243. G244. ►
G240. Secondary malignant hypertension
G2400 G2401 G2402 G2403 G2404
G2400 Secondary malignant renovascular hypertension
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Table 4.1 -  ASCII 7-blt codes
BINARY CODE DECIMAL CHARACTER DESCRIPTOR
0000000-0011111 0-31 Control characters
100000 32 Space
100001 33 ! Exclamation mark
100010 34 " Quotation mark
100011 35 # Hash
100100 36 $ Dollar sign
100101 37 % Percent sign
100110 38 & Ampersand
100111 39 ' Apostrophe or right quote
101000 40 ( Left parenthesis
101001 41 ) Right parenthesis
101010 42 * Asterisk
101011 43 + Plus sign
101100 44 Comma
101101 45 - Hyphen
101110 46 Full stop
101111 47 / Forward slash
0110000-0111001 4 8 -5 7 0 - 9 Numbers 0 -  9 (in order)
111010 58 Colon
111011 59 ; Semi-colon
111100 60 < Less than
111101 61 Equals
111110 62 > Greater than
111111 63 ? Question mark
1000000 64 @ Commercial at
1000001-1011010 6 5 -9 0 A -Z Capital letters A -  Z (in order)
1011011 91 [ Left square bracket
1011100 92 \ Back slash
1011101 93 ] Right square bracket
1011110 94 A Caret
1011111 95 Underline
1100000 96 ‘ Back apostrophe or left quote
1100001-1111010 9 7 -1 2 2 a -  z Lower case letters a -  z (in order)
1111011 123 { Left curly bracket
1111100 124 1 Vertical bar
1111101 125 } Right curly bracket
1111110 126 Tilde
1111111 127 Delete or rubout
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5.1 Introduction
This study made use o f a new equation to predict absolute risk o f death from 
stroke in elderly hypertensive patients. This chapter describes the most 
commonly used scoring systems designed to predict risk o f cardiovascular disease 
and outlines the reasons why these were unsuitable for use in this study. The 
method used to derive and validate the equation used is described, as is the result 
o f its comparison with one o f the most widely used systems, the Joint British 
guidelines. The chapter also outlines the patient groups included in the absolute 
risk feedback.
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5.2 Risk factors for cardiovascular disease
In response to an increase in the prevalence o f cardiovascular disease in the 
1930s, the United States Public Health Service established a project to determine 
the biologic and environmental factors contributing to the rapid rise in 
cardiovascular death and disability. In 1948, the town o f Framingham, 
Massachusetts, was selected as the study site and 5,209 healthy residents aged 
between 30 and 60 years, both men and women, were enrolled as the first cohort 
o f participants. In 1971, the study recmited 5,124 children (and their spouses) of 
the original cohort for a second study, the ‘Offspring Study’. The Framingham 
Heart Study has been one o f the most influential community based 
epidemiological studies to date, and the first to determine that it was possible to 
identify and modify the risk factors associated with cardiovascular disease 
(Kannel, Dawber, & McNamara 1966).
Independent risk factors for cardiovascular disease are older age, elevated blood 
pressure, elevated blood cholesterol, smoking and diabetes mellitus. Other 
predisposing risk factors include obesity, physical inactivity, family history of 
cardiovascular disease, etlmicity and psychosocial characteristics. In the years 
following the establishment o f Framingham, cardiovascular prevention focused 
primarily on the management o f individual risk factors, in particular elevated 
blood pressure and cholesterol. However, longitudinal data from Framingham 
and other subsequent trials have helped demonstrate the relationship that exists 
between risk factors. The major risk factors are cumulative in effect and as such, 
total risk can be predicted by summing the risk from each of the individual 
factors. Consequently, there has been a shift away from preventive care based on 
relative risk towards care based on absolute risk.
High blood pressure is no longer viewed as an isolated risk factor and assessment 
o f absolute risk is now regarded as the most accurate way o f judging the benefits 
or otheiwise o f antihypertensive treatment (Ramsay et al. 1999) (Wood et al. 
1998b). This approach allows identification o f high risk patients and appropriate 
targeting o f risk reduction therapies to those most in need. As such, patients at 
highest risk can be treated as a priority.
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5.3 Predictors of cardiovascular risk
Numerous methods to calculate individuals’ absolute risk of cardiovascular 
disease have been developed (Table 5.1). Many o f these are based on data from 
the Framingham Heart Study and several were available at the outset of this study.
5.3.1 The Framingham equations
The first predictors o f absolute risk were derived from data on 5,573 
cardiovascular disease free subjects aged 30-74 in the Framingham Heart Study. 
Several equations were developed and they were designed to predict the risk of 
several cardiovascular endpoints -  myocardial infarction (MI), coronary heart 
disease (CHD), death from CHD, stroke, cardiovascular disease and death from 
cardiovascular disease. The equations predict ten year risk based on the aggregate 
o f age, sex, systolic and diastolic blood pressure, total serum cholesterol, high 
density lipoprotein (HDL) cholesterol, smoking, diabetes and left ventricular 
hypertrophy as measured by electrocardiography (ECG-LVFI) (Anderson et al. 
1991).
5.3.2 Dundee coronary risk disk
The Dundee coronary risk disk was developed from data on 5,203 men aged 40- 
59 from the United Kingdom heart disease prevention project. As such, it has not 
been validated for use with women. The system estimates five year modifiable 
risk o f MI and death from CHD for 35-64 year olds and is based on smoking, 
systolic and diastolic blood pressure and blood cholesterol. The disk, a solid two 
sided calculator, provides an age-sex related ranking for each patient, from 1 (high 
risk, priority action) to 100 (low risk, general advice) (Tunstall-Pedoe 1991).
5.3.3 The PROCAM risk function
The Prospective Cardiovascular Münster study was a workplace study established 
in Minister, Gemiany in 1979 to examine cardiovascular risk factors, events and 
mortality in the employees o f 52 companies. Recmitment ended in 1985, after 
data had been collected for 13,737 men and 5,961 women. The PROCAM risk 
function was developed from eight year follow up data from a cohort o f men aged
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35-65. As such, it has not been validated for use with women. The score 
estimates the ten year risk o f MI or CHD death in those who do not have existing 
cardiovascular disease. It is based on age, systolic blood pressure, low density 
lipoprotein (LDL) cholesterol, HDL cholesterol, triglycerides, smoking, diabetes 
and family history o f MI (Assmami 1993).
5.3.4 The Joint European guidelines
The Joint European guidelines are founded on the recommendations o f the 
European Society of Cardiology, European Atherosclerosis Society and European 
Society o f Hypertension. The risk prediction is based on the Framingham 
equation and estimates the ten year risk o f non fatal CHD or coronary death in 
those aged 30-70 who have not yet developed symptomatic CHD or other 
atherosclerosis. The estimate is based on age, sex, systolic blood pressure, total 
cholesterol and smoking (Wood et al. 1998a).
5.3.5 The Sheffield table
The Sheffield table is based on the Framingham risk equation and can be used 
with people aged 52-70, who are cuirently free o f cardiovascular disease, as a 
means o f identifying those whose risk of a coronary death is 1.5% or more per 
year. Estimation o f risk is based on age, sex, hypertension (based on 
dichotomised systolic blood pressure where blood pressure controlled to 160 mm 
Hg is ‘yes’ and to 139 mm Hg is ‘no’), cholesterol (based on population mean 
HDL values), smoking, diabetes and ECG-LVH (Haq et al. 1995). A revised 
Sheffield table has since been developed which identifies coronary risk for 
thresholds specified in most guidelines, namely 15% and 30% risk over ten years 
(Wallis et al. 2000).
5.3.6 The New Zealand guidelines
The New Zealand guidelines and charts are based on the Framingham risk 
equation and predict the five year risk of a cardiovascular event -  MI, new angina, 
CHD death, fatal or non fatal stroke or transient ischaemic attack, congestive 
cardiac failure or peripheral vascular disease. Risk is based on age, sex, systolic 
and diastolic blood pressure, ratio o f total cholesterol to HDL cholesterol.
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smoking and diabetes. The guidelines can be used for those aged 35-75 who do 
not already have symptomatic cardiovascular disease (National Health Committee 
1995) (Dyslipidaemia Advisory Group 1996).
5.3.7 The Joint British guidelines
The Joint British guidelines are based on the recommendations of the British 
Cardiac Society, British Hyperlipidaemia Association, British Hypertension 
Society and British Diabetic Association. The risk prediction is based on the 
Framingham equation and is used to estimate the 10 year risk of MI or CHD death 
in people aged 32-74 who do not have established CHD or atherosclerosis. The 
estimate is based on age, sex, systolic and diastolic blood pressure, total 
cholesterol, HDL cholesterol, smoking, diabetes and ECG-LVH (Wood et al. 
1998b).
5.3.8 Unsuitability of existing equations
Framingham has the advantage over many other studies in that it generated data 
for both men and women in a wide range o f age giroups over a long period of time. 
However, whilst the Framingham equations and their derivatives are widely used, 
there are some caveats in relation to their use with other populations.
Framingham equations were not designed for use in people with pre-existing 
cardiovascular disease, since this group were excluded from the study. As such, 
they can only be used to assess risk for primary prevention. In addition, the 
equations have been shown to overestimate absolute risk when applied to low risk 
populations, such as those in Europe (Laurier et al. 1994) (Hense et al. 2003) 
(Brindle et al. 2003) (Empana et al. 2003). Furthermore, the data are derived firom 
a predominately white, middle class, American population and as such, the 
equations may not accurately predict risk for those in ethnic minority gi'oups or on 
low incomes. Despite their limitations, these multiple risk scores are one o f the 
best and most widely used methods o f predicting absolute risk.
Assessment o f risk using Framingham based or other, alternative equations 
requires infoimation on both total and HDL cholesterol. At present, general 
practice patients are not routinely screened for hyperlipidaemia, since it is neither 
cost effective in teims o f targeting risk nor feasible in teims of workload (NHS
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Centre for Reviews and Dissemination 1998). In addition, the versions of GPASS 
in use at the outset o f the study did not record cholesterol readings. The aim of 
this study was to provide general practices with feedback relating to all patients at 
risk, not just those with their risk factors recorded. In addition, the feedback was 
to be based on data collected as part o f routine practice rather than on data 
collected specifically for the puiposes o f the study. As such, it was not possible to 
utilise an existing risk predictor, since data on cholesterol would be unavailable.
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5.4 The Hyper absolute risk equation
5.4.1 Development of a new equation
Between 1972 and 1976, all residents of Renfrew and Paisley in the West of 
Scotland aged 45 to 64 years were invited to complete a questionnaire and attend 
a cardio-respiratory examination as part o f the Paisley-Renfrew (Midspan) study. 
Almost 80% o f those contacted, 15,406 men and women, participated in screening 
(Watt et al. 1995). Mark Upton, who at the time o f this study was a Wellcome 
Research Fellow in Clinical Epidemiology conducting a survey on the offspring 
o f over 4000 of the original Paisley-Renfrew couples, and Alex McConnachie, a 
statistician, used Midspan data to develop an equation for this study -  the Hyper 
equation.
Record linked follow up data together with baseline screening infonnation 
collected between 1974 and 1976 were used to develop a logistic regi'ession 
model which predicts absolute risk o f death from stroke over the next ten years. 
Data used were from the Paisley population only since the original Renfrew 
questionnaire did not ask specifically about treatment for hypertension. The 
model was developed using data for a random 50% sample o f the Paisley 
population (n=6,121; 66 (1.08%) stroke deaths over ten year follow up). The 
equation incorporates a constant plus patient age, systolic blood pressure (mm 
Hg), cun-ent smoker (yes/no), diabetes (yes/no), previous stroke (yes/no) and on 
antihypertensive treatment (yes/no). There is no teim for gender since gender by 
itself did not have an association with stroke death during the first ten years of 
these data. There were also no important gender-risk factor interactions. As such, 
the model can be used for both men and women (Table 5.2). The fit of the model 
could not be rejected using the Hosmer-Lemeshow statistic (X^ -  13.05, p=0.11); 
the area under the Receiver Operating Characteristic (ROC) curve was 77.7%.
The model was then used to predict the risk o f stroke on the remaining Paisley 
population (n=6,195; 78 (1.26%) stroke deaths over ten year follow up). The fit 
o f the model could not be rejected using the Hosmer-Lemeshow statistic (X^ = 
8.49, p=0.58); the area under the ROC cuiwe was 76.7%.
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5.4.2 Comparison with Framingham equations
At the outset o f the study, prior to electronic data collection, a medical records 
review was conducted for a small sample o f elderly hypertensive patients (n=21) 
from a general practice not participating in the study. The data collected were 
those required for both the Hyper equation and the Joint British guidelines, one of 
the most commonly used risk predictors in general practice, including cholesterol 
and ECG-LVH. The data were then entered into the risk models and the two 
scores for each patient compared. Scores from the Hyper equation consistently 
followed the pattern determined by the Joint British guidelines and in 71% of 
cases, scores were almost identical (Figure 5a). In the remaining six patients, the 
Hyper equation consistently predicted higher levels o f absolute risk. However, 
each o f these patients was at very high risk. All six were diabetic, all were 
already receiving antihypertensive treatment, five had blood pressure >140/90, 
one had a previous stroke, three were smokers and four were aged 73-78. 
Prediction o f absolute risk is always likely to incorporate some error. However, 
the Hyper equation was not underestimating risk, nor did it appear to be 
overestimating risk for those who were not at higher risk.
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5.5 Risk feedback
The data required by the Hyper equation (section 5.4.1) were exported from MS 
Access into a MS Excel spreadsheet. These data were then re-coded according to 
their relative weightings and the risk score was automatically calculated using 
formulae stored in the spreadsheet. Information on individual patient risk was 
provided only to practices in the Strategic group. This infoimation was presented 
in the form of a colour coded list prioritising patients according to their risk level. 
Patients at the top o f the list in red were at greatest risk o f death from stroke, 
patients at the bottom in green were at lowest risk. Feedback was provided on 
patients with diagnosed hypertension regardless of blood pressure level and on 
patients who did not have diagnosed hypertension but who had a blood pressure 
o f >160 / >90 mm Hg. Patients without a blood pressure recorded were excluded. 
Feedback included both those who had already had a stroke and those who had 
not. The feedback list contained the patient’s ID, age-gi'oup, sex, date o f last 
recorded blood pressure, systolic and diastolic blood pressure, whether they had 
diagnosed hypertension, whether they were receiving antihypertensive drug 
treatment, smoking status, whether they had diabetes, whether they had a previous 
stroke and their absolute risk.
For the purposes o f the risk equation, never smokers and ex smokers were 
considered to be non-smokers; only current smokers were regarded as smokers 
Patients without a Read coded diagnosis o f hypertension, diabetes or stroke were 
regarded as not having the disease. However, patients who did not have a record 
of smoking status could not be regarded as non-smokers. The risk equation does 
not calculate risk unless each o f the fields has an entry. Thus patients without a 
record o f smoking status had two risk scores predicted, one based on their being a 
smoker, the other on being a non-smoker.
Practices were provided with feedback for patients with an absolute risk of 10% 
or more. No instruction was given as to how these patients should be managed, 
since the purpose o f the study was to determine the impact o f the provision of 
feedback on decision making, not to direct decision making. However, in order to 
minimise any influence that might be brought to bear by providing selected
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feedback, practices were infomied that they could receive risk scores for all 
patients if  they wished.
114
5.6 Summary
Whilst various risk predictors are cuiTently in existence, some o f which are widely 
used in primary care, it was not possible to make use o f these in this research.
The equation developed specifically for the study, the Hyper equation, allowed 
patient risk to be predicted using individual items o f data which were not only 
major risk factors for stroke, but were also accessible in electronic patient records. 
Changes in patient risk over the period under study are presented in the results 
chapter (chapter 6, section 6.8).
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Table 5.2 -  Hyper equation to calculate absolute risk of stroke death
LOGIT = constant + age group + SBP + smoker + diabetes + stroke + treatment 
Likelihood of sustaining a CVA over 10-years P = 1/1+exp (-LOGIT)
VARIABLE
Constant 
Age group
SBP
Current smoker 
Diabetes 
Previous stroke 
On drug treatment
SCORE
-7.9892
4 5 - 4 9  0
50 -  54 0.4362
5 5 - 5 9  0,8533
6 0 - 6 4  1.7752
6 5 - 6 9  2.1579
70 -  74 2.6973
7 5 - 7 9  3.2368
0.0119 (per mm Hg)
Yes 0.9364
No 0
Yes 1,6120
No 0
Yes 1.6244
No 0
Yes 1.0243
No 0
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6.1 Introduction
This section presents the results obtained from electronic data collection, 
questiomiaire surveys and casenote review. The organisational characteristics of 
participating practices will be presented first, followed by figures relating to 
identification, treatment and control of elderly hypertensive patients at the study 
outset, and changes in these figures over time. The initial results relate to all of 
the practices that returned one or more batch of electronic data; the comparative 
analyses are based only on those practices which returned data over time (n=34). 
Figures relating to mean systolic pressure and levels o f control, adjusted for 
practice and patient factors, will also be presented. Finally, data relating to patient 
risk and the characteristics o f those patients who went on to have a stroke will be 
shown. All results reported in the tables and in the text are given for the Control 
group first, followed by the Audit group, followed by the Strategic group.
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6.2 Participating practices
In total, 54 practices were recmited to the study. The target number of practices 
required was achieved in five of the nine sampling strata (Table 6.1). Medium 
sized practices were well represented, whilst small and large practices, 
particularly those with high deprivation, were under represented.
Two practices withdrew from the study shortly after recruitment and before data 
collection began, leaving 52 participating practices (Figure 6a).
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6.3 Practice characteristics
6.3.1 Population coverage
The 52 participating practices were located in eleven o f the twelve mainland 
Scottish health boards. More than one quarter were from Greater Glasgow, the 
largest health board area, followed by Lothian (12%) and Forth Valley (12%). 
They incoiporated members from almost half (46%) of the 80 possible Local 
Health Care Co-operatives (Table 6.2). Combined, the practices represented a 
population o f over 260,000 patients, equivalent to almost 5% of the total 
population of Scotland (Table 6.3).
6.3.2 Practice structure and organisation
At the outset o f the study, practices in all tln*ee groups were similar in terms of 
number of partners, list size and deprivation payment level (Table 6.4). 
Approximately one quarter of practices in each group were categorised as having 
low deprivation (Control 21% v Audit 25% v Strategic 23%), with the majority 
having between 5-15%  (42% v 50% v 65%).
Almost all o f the practices had a practice nurse available, but there was a marked, 
although not statistically significant, difference between the Control group and the 
other two groups with respect to training practice status (50% v 29% v 25%, 
X^^O.272, DF=2, p^O.257). In addition, the availability of a register of patients 
with hypertension (89% v 57% v 75%) and the provision of a hypertension clinic 
(44% V 29% V 25%) and recall system (78% v 64% v 63%) was also greater in the 
Control group (Table 6.5). The majority o f practices in the Audit (70%) and 
Strategic (63%) groups used a previously arranged appointment as their primary 
method o f recall, whilst the remainder used either letters and / or telephone 
reminders. Conversely, only 36% of practices in the Control group used pre­
arranged appointments, half used either letters and / or telephone reminders and 
the remainder noted the need for recall on the repeat prescription card or 
appointment list.
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Comparisons o f organisational characteristics were also made by practice size 
(Table 6.6) and deprivation payment level (Table 6.7). Although not statistically 
significant, around one quarter o f the small and medium sized practices had 
training status compared with almost two thirds o f the large practices (24% v 28% 
V 62%; X^=5.39, DF^2, p=0.068). Conversely, the availability o f a hypeitension 
register and provision o f a clinic and recall system decreased as practice size 
increased (Table 6.6), with the difference in the occurrence of recall systems 
between small to large practices being statistically significant (94% v 61% v 46%, 
X^=8.67, DF=2, p=0.013).
When compared by practice deprivation payment level, whilst not statistically 
significant, each o f five organisational factors considered was generally more 
frequent as deprivation increased from 0% to >25% (Table 6.7). The difference 
was particularly marked in relation to the availability of a hypertension register 
(58% V 73% V 100%, X^=5.16, DF=2, p=0.076) and provision o f a hypertension 
clinic (17% V 39% v 40%, X W .O I, D F-2, p-0.366).
During the period under study, amongst other organisational changes, three 
practices gained an additional partner, seven changed partners, seven changed 
practice managers and two became training practices (Table 6.8).
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6.4 Electronic clinical data
The first batch of electronic patient data was downloaded in October 1999 and the 
last in December 2001. Data were returned by 47 of the 52 participating 
practices. Three practices returned a single batch o f data which was coiTupted and 
could not be used. Useable data were obtained from a total o f 44 practices; from 
37 practices in the first Electronic Questionnaire (EQ), 25 in the second and 28 in 
the third (Table 6.9). Twelve practices provided useable data in all three EQ runs, 
22 provided data in two and ten provided data in one. Thus, comparable data 
were available for 34 practices.
The amount of data extracted varied with each EQ mn. In total, the 44 practices 
generated an electronic record for a total of 265,572 patients, 217,125 o f which 
were pennanently registered (Table 6.10). The records contained almost 500,000 
items of measurement related information, blood pressures, weights etc., over four 
million Read coded items, symptoms, diagnoses etc., and over 7 million items of 
data relating to prescribing. More than 26,000 o f the permanently registered 
patients were aged between 65 and 79 years; 7,204 had a recorded diagnosis of 
hypertension (Table 6.11).
6.4,1 Validation of data
Retrospective casenote review was conducted for 229 patients from ten practices. 
Due to the difficulties described in chapter 3 (section 3.4.2), in relation to linking 
patient identifiers, comparisons between the paper and electronic record could 
only be made for 192 o f these patients (Control n=84; Audit n=80; Strategic 
11=28). Comparisons were made for all o f the variables required for practice 
feedback, namely hypertension diagnosis, presence of diabetes, presence of 
previous stroke, antihypertensive treatment, most recent blood pressure reading 
and smoking status (Table 6.12).
Agreement across the groups was high for diagnosis o f hypertension (90%), 
diabetic status (98%) and previous stroke (96%). Kappa co-efficient for 
agreement beyond chance was 0.89. Agreement was also high for 
antihypertensive treatment (95%, kappa=0.82. Figure 6b). Discrepancies related
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to these items were primarily due to a diagnosis or treatment being recorded in the 
casenote but not in the electronic record (hypertension n=16; previous stroke n=7; 
antihypertensive treatment n=7). Agreement for smoking status was lower (84%, 
kappa=0.70). There was concurrence for less than one quarter o f blood pressure 
readings (23%, kappa=0.32, Figure 6c). In the main, discrepancies were due 
either to the most recent blood pressure having been recorded in the casenote and 
not updated on computer (62%), or to the most recent record having been 
recorded on the computer only (15%). Thus, only 36% o f patients had their most 
recent blood pressure recorded in their electronic records. O f the 119 patients 
whose most recent blood pressure was recorded in the casenote, the level of 
pressure recorded in the electronic record was the same as that recorded in the 
casenote for 60%, that is both records were high or both were normal (Table 
6.13). Whilst records did not correspond for 40% of patients, there was no 
systematic bias in recording between the groups and no group consistently 
recorded only nomial blood pressures in their electronic records. In the majority 
o f cases where the two readings did not correspond, the electronic record 
contained a reading of >160 / >90, whilst the casenote contained a normal reading.
Thus, it is likely that most patients in this study will have been correctly included 
or excluded from practice feedback. However, there may have been discrepancies 
where patients did not already have a diagnosis o f hypertension. Those whose 
blood pressure was recorded as high in the casenote but normal in the electronic 
record will not have been identified as potential hypertensives and as such will 
have been missed from feedback. Those whose blood pressure was recorded as 
high in the electronic record but nomial in the casenote will have been incorrectly 
included as potential hypertensives. Systolic blood pressure was one of several 
factors included in the Hyper absolute risk equation and as such, where 
discrepancies between records related to systolic pressure, this may have affected 
the score allocated. However, this is unlikely to have affected the scores 
substantially. For example, a patient with undiagnosed hypertension, in the 65-79 
age range, with no additional risk factors and a systolic blood pressure o f 160 mm 
Hg, is allocated an absolute risk score o f 5.2%. If that person’s pressure is in fact 
150 mm Hg, their risk is reduced to 4.6%. In either case, they would have been 
excluded from practice feedback since their risk was <10% (section 2.9). If that 
person has one risk factor, for example smoking, risk is increased from 11.1% to
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12.3%. If  they have diabetes, their risk increases from 19.6% to 21.6%. In both 
cases, the patient would have been included in feedback. In the first, the practice 
may be less likely to have intervene, in the second given the relatively high risk 
score, they may well have done. In this situation, whilst targeting may be 
appropriate given the risk, in relation to hypertension management, it may be 
misplaced. However, given the results of the validation exercise, this is likely to 
have been an issue for only a minority o f patients. Furthermore only 639 of the 
7,198 patients eligible to be included in final feedback (8.8%) were undiagnosed 
with one or more risk factors.
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6.5 Rule of halves at study outset
6.5.1 Identification
Data from the first EQ returned by 37 practices, established that the majority of 
patients aged 65-79 in each group had a blood pressure recorded on computer 
(Table 6.14). This was within normal limits for around half o f those patients 
(55.7% V 45.1% V 47.6%) but left sizable proportions of patients whose blood 
pressure was >160 / >90. O f those, only one third had been identified as having 
hypertension (38.7% v 35.8% v 35.3%, x W .2 7 , DF=2, p=0.072).
6.5.2 Treatment and control
Few o f the patients diagnosed with hypertension were without a recorded blood 
pressure (Table 6.15). The majority were receiving antihypertensive treatment 
and the difference between the three groups, although small, was significant 
(88.0% V 85.7% V 81.7%, X^=27.28, DF=2, p<0.001). In addition, around half of 
the patients in each group who were receiving treatment were not adequately 
controlled (52.3% v 42.4% v 48.2%, X^=25.76, DF=2, p<0.001).
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6.6 Changes to the rule of halves
The following data relate to the 34 practices which returned two or more sets of 
electronic data (Control n=12; Audit n=9; Strategic n=13). Initial and final 
figures were compared; if  a practice returned three sets o f data, the first and last 
were compared.
6.6.1 Practice organisation and structure
The practices in all tlmee groups returning multiple sets o f data were similar in 
tenns o f number of partners, list size and median deprivation payment level 
(Table 6.16). Practices in the Control and Audit gi'oups were evenly spread across 
the low, medium and high deprivation categories, whilst the majority of practices 
in the Strategic group had medium deprivation (n=9, 69%).
Almost all o f the practices had a practice nurse available, but again, there was a 
clear, although not statistically significant, difference between the Control group 
and the other two groups with respect to training practice status and the provision 
o f a hypertension clinic. The difference in relation to recall systems was not as 
great as had been the case overall (67% v 56% v 54%, X^=0.48, DF=2, p=0.788), 
although a greater proportion o f practices in both the Control and Strategic groups 
had a hypertension register available compared with the Audit group (92% v 44% 
V 69%, X^=5.54, DF=2, p=0.063. Table 6.17).
6.6.2 Levels of computerisation and use
Data from the survey on levels of computerisation showed that 28 o f the 34 
practices (82%) used both paper and electronic records for recording clinical data. 
All 34 electronically recorded recall information for all patients (Table 6.18). 
Doctors in all o f the Audit group practices had a computer available in their 
consulting room compared with 90% of the Control gi'oup practices and just over 
three quarters in the Strategic group. There was a similar pattern for data entry by 
GPs. Only half o f the practices in each group stated that they electronically 
recorded measurement data and diagnoses for all patients. One third o f Control
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gi'oup practices used mainly computerised guidelines, compared with only 11% of 
practices in the Audit gi'oup and 8% in the Strategic group (Table 6.18).
6.6.3 Changes in identification of patients with hypertension
The majority o f 65-79 year olds in each group had a blood pressure recorded at 
the initial download, with the lowest proportion obseiwed in the Audit group 
(78.3% V 66.2% V 79.0%, Table 6.19). The numbers increased over the study 
period, with the largest improvement seen in the Audit group.
The greatest proportion o f patients whose initial blood pressure was within nonnal 
limits was found in the Strategic group, where more than half o f the patients had a 
blood pressure o f <160/90 mm Hg (49.5% v 40.1% v 51.9%, Table 6.19). This 
improved over the study period in all tlmee groups, rising to almost two thirds in 
the Strategic group and to more than half in the Control group (58.0% v 47.3% v 
61.4%).
Of those patients whose blood pressure was initially >160 / >90 mm Hg, more 
than 40% of those in the Control gi'oup had been diagnosed as having 
hypertension, compared with just over one third in the other two groups, a 
difference which was statistically significant (41.2% v 37.7% v 36.0%, X^=l 1.20, 
DF=2, p=0.004). By the end of the study, identification had improved in all three 
groups and again the difference was statistically significant; the improvement 
made in the Control and Audit groups was respectively three times and twice that 
made in the Strategic group (49.3% v 43.8% v 38.6%, X^=39.03, DF=2, p<0.001 ).
6.6.4 Changes in treatment and control of diagnosed hypertensives
Only a small proportion o f patients diagnosed with hypertension did not have an 
initial blood pressure recorded electronically, more so in the Audit group than in 
the other two groups (8.9% v 24.7% v 3.9%, Table 6.20). The numbers in each 
group decreased over the study period, with the greatest improvement obseiwed in 
the Audit group (-0.6% v -6.7% v -1.1%). Over 40% of the patients in each group 
had an initial high blood pressure (45.4% v 42.1% v 42.5%). These numbers 
reduced over the study period, falling to nearer one third in the Strategic and 
Control groups (35.0% v 38.3% v 34.6%).
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The majority o f patients in each group were initially receiving antihypertensive 
treatment, the greatest proportion found in the Control group and the lowest in the 
Strategic group, differences which were statistically significant (88.2% v 86.1% v 
84.3%, X^=10.64, DF=2, p=0.005, Table 6.20). Over the study, the numbers of 
treated patients increased to more than 90% in all three groups, with the greatest 
improvement found in the Strategic group which showed an increase three times 
gi'eater than that obseiwed in the Control group and more than twice that observed 
in the Audit gi'oup (91,4% v 90.5% v 93.9%, X^=16.95, DF=2, p<0.001).
Initially, more than half o f the patients with diagnosed hypertension in the 
Strategic group were receiving treatment and were adequately controlled, 
compared with over 40% in the Control group and one third in the Audit group 
(45.8% V 34.0% V 53.4%, X^=98.87, DF=2, p<0.001). By the end of the study, 
the numbers had risen by around 10% in each gioup. However, more than one 
third of all patients with diagnosed hypertension remained uncontrolled (57.8% v 
43.8% V 62.4% X^=126.59, DF=2, p<0.001. Table 6.20).
6.6.5 Comparison with patients aged 45-64
Comparisons were made with patients aged 45-64 as a means o f detemiining 
where the study groups targeted effort in relation to hypertension management. 
Fewer patients aged 45-64 whose blood pressure was initially >160 / >90 mm Hg 
were identified as hypertensive and this was observed across the three groups 
(Figure 6d). Similar figures to those found for patients aged 65-79, with respect 
to diagnosed and treated patients (84.7% v 80.8% v 80.8%) and treated and 
controlled patients (47.3% v 34.9% v 49.2%) were seen.
6.6.6 Changes by practice size
There were significant differences between small (1-2 GPs), medium (3-4 GPs) 
and large (>5 GPs) sized practices in relation to the numbers o f hypertensive 
patients identified, treated and controlled (Table 6.21). The proportion o f patients 
identified as hypertensive and treated with antihypertensive medication tended to 
increase as practice size increased, whilst the proportion treated and controlled 
increased with reduced practice size (small 69.0% v medium 60.1% v large 
57.7%, X^=20.21, DF=2, p<0.001).
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6.6.7 Changes by practice deprivation level
There were significant differences between practices in low (0%), medium (5- 
15%) and high (>20%) deprivation payment levels in relation to the numbers of 
hypertensive patients identified, treated and controlled (Table 6.22). The 
proportions o f patients identified, treated and controlled tended to increase as 
deprivation level increased (final control: low 53.6% v medium 58.6% v high 
68.7%, X W 0 .4 1 , DF=2, p<0.001).
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6.7 Changes for patients with linked records
The remainder of the results relate to comparisons made for patients on whom 
absolute risk feedback had been based, that is, those patients who had a recorded 
diagnosis o f hypertension or who did not have a recorded diagnosis of 
hypertension, but whose blood pressure was >160 / >90 mm Hg. In the case of 
the Audit and Control gi'oups, these data were compared for those patients who 
would have been on absolute risk feedback had it been provided. Data were 
compared for a total o f 5,103 patients. Ai'ound 60% in each group were female, 
20% were smokers, 10% had diabetes and 5% had a record o f a previous stroke 
(Table 6.23). Fewer o f the most affluent patients were from the Audit group and 
fewer o f the most deprived patients were from the Strategic group.
6.7.1 Mean blood pressure
There was a significant difference in the initial mean systolic blood pressure for 
patients aged 65-79 across the tlri'ee groups (153.3 mm Hg v 156.0 mm Hg v
152.5 mm Hg, p<0.001, Table 6.24). This fell in all three groups, with the largest 
reduction found in the Control gioup (3.3 mm Hg v 1.7 mm Hg v 2.7 mm Hg). 
There was also a significant difference in mean diastolic pressures, which also fell 
over the study period, again with the largest reduction seen in the Control group 
(2.2 mm Hg v 1.3 mm Hg v 2.0 mm Hg, Table 6.24).
Mean systolic blood pressure for patients with diagnosed hypertension was lower 
than for patients aged 65-79 generally, with the lowest levels found in the 
Strategic group (150.0 mm Hg v 153.0 mm Hg v 148.8 mm Hg, p<0.001, Table
6.25). This was also the case for mean diastolic pressure. Again, both fell in all 
tlu'ee groups over the period of study, the largest reductions being seen in the 
Control group.
6.7.2 Final systolic blood pressure
Final systolic blood pressure for each patient was analysed adjusting for their 
initial systolic reading. This model also accounted for the patient’s sex, smoking 
status (current, non-smoker, ex-smoker and unloiown) and Carstairs deprivation
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category (1-7). The practice factors o f training status, availability of a practice 
nurse, hypertension register and recall system were also adjusted for. The lowest 
unadjusted mean systolic blood pressure was found in the Strategic group (Table
6.26). After adjusting for clustering, and for practice and patient level factors, 
there was a significant difference in mean systolic pressure between the Strategic 
and Audit groups (3.09, Cl 1.28-5.71, p=0.019).
6.7.3 Final level of hypertension control
Final level o f control of hypertension was analysed adjusting for the patient’s sex, 
smoking status and deprivation category and for the practice factors of training 
status and practice nurse, and hypertension register and recall systems, which 
were more predominant in Control group practices. These were entered into a 
logistic model along with a binary indicator o f hypertension control (Table 6.27). 
The greatest proportions of control were found in the Strategic and Control groups 
(45.7% V 33.5% V 45.5%, Table 6.28). After adjusting for clustering, patient and 
practice effects, there was a significant difference in the level o f control of 
hypertension in the Strategic group compared with the other two groups (1.72, Cl 
1.09-2.70, p=0.019).
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6.8 Changes in absolute risk
There was a significant difference between the groups in relation to patients 
whose level o f risk increased or reduced. At the end of the study, level of risk had 
remained static for just under half of the patients in the Audit gioup, compared 
with ai'ound 40% in the Control group and less than one third in the Strategic 
group (41.8% V 48.9% v 31.4%, Table 6.29). Conversely, risk had increased for 
half o f patients in the Strategic group and for around 40% in the other two groups 
(41.6% V 39.9% V 49.9%). Risk was reduced for between 10-20% of patients in 
each group (16.6% v 11.2% v 18.7%). Differences between the groups in relation 
to changes in absolute risk were statistically significant (X^=l 16.10, DF=4,
p<0.001).
6.8.1 Revised blood pressure records
There was a significant difference in the proportion o f patients in each group who 
had their blood pressure record updated during the period o f study (Table 6.30). 
More than 80% of the patients in the Strategic had an updated record compared 
with just over half o f the Control gi'oup and less than half o f the Audit group 
(57.5% V 43.2% V 82.3%, X^=559.73, DF=2, p<0.001).
6.8.2 Changes in recorded risk factors
The greatest change in risk factors related to control o f blood pressure and this 
was significantly different across the groups (Table 6.31). The greatest proportion 
o f newly controlled patients was observed in the Control gi'oup and the least in the 
Audit group (16.3% v 11.4% v 15.5%, X^=73.42, DF=6, p<0.001). There was no 
statistically significant difference in the numbers o f patients in each group who 
went on to have a stroke (1.5% v 1.6% v 1.6%) or who were diagnosed with 
diabetes (2.5% v 2.3% v 2.8%). There was however, a significant difference in 
relation to changes in smoking status. Twice as many patients in the Strategic 
group had their record changed to reflect that they were a non-smoker or ex­
smoker (1.7% V 2.0% V 4.9%) whilst fewer patients in that group were newly 
recorded as current smokers (1.3% v 0.8% v 0.6%, X^=145.45, DF=8, p<0.001, 
Table 6.31).
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6.8.3 Changes for patients with reduced risk
Ai-oimd one third of the 816 patients whose level of risk fell had blood pressure 
which remained controlled during the period of study (Table 6.32). Almost half 
of the patients in the Control and Audit gioups had newly controlled blood 
pressure, as did just over one third o f patients in the Strategic group (45.5% v 
44.7% V 36.2%, X^=14.87, DF=6, p=0.021). In addition, 52 patients were now 
non-smokers or ex-smokers, the majority of them in the Strategic group, a 
difference which was statistically significant (1.7% v 6.7% v 10.1%, X^=l 05.37, 
DF=6, p<0.001).
6.8.4 Changes for patients with increased risk
Approximately half of the 2,263 patients whose risk level increased had 
uncontrolled blood pressure which remained uncontrolled throughout the study 
(45.7% V 56.6% V 44.3%, X^=33.33, DF=6, p<0.001, Table 6.33). There were no 
statistical differences between the groups in relation to the 79 patients who had a 
new stroke or the 121 patients who were newly diagnosed with diabetes, although 
there was a significant difference in the numbers newly recorded as smokers (3%
V 2.1% V 1.2%, X^=19.02, DF=6, p=0.004).
6.8.5 Attention bias
Analysis o f initial and final blood pressure control was also conducted for patients 
with isolated hypertension, that is, no additional stroke risk factors, compared 
with patients who had at least one o f the risk factors o f smoking, diabetes or 
previous stroke. Whilst there were significant differences in levels of control 
between the three study groups, there were no systematic differences related to the 
presence of additional risk factors (Table 6.34). Data from the casenote review 
showed that patients with additional risk factors had more visits to the GP in a 
year (median visits 12 v 8), had their blood pressure recorded more often (median 
record 6 v 4) and had higher mean systolic blood pressure (152.4 mm Hg v 146.5 
mm Hg) and lower mean diastolic pressure (79.6 mm Hg v 81.3 mm Hg).
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6.8.6 Characteristics of patients with new stroke
Seventy nine patients had a new stroke during the period o f study, 13 o f these also 
had a record o f a previous stroke (14.8% v 19.1% v 16.1%, Table 6.35). Two 
thirds o f the patients in the Audit and Strategic groups had been diagnosed with 
hypertension, compared with over 90% in the Control group. The majority were 
receiving antihypertensive treatment. Prior to this stroke, half o f the patients were 
in the low risk category (48.2% v 52.4% v 54.8%), whilst only one third were at 
highest risk (22.2% v 33.3% v 35.6%).
6.8.7 Co-existing disease
It was also possible to determine the presence o f co-morbidity for 4,129 patients 
with diagnosed hypertension (Table 6.36). Two thirds (65.6%) had co-existing 
major disease. The degi'ee o f co-morbidity ranged from one to seven additional 
major conditions. One third (33.5%) had two or more additional conditions, 14% 
had four or more, 5.3% had four or more and 1.5% of patients had five or more 
major conditions in addition to their hypertension. More than 900 of the patients 
had cardiovascular disease (22.2%), 17.4% had depression or other mental health 
problems and 8.2% had a cancer. Three hundred o f the patients had already had a 
stroke.
There was no increase in the prevalence o f co-morbidity with increasing 
deprivation. Two thirds (67%) o f affluent patients (deprivation categories 1 and 
2) had co-morbidity, as did 66% of those living in deprivation categories 3-5 and 
61% o f those living in the most deprived areas (6-7).
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6.9 Summary
The results o f this study demonstrate that there was a significant difference 
between the Control group and the other two gi'oups in relation to the number of 
practices with tiaining status, hi addition, the availability o f a hypertension 
register, hypertension clinic and recall system was also gi’eater in the Control 
group. Validation of electronic data against casenotes showed that whilst 
recording o f diagnoses, treatment and smoking status was high, only one third of 
patients had their most recent blood pressure recorded electronically.
At the outset o f the study, the majority of patients aged 65-79 had a blood 
pressure recorded, as did almost all diagnosed hypertensive patients. However, 
around half o f the treated hypertensive patients in each gi’oup were not controlled. 
Results for the 34 practices returning data over time demonstrate that the numbers 
of 65-79 year olds with a blood pressure recorded increased in each group, with 
the largest improvement seen in the Audit group. The greatest proportion of 
patients whose initial blood pressure was within nonnal limits was found in the 
Strategic group. This increased in all three groups, rising to almost two thirds in 
the Strategic group and to more than half in the Control gioup. More than 40% of 
the patients in the Control group whose blood pressure was initially uncontrolled 
were diagnosed as hypertensive, compared with just over one third in the other 
two groups, a difference which was statistically significant. Identification 
improved in all three gioups and the improvement made in the Control and Audit 
groups was two to tlri'ee times that made in the Strategic group.
During the study, the numbers of treated patients increased to more than 90% in 
all three groups, with the greatest improvement in the Strategic group. The 
numbers o f patients treated and adequately controlled rose by around 10% in each 
gi’oup. However, more than one third of all patients with diagnosed hypertension 
remained uncontrolled.
The largest reduction in observed systolic and diastolic blood pressure was seen in 
the Control group. In all three groups, mean pressure for diagnosed hypertensive 
patients was lower than for patients aged 65-79 generally, with the lowest levels 
found in the Strategic gi’oup. The lowest mean systolic blood pressure was found
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in the Strategic group and the greatest proportions o f control in the Strategic and 
Control groups. After adjusting for clustering, patient and practice effects, there 
was a significant difference in the level o f control in the Strategic group compared 
with the other two groups.
Absolute risk was reduced for between 10-20% of patients in each group. The 
largest reduction was found in the Strategic group. More than 80% of the patients 
in the Strategic group had their blood pressure updated compared with around half 
in the Audit and Control groups. There was no significant difference in the 
numbers of patients in each group who went on to have a stroke or who were 
diagnosed with diabetes. However, twice as many patients in the Strategic gioup 
had their record changed to reflect that they did not smoke and fewer patients in 
that gi'oup were newly recorded as smokers.
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Table 6.1 -  Recruited practices by strata
DEPRIVATION PRACTICE SIZE
PAYMENT LEVEL 1-2 GPs 3-4 GPs > 5  GPs
Require* Recruit** Require Recruit Require Recruit
0% (low) 7 6 4 4 2 2
5-15% (medium) 7 7 11 11 10 9
> 20% (high) 9 7 7 7 3 1
Number of practices required from stratum {n=60}
* Num ber o f practices recruited from stratum (n=54)
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Figure 6a -  Flow of practices through the study
744 GRASS practices
179 practices contacted
12 provided 
comparative data
9 provided 
comparative data
13 provided 
comparative data
17 assigned 
audit only
18 assigned 
audit plus strategic
19 assigned 
control
153 practices with 1-4% 
or 16-19% deprivation
54 randomised
6 practices had no 
deprivation data
585 potentially 
eligible practices
12 practices 
included
85 declined participation 
40 did not respond
15 practices 
included
1 withdrew 
2 did not 
return data
2 did not 
return data
1 withdrew 
4 did not 
return data
17 practices 
included
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Table 6.2 -  Local Health Care Co-operatives covered by participating 
practices
HEALTH BOARD (TOTAL LHCCs) NUMBER OF F
Argyll & Clyde (n=7)
Inverclyde LHCC 1
Lomond LHCC 1
West Renfrew LHCC 2
Ayrshire & Arran (n=7)
Ayr, Prestwick & Troon LHCC 3
Irvine, Kilwinning & Dundonald LHCC 1
Stevenston, Saltcoats & Kilwinning LHCC 1
Borders (n=2)
Borders LHCC 1
Borders West LHCC 1
Dumfries & Galloway (n=4)
Wigtownshire LHCC 2
Forth Valley (n=2)
Forth Valley LHCC (North) 3
Forth Valley LHCC (South) 3
Greater Glasgow (n=16)
Anniesland/Bearsden/Milngavie LHCC 1
Camglen LHCC 1
Dennistoun LHCC 1
Drumchapel LHCC 1
Eastern Glasgow LHCC 1
Greater Shawlands LHCC 1
North Glasgow LHCC 1
Riverside LHCC 2
South West Glasgow LHCC 2
Strathkelvin LHCC 2
Westone LHCC 1
Grampian (n=8)
Central Aberdeenshire LHCC 2
Deeside LHCC 1
Moray LHCC 1
Highland (n=9)
East Sutherland LHCC 1
Inverness LHCC 2
Lanarkshire (n=8)
Clydesdale LHCC 1
Hamllton/Blantyre LHCC 1
Motherwell LHCC 2
Wishaw/Newmains/Shotts LHCC 1
Lothian (n=8)
Midlothian LHCC 1
North East Edinburgh LHCC 2
South Central Edinburgh LHCC 1
South East Edinburgh LHCC 1
West Lothian LHCC 1
Tayside (n=4)
Arbroath & Friockheim LHCC 1
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Table 6.4 -  Practice size and deprivation level at study outset
PRACTICE
CHARACTERISTIC
STUDY GROUP (Practices)
Control Audit Strategic
(n=19) (n=16) (n=17)
Number of GPs -  mean (range) 3.4 (1-11) 3.5 (1-6) 3.5 (1-6)
List size -  mean 4624 5231 5207
(750-18335) (1000—11500) (1900-9000)
Deprivation payment -  median 8% (0-54) 9% (0-43) 8% (0-28)
Low deprivation (0%) 4 (21%) 4 (25%) 4 (23%)
Medium deprivation (5-15%) 8 (42%) 8 (50%) 11(65%)
High deprivation (> 20%) 7 (37%) 4 (25%) 2(12%)
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Table 6.5 -  Practice structure and organisation at study outset
PRACTICE
CHARACTERISTIC
STUDY GROUP (Practices) CHI-SQUARED 
TEST RESULT
Control
(n=18)*
Audit
(n=14)*
Strategic
(n=16)*
Training practice 9 (50%) 4 (29%) 4 (25%) X" = 2.72; d f - 2 ;  
p=0.257
Practice nurse 16 (89%) 12 (86%) 15 (94%) X^= 0.53; df = 2; 
p=0.767
Hypertension register 16 (89%) 8 (57%) 12 (75%) X^= 4.23; df = 2;
p=0.120
Hypertension clinic 8 (44%) 4 (29%) 4 (25%) X^“ 1.64; df = 2; 
p=0.440
Recall system 14 (78%) 9 (64%) 10 (63%) X^= 1.10; df = 2; 
p=0.576
* Relates to practices which returned a questionnaire prior to the collection of electronic data (n-48)
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Table 6.6 -  Practice structure and organisation by practice size
PRACTICE
CHARACTERISTIC
PRACTICE SIZE CHI-SQUARED 
TEST RESULT
1-2 GPs
(n=17)*
3-4 GPs 
(n=18)*
>5 GPs 
(n=13)*
Training practice 4 (24%) 5 (28%) 8 (62%) X^=5.39; df ~2;
p—0.068
Practice nurse 15(88%) 15(83%) 13 (100%) X^=2.30; df = 2; 
p=0.317
Hypertension register 15 (88%) 13 (72%) 8 (62%) X='=2.92; df = 2; 
p=0.232
Hypertension clinic 7 (41%) 6 (33%) 3 (23%) X^= 1 09; df = 2; 
p=0.581
Recall system 16 (94%) 11 (61%) 6 (46%) X^=8.67; df = 2; 
p=0.013
* Relates to practices which returned a questionnaire prior to the collection of electronic data (n=48)
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Table 6.7 -  Practice structure and organisation by deprivation
payment level
PRACTICE
CHARACTERISTIC
DEPRIVATION PAYMENT LEVEL CHI-SQUARED 
TEST RESULT
0%
(n=12)*
5-15%
(n=26)*
>20%
(n=10)*
Training practice 4 (33%) 9 (35%) 4 (40%) X^=0.12; df = 2; 
p=0.941
Practice nurse 9 (75%) 25 (96%) 9 (90%) X^= 3.94; df = 2; 
p=0.139
Hypertension register 7 (58%) 19 (73%) 10 (100%) X^=5.16; df = 2; 
p=0.076
Hypertension clinic 2(17%) 10(39%) 4 (40%) X  ^= 2.01; df = 2; 
p=0.366
Recall system 8 (67%) 17 (65%) 8 (80%) X^=0.75; df = 2; 
p=0.687
Relates to practices which returned a questionnaire prior to the collection of electronic data (n=48)
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Table 6.8 -  Practice changes between recruitment and end of study
CHANGE IN PRACTICE STUDY GROUP
CHARACTERISTIC Control Audit Strategic
Addition of partner 1 1 1
Loss of partner 1
Change of partner 3 6 -
Addition of practice nurse 1 1
Loss of practice nurse
Change of practice manager 6 - 1
Became training practice - - 2
No longer training practice 1
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Table 6.9 -  Electronic data returns by practice
PRACTICE HEALTH BOARD AREA EQ1 EQ 2 EQ 3
A01 GGHB ■ ■ ■
C02
A03
Lothian
Highland
■ ■
S04 Ayrshire & Arran ■ ■ ■
005 GGHB ■ ■
S06 Lothian ■ ■ ■
007 Grampian ■ ■
S09 Forth Valley ■ [X] ■
A10 Lothian ■
O il Dumfries & Galloway ■ 0 ■
812
A13
Argyll & Oiyde 
GGHB
■
■
■
814 Lothian ■ ■ ■
A15 Grampian ■ 0 ■
816 Lothian ■ 0 H
817 Argyll & Olyde ■ ■ ■
018 Lothian ■ ■ ■
819 Tayside ■ ■
020 Forth Valley ■ ■ m
021
022
Argyll & Olyde 
Lanarkshire
■ ■
A23 Lanarkshire ■ ■ ■
A24 Forth Valley ■ 0 ■
825 Ayrshire & Arran ■ ■
A26 GGHB ■ ■
A27
828
Grampian
Lanarkshire
■ ■
029
A30
Highland
GGHB
■ 0
831 Forth Valley ■ ■
832 GGHB ■ ■
033
A34
GGHB
GGHB
■
■
■ ■
035
036
Ayrshire & Arran 
GGHB ■
■ ■
037 GGHB ■ ■
A38
A39
840
A41
842
043
Forth Valley
GGHB
GGHB
Highland
Forth Valley
Lanarkshire
■
■
m
m
0
844 Dumfries & Galloway m 0
046 Borders m ■ ■
A47 Lanarkshire ■ ■
048 Argyll & Olyde ■ ■
A49
050
051
Ayrshire & Arran 
GGHB
Ayrshire & Arran
■ ■ ■
■
852 Grampian ■ 0 ■
053 Borders m 0 0
854 GGHB tHI ■ ■
Practice returned data
System problem prevented data return or processing
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Table 6,10 -  Content of electronic data returned by participating 
practices
DATA EXTRACTED EQ EXTRACTION PERIOD (Practices)
Extract 1 Extract 2 Extract 3
(n=37) (n=25) (n=28)
Total number of patients 197,702 124,368 182,743
Number of patients aged 65-79 23,512 14,197 20,744
Items of measurement data 308,474 327,327 329,571
Items of Read coded data 2,810,505 2,162,668 3,150,223
Items of prescribing data 2,400,823 3,390,391 6,127,119
Total number of practices returning data during the study
Total number of patients for whom data was extracted
Total number of patients aged 65-79
Total number of measurement items extracted
Total number of Read coded Items extracted
Total number of prescribing items extracted
44
217,125
30,345
498,748
4,431,067
7,576,425
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Table 6.11 -  Electronic data for patients aged 65-79
EXTRACTION PERIOD STUDY GROUP (PRACTICES)
Extract 1 Control (n=12) Audit (n=11) Strategic (n=14)
Number of patients aged 65-79 5,777 6,584 8,796
Mean per practice (range) 481 (122-1014) 599 (199-1290) 628 (239-1375)
With diagnosed hypertension 1,511 1,466 1,972
Mean per practice (range) 126 (18-344) 133 (30-342) 141 (39-315)
Extract 2 Control (n=11) Audit (n=7) Strategic (n=7)
Number of patients aged 65-79 5,828 4,250 4,119
Mean per practice (range) 530 (129-954) 607 (199-1292) 588 (229-1334)
With diagnosed hypertension 1,757 1,137 1,065
Mean per practice (range) 160 (24-355) 162 (32-365) 152 (56-360)
Extract 3 Control (n=11) Audit (n=6) Strategic (n=11)
Number of patients aged 65-79 4,979 4,731 7,547
Mean per practice (range) 453 (127-970) 789 (191-1297) 686 (192-1328)
With diagnosed hypertension 1,657 1,366 1,927
Mean per practice (range) 151 (39-319) 228 (72-442) 175 (63-342)
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Table 6.12 -  Validation of electronic data
ITEM
VALIDATED
Diagnosis of hypertension
Agreement in both record formats 
Diagnosis in casenote only 
Diagnosis on electronic record only
STUDY GROUP (Patients)
Control
(n=84)
79 (94%) 
4 
1
Audit
(n=80)
Strategic
(n=28)
68 (85%) 26 (93%)
10 2
2 0
Diagnosis of diabetes
Agreement in both record formats 83 (99%) 77 (96%) 28 (100%)
Diagnosis in casenote only 0 2 0
Diagnosis on electronic record only 1 1 0
Diagnosis of previous stroke
Agreement in both record formats 81 (96%) 78 (98%) 26 (93%)
Diagnosis in casenote only 3 2 2
Diagnosis on electronic record only 0 0 0
Receiving anti-hypertension drug(s)
Agreement in both record formats 77 (92%) 78 (98%) 28 (100%)
Treatment in casenote only 5 2 0
Treatment In electronic record only 2 0 0
Most recent blood pressure
Recorded In both record formats 18(21%) 13(16%) 9(32%)
Most recent in casenote only 52 54 13
Most recent in electronic record only 10 13 6
Dates tally, variance in reading 4 0 0
Recorded smoking status
Agreement in both record formats 68 (81%) 71 (89%) 23 (82%)
Smoker in casenote, not in electronic 3 1 1
Smoker In electronic, not In casenote 9 3 1
Variance between non / no record 4 5 3
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Table 6.13 -  Comparison of blood pressure levels for patients with 
most recent recording in casenote (n=119)
BLOOD PRESSURE 
LEVEL RECORDED
<160/90 or >160/90 in both formats 
<160/90 in casenote, >160/90 on computer 
>160/90 in casenote, <160/90 on computer
STUDY GROUP (Patients)
Control
(n=52)
31 (60%) 
12(23%) 
9(17% )
Audit
(n=54)
29 (54%) 
18 (33%) 
7 (13%)
Strategic
(n=13)
11 (84%) 
1 (8%)
1 (8%)
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Table 6.14 -  Identification of hypertension in 65-79 year olds at
baseline*
PATIENT VARIABLE STUDY GROUP (Practices)
Control Audit Strategic
(n=12) (n=9) (n=14)
All patients: mean (range) 481 599 628
(122-1014) (199-1290) (239-1375)
Male 44.3% 42.0% 44.1%
Female 55.7% 58.0% 55.9%
BP recorded 86.5% 73.5% 74.4%
BP <160/90 55.7% 45.1% 47.6%
BP >160/>90 30.8% 28.4% 26.8%
BP >160/>90, 38.7% 35.8% 35.3%
diagnosed hypertensive
Based on data returned In the Initial Electronic Questionnaire
CHI-SQUARED 
TEST RESULT
5.27; df = 2; 
p=0.072
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Table 6.15 -  Treatment and control of 65-79 year old diagnosed
hypertensives at baseline
PATIENT VARIABLE
Hypertensive patients: 
mean (range)
BP <160/90 
BP >160/>90 
No record of BP
Diagnosed hypertensive, 
on treatment
Treated, no record of BP 
Treated, BP >160 / >90
Diagnosed, on treatment, 
BP controlled
STUDY GROUP (Practices) CHI-SQUARED 
TEST RESULT
Control
(n=12)
126
(18-344)
52.3%
45.5%
2 .1 %
88 .0%
2 .0%
45.7%
52.3%
Audit
(n=9)
163
(30-342)
41.3%
45.7%
13.0%
85.7%
11.5% 
46.2%
42.4%%
Strategic
(n=14)
141
(39-315)
48.3%
42.3%
9.4%
81.7%
8 .6%
43.2%
X^= 27.28; df = 2;
p<0.001
48.2%% X" = 25.76; df = 2; 
p<Q.001
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Table 6.16 -  Size and deprivation status of practices returning
comparative data (n=34)*
PRACTICE
CHARACTERISTIC
Number of GPs -  mean (range) 
List size -  mean
Deprivation payment -  median 
Low deprivation (0%)
Medium deprivation (5-15%) 
High deprivation (> 20%)
STUDY GROUP (Practices)
Control
(n=12)
3.2 (1-6) 
3972 
(750-6700)
8% (0-37)
4 (33%)
3 (25%)
5 (42%)
Audit
{n=9)
4.0 (2-6) 
5667 
(1500—11500)
9% (0-22)
3 (33%)
3 (33%)
3 (33%)
Strategic
(n=13)
3.8 (1-6) 
5602 
(1900-9000)
8% (0-23)
3 (23%)
9 (69%)
1 (8%)
* Practices which returned data in two or more Electronic Questionnaires. If the practice returned 
data In all three, the first and the last were compared.
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Table 6.17 -  Practice structure and organisation of practices
returning comparative data
PRACTICE
CHARACTERISTIC
STUDY GROUP (Practice) CHI-SQUARED 
TEST RESULT
Control
(n=12)
Audit
(n=9)
Strategic
(n=13)
Training practice 7 (58%) 2 (22%) 4 (31%) X^=3.34; df = 2; 
p=0.189
Practice nurse 10(83%) 8 (89%) 13 (100%) *
Hypertension register 11 (92%) 4 (44%) 6 (69%) X^=5.54; df = 2; 
p=0.063
Hypertension clinic 5 (42%) 2 (22%) 3 (23%) X^= 1.34; df = 2; 
p=0.511
Recall system 8 (67%) 5 (56%) 7 (54%) X^=0.48; df = 2; 
p=0.788
* Unable to run Chl-squared test due to lack of data In some cells
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Table 6.18 -  Computer use in practices returning comparative data
FEATURE OF COMPUTER UTILISATION STUDY GROUP (Practices)
Control Audit Strategic
(n=12) (n=9) (n=13)
Terminai available in all doctor rooms 11 (92%) 9 (100%) 10(77%)
Terminal available in all nurse rooms 10 (83%) 8 (89%) 10(77%)
GP data entry 10 (83%) 9 (100%) 10 (77%)
Nurse data entry 11 (92%) 7 (78%) 11 (85%)
Minimum dataset collected for all patients 9 (75%) 6 (67%) 10 (77%)
Disease registers totally/largely computerised 6 (50%) 7 (78%) 7 (54%)
Clinical records totally/largely computerised 1 (8%) 1 (11%) 1 (8%)
Call and recall totally/largely computerised 7 (58%) 8 (89%) 10 (77%)
Highlighting tasks totally/largely computerised 2 (18%) 4 (44%) 6 (46%)
Guidelines totally/largely computerised 4 (36%) 1 (11%) 1 (8%)
Past medical history entered for all patients 9 (75%) 7 (78%) 11 (85%)
Recall information entered for all patients 12 (100%) 9 (100%) 13 (100%)
Measurement data entered for all patients 6 (50%) 5 (56%) 6 (50%)
Diagnosis entered for all patients 6 (50%) 5 (56%) 4 (36%)
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Table 6.21 -  Identification, treatment and control by practice size
RULE OF HALVES PRACTICE SIZE CHI-SQUARED
TEST RESULT
1-2 GPs 3-4 GPs >5 GPs
Identified-INITIAL 43.8% 38.3% 51.3% X^= 51.35; df = 2;
p<0.001
Identified -  FINAL 46.2% 45.3% 52.5% X^= 14.02; df = 2;
p=0.0Q1
Treated-INITIAL 81.3% 91.1% 87.7% X^= 30.95; df = 2;
p<0.001
Treated -  FINAL 93.9% 92.4% 94.4% X^= 5.18; df = 2;
p=0.075
Controlled-INITIAL 57.5% 53.3% 48.5% X^= 11.98; df = 2;
p=0.003
Controlled -  FINAL 69.0% 60.1% 57.7% X^= 20.21; df = 2;
p<0.001
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Table 6.22 -  Identification, treatment and control by practice
deprivation payment level
RULE OF HALVES DEPRIVATION CHI-SQUARED
PAYMENT LEVEL TEST RESULT
0% 5-15% >20%
Identified -  INITIAL 44.4% 43.5% 48.9% X^= 6.36; df = 2;
p=0.042
Identified -  FINAL 46.8% 46.3% 58.8% X^= 26.71; df = 2;
p<0.001
Treated -  INITIAL 84.6% 87.3% 92.1% X" = 20.52; df = 2;
Treated -  FINAL 93.1% 94.0% 92.9% X^“ 1.67; df = 2;
p<0.001
 
p=0.435
Controlled -  INITIAL 44.0% 51.1% 57.6% X^  = 23.22; df = 2;
p<0.001
Controlled -  FINAL 53.6% 58.6% 68.7% X^  = 40.41 ; df = 2;
p<0.001
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Table 6.23 -  Characteristics of patients with matched records 
(n=5103)*
PATIENT FACTOR STUDY GROUP (Patients)
Control Audit Strategic
(n=1813) (n=1339) (n=1951)
Male 40.5% 37.1% 40.5%
Female 59.5% 62.9% 59.5%
Patient deprivation category
1-2 (most affluent) 19.1% 1.5% 39.3%
3-5 45.8% 82.4% 55.3%
6-7 (most deprived) 35.1% 16.1% 5.4%
Smoking status
No record 15.9% 15.4% 12.3%
Non-smoker / ex-smoker 63.4% 65.4% 66.7%
Smoker 20.7% 19.2% 21,0%
Diabetic 9.9% 9.5% 8.7%
Previous stroke 5.1% 4.8% 4.3%
* Patients on whom feedback was provided and whose initial and final data could be linked for 
comparison
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Table 6.24 -  Change In mean blood pressure for patients aged 65-79 
with matched records
MEAN BLOOD 
PRESSURE
STUDY GROUP (Patients) RESULTS OF 
AN OVA
Control Audit Strategic
(n=1813) (n=1339) (n=1951)
Initial systolic 153.3 156.0 152.5 p<0.001
Final systolic 150.0 154.3 149.8 p“ 0.005
Reduction in systolic 3.3 mm Hg 1.7 mm Hg 2.7 mm Hg
Initial diastolic 86.2 87.1 85.9 p<0.001
Final diastolic 84.0 85.8 83.9 P<0.001
Reduction in systolic 2.2 mm Hg 1.3 mm Hg 2.0 mm Hg
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Table 6.25 -  Change In mean blood pressure for diagnosed
hypertensive patients aged 65-79 with matched records
MEAN BLOOD 
PRESSURE
STUDY GROUP (Patients) RESULTS OF 
AN OVA
Control
(n=1165)
Audit
(n=775)
Strategic
(n=1258)
Initial systolic 150.0 153.0 148.8 p<0.001
Final systolic 146.6 151.3 145.7 P<0.0G1
Reduction in systolic 3.4 mm Hg 1.7 mm Hg 3.1 mm Hg
Initial diastolic 84.3 85.5 83.6 p<0.001
Final diastolic 81.8 83.8 81.3 P<0.001
Reduction in systolic 2.5 mm Hg 1.7 mm Hg 2.3 mm Hg
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Table 6.26 -  Summary results of mixed model for final systolic blood
pressure in patients aged 65-79 with matched records
FINAL SYSTOLIC 
PRESSURE
Mean final SBP 
Model adjusted SBP 
vs. Control (95% Cl)
vs. Strategic (95% Cl)
STUDY GROUP (Patients)
Control Audit Strategic
(n=1813) (n=1339) (n=1951)
150.0 154.3 149.8
151.2 152.7 149.6
1.43 (-0.65, 4.14); 
p=0.723*
1.66 (-0.33, 3.98); 3.09 (1.28, 5.71);
p=0.398* p=0.019*
-1.66 (-3.98, 0.33); 
p=0.398*
* Bonferroni corrected and adjusted for patient’s initial SBP, sex, smoking status, social deprivation 
and practice level factors of training status, practice nurse, hypertension register and recall system
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Table 6.27 -  Summary results of GEE model for final control of 
hypertension in patients aged 65-79 (yes I no)
VARIABLE RR 95% Cl p-value
Trial arm
Audit V  Strategic 0.540 0.331 to 0.880 0.013
Control V  Strategic 0.582 0.370 to 0.915 0.019
Strategic v Control 1.718 1.093 to 2.703 0.019
Audit V  Control 0.928 0.550 to 1.568 0.782
Initial control (yes v no) 20.9 17.6 to 24.9 <0.001
Sex (male v female) 1.015 0.881 to 1.170 0.835
Smoking status
Current v unknown 1.139 0.896 to 1.448 0.287
Non-smoker v unknown 1.310 1.060 to 1.619 0.012
Ex-smoker v unknown 1.176 0.910 to 1.519 0.213
Social deprivation
Unknown v 7 0.515 0.325 to 0.818 0.005
1 V  7 0.546 0.344 to 0.865 0.010
2 V  7 0.431 0.275 to 0.677 <0.001
3 v7 0.468 0.306 to 0.717 <0.001
4 V  7 0.623 0.421 to 0.923 0.018
5 V  7 0.639 0.422 to 0.968 0.035
6 V  7 0.656 0.447 to 0.962 0.031
Practice level variables
Training status 0.870 0.577 to 1.310 0.504
Practice nurse availability 0.451 0.237 to 0.855 0.015
Hypertension register 1.594 0.960 to 2.649 0.072
Recall system 1.568 0.991 to 2.479 0.055
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Table 6.28 -  Summary results of GEE model for final proportion of
controlled hypertensives aged 65-79 with matched records
FINAL CONTROL
Final proportion 
controlled
Mean predicted 
proportion
Adjusted RR (95% 01)
Control
(n=1813)
45.7%
46.5%
1.00
STUDY GROUP (Patients)
Audit Strategic
(n=1339) (n=1951)
33.5% 45.5%
35.4% 49.4%
0.93 (0.55, 1.57); 
p=0.782*
1.72 (1.09, 2.70): 
p=0.019*
* Adjusted fo r patient’s initial hypertension control, sex, smoking status, social deprivation and for 
the practice level factors o f training status, practice nurse, hypertension register and recall system.
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Table 6.29 -  Change in level of absolute risk* for patients aged 65-79
with matched records
LEVEL OF RISK STUDY GROUP (Patients) CHI-SQUARED TEST RESULT
Control
(n=1813)
Audit
(n=1339)
Strategic
(n=1951)
Reduced risk 16.6% 11.2% 18.7%
Increased risk 41.6% 39.9% 49.9%
X^= 116.10; 
df = 4; p<0,001
No change 41.8% 48.9% 31.4%
* Change related to any Increase or decrease In the level of absolute risk, regardless of the size of 
the change
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Table 6.30 -  Updated blood pressure record for patients aged 65-79
with matched records
BLOOD PRESSURE 
RECORD
Electronic record 
Updated during study
Electronic record not 
updated during study
STUDY GROUP (Patients)
Control
(n=1813)
57.7%
42.3%
Audit
(n=1339)
43.2%
56.8%
Strategic
(n~1951)
82.3%
17.7%
CHI-SQUARED 
TEST RESULT
559.73; 
df = 2; p<0.001
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Table 6.31 -  Change in risk factors for patients aged 65-79 with
matched records
RISK FACTOR
Blood pressure
Newly controlled 
Newly uncontrolled
Stroke status
New CVA
Diabetes status
New diabetes 
Previously diabetic*
Smoking status
New non / ex smoker 
New smoker
STUDY GROUP (Patients) CHI-SQUARED 
TEST RESULT
Control
(n=1813)
16.3%
3.8%
1.5%
2.5%
0 .2%
1.7% 
1.3%
Audit
(n=1339)
11.4% 
4.0%
1 .6%
2.3%
0 .0%
2 ,0%
0 .8%
Strategic
(n=1951)
15.1%
5.5%
1.6%
2 .8%
0 .2%
4.9%
0 .6%
X^= 73.42;
df = 6; p<0.001
1.89; 
df = 4; p=0.756
= 3.50; 
df = 4; p=0.477
145.45;
df = 8; p<0.001
Patients who previously had a diagnosis of diabetes on com puter which was subsequently deleted
173
Table 6.32 -  Risk reducing factors in patients with reduced risk
STUDY GROUP (Patients)RISK FACTOR CHI-SQUARED 
TEST RESULT
Control
(n=301)
Audit
(n=150)
Strategic
(n=365)
Newly controlled 45.5% 44.7% 36.2% X^= 14.87; 
df = 6; p=0.021Still controlled 33.6% 26.0% 34.2%
Previously diabetic 0.7% 0.0% 1.1% X^=4.27; 
df = 4; p=0.370
New non / ex smoker 1.7% 6.7% 10.1% X^= 105.37; 
df = 6; p<0.001
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Table 6.33 -  Risk increasing factors in patients with increased risk
RISK FACTOR STUDY GROUP (Patients)
Control Audit Strategic 
(n-755) (n=534) (n=974)
CHI-SQUARED 
TEST RESULT
Newly uncontrolled 6.9% 9.2% 8.1% X^= 33.33;
Still uncontrolled 45.7% 56.6% 44.3% df = 6; p<0.001
New CVA 3.2% 2.8% 2.8% X^= 4.96; 
df = 4; p=0.291
New diabetes 5.4% 5.4% 5.2% X^=0.41; 
df -  2; p=0.979
New smoker 3.0% 2.1% 1.2% X^= 19.02; 
df = 6; p=0.004
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Table 6.34 -  Control of hypertension in patients aged 65-79 with and
without risk factors
PATIENT
CHARACTERISTIC
Isolated hypertension
Controlled at outset
Controlled at end
Additional risks
Controlled at outset
Controlled at end
STUDY GROUP 
Control Audit Strategic
50.7%
57.6%
53.3%
65,3%
45.7%
51.8%
44.0% 
51.6%
57.0%
64.0%
52.7%
67.1%
CHI-SQUARED 
TEST RESULT
X^= 17.34; df = 2;
p<0.001
X^= 25.85; df = 2;
p<0.001
X"=6.39; df = 2; 
p=0.41
X^= 26.27; df = 2;
p<0.001
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Table 6.35 -  Initial characteristics of patients who had a new stroke
PATIENT FACTOR STUDY GROUP (Patients)
Control
(n=27)
Audit
(n=21)
Strategic
(n=31)
Male 44.4% 42.9% 61.3%
Female 55.6% 57.1% 38.7%
Age group
6 5 -6 9 37.0% 52.4% 41.9%
7 0 -7 4 33.3% 19.1% 32.3%
7 5 -7 9 29.6% 28.6% 25.8%
Deprivation category
1-2 (most affluent) 14.3% 0.0% 34.6%
3-5 76.1% 94.1% 46.1%
6-7 (most deprived) 9.6% 5.9% 19.2%
Hypertensive status
Diagnosed 92.6% 66.7% 67.7%
Undiagnosed 7.4% 33.3% 32.3%
Treatment
Anti-hypertensive drugs 92,6% 66.7% 83.9%
No anti-hypertensive drugs 7.4% 33.3% 16.1%
Smoking status
No record 7.4% 28.6% 32.3%
Non-smoker / ex-smoker 59.3% 52.4% 48.4%
Smoker 33.3% 19.1% 19.4%
Diabetic 22.2% 9.5% 22.6%
Previous stroke 14.8% 19,1% 16.1%
Initial absolute risk
Low (0-15%) 48.2% 52.4% 54.8%
Medium (15-25%) 29.6% 14.3% 9.7%
High (>25%) 22.2% 33.3% 35.6%
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Table 6.36 -  Prevalence of major morbidity in diagnosed
hypertensive patients aged 65-79 (n=4129)
CONDITION NUMBER OF 
PATIENTS (%)*
PERCENT
Ischaennic heart disease 915 22.2
Circulatory system problems 794 19.2
Osteoarthritis / other arthropathy 748 18.1
Depression / mental health problem 717 17.4
Respiratory disease 517 12.5
Diabetes 465 11.3
Cancer 338 8.2
Breast 63 1.5
Gastro-intestinal 30 0.7
Gynaecological 25 0.6
Prostate 15 0.4
Lung 14 0.3
Other 212 5.1
Stroke 300 7.3
Renal disease 79 1.9
Epilepsy 50 1.2
* Patients have more than one condition; therefore percentages do not total 100
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7.1 Chapter overview
The research reported in this thesis has raised many issues worthy of discussion, 
both with respect to the study methodology and its findings, and to developments 
within general practice. This chapter discusses these issues in detail, beginning 
with reflections on the methods used to carry out this research. This is followed 
by consideration o f the issues related to changes in the rule o f halves over time 
and the importance o f practice organisation in relation to those changes. The 
content o f the feedback provided is discussed along with important factors related 
to the communication o f risk. Finally, the importance of practitioner and patient 
behaviour is considered, as are the implications o f using electronic data in this 
type o f research. The chapter ends with a summary o f the potential impact, good 
and bad, o f the 2003 General Medical Services (GMS) contract.
Two different types of analyses were conducted in this study (section 2.11); 
cluster analysis of final systolic blood pressure and final proportion of patients 
controlled in each group (Results tables 6.26 and 6.28), and comparative analyses 
of all other data, including the proportion of hypertensive patients obseived to be 
identified, treated and controlled (6.5-6.25; 6.29-6.35). The results presented in 
this chapter have been distinguished as resulting from either cluster analysis or 
comparative analysis and have been discussed in relation to the issues that they 
raise.
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7.2 Reflections on the study methodology
This study was designed to evaluate the impact o f feedback, developed from 
electronic records, on management of hypertension in patients aged 65-79. This 
was done by means o f a randomised controlled trial comparing a gi’oup which did 
not receive feedback with one which received audit feedback and another which 
received strategic feedback prioritising patients at risk of stroke. The methods 
have been described in chapter 2 and additional chapters have reported specific 
issues related to the development and conduct o f the study (chapters 3 and 4). As 
is the case with most research, there are aspects of this study which proved 
strengths; there are also aspects which could have been carried out in a different 
way.
7.2.1 Practice recruitment
One o f the main limitations to the study relates to the numbers o f practices taking 
part. The original sample size calculation was based on recmiting 60 practices, 20 
to each o f the three study arms. In reality, only 52 practices were recruited and of 
those only 34 practices returned more than one set o f electronic data. However, 
this calculation was based on acquiring data from 40 patients in each practice. 
Clearly, even considering only those 34 practices which returned multiple sets of 
data, more than 2,400 patients were included. In addition, the ICC used in the 
calculation was estimated conservatively at 0.1, compared with 0.06 suggested by 
Fahey and Peters (Fahey & Peters 1996). This reduced number o f practices still 
gives 80% power to detect differences o f 15% or more, assuming a lower but still 
acceptable ICC of 0.04.
7.2.2 Sampling criteria
The organisational and the structural characteristics o f practices will undoubtedly 
impact on whether and how they respond to feedback information. When 
recruiting practices to a study of this type, it was therefore important to attempt to 
account for those factors which were likely to have the greatest impact. Level of 
practice computerisation may determine the sorts o f data that are collected 
electronically and as such, influence the knowledge that can be gleaned from
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those data. However, that may be more likely to impact on a practice’s ability to 
generate feedback for research rather than their ability to utilise it. In addition, 
geographic and health board location may influence practice decision making and 
activity, reflecting either population need or local priorities. Nonetheless, at the 
outset o f the study we considered that two of the most important determinants of 
practice response to the intervention would be the availability o f practitioners and 
existing practice workload. It was therefore decided to use these as sampling 
criteria and eligible practices were stratified by practice size and by deprivation 
payment level, a proxy for workload, before recmitment began.
Results from the study have shown that practices recruited to the three groups 
were similar in terms o f number o f partners, practice list size and deprivation 
payment levels (Table 6.4). However, data obtained from the Practice Structure 
Questionnaire showed a marked, although not statistically significant difference, 
between the Control gioup and the other two groups with respect to training 
practice status. In addition, and most likely as a result o f this, there were also 
greater numbers o f practices in the Control group with a register o f hypertensive 
patients, running a hypertension clinic and operating a recall system for 
hypertension (Table 6.5).
Accreditation for training practice status is gi'anted only if  a practice meets certain 
criteria, relating both to services for patient and to the primary care team itself. 
Training practices are expected to manage chronic diseases in line with existing 
guidelines and there are several criteria related to this which are likely to impact 
on management o f hypertension (NHS Education for Scotland 2002). These 
criteria include the provision of evidence that,
“The practice collects information on the factors that put their 
patients’ health at risk, including smoking habit, alcohol intake, and 
blood pressure ”
“Thepractice maintains a register o f patients with chronic disease 
and there are agreed definitions for entering data ’’
“The team ensures that systematic call and recall o f  patients on their 
register is taking place and that they are reviewed regularly ”
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“The team has developed protocols fo r  the management o f  chronic
disease which are to guide the care that they provide”
“The team audits their chronic disease management regularly”
Practices which have been granted training practice status are required to 
demonstrate that they have a formalised approach to the management and 
continued audit o f care for patients with clnonic diseases. This may explain why 
the Control group had the best rates o f identification and treatment at the outset of 
the study and why they demonstrated improvements in these and the largest 
observed improvement in the proportion of patients controlled, despite having 
received no feedback. Thus, if a similar type o f study were to be carried out in the 
future, it would be prudent to include training practice status as a stratification 
variable.
7.2.3 Participating practices
The recruitment strategy used in this study was designed to try and ensure that the 
participants were representative of general practices in Scotland. Practices were 
stratified by size and deprivation and a random sample from each stratum was 
then contacted by letter and invited to participate. Eight iterations o f this process 
were necessary and a total o f 179 practices were contacted, 17% of the total 
number of practices in Scotland at that time. Fifty four o f these practices gave 
initial agreement to take part, a recruitment rate o f 30%; 52 actually participated, 
87% of the planned sample. Given the aim o f the study and the population 
required, this was a valid method o f trying to minimise bias, the issue o f training 
practice status notwithstanding. Whilst the rate of participation is relatively low, 
it is in keeping with results from similar studies recruiting in general practice.
This includes the Australian National Blood Pressure study, which employed a 
range o f methods, including peer to peer recruitment, financial incentives, 
reimbursement o f consultation and treatment costs and continuing vocational 
registration for a three year period, and had an uptake rate o f 24% (Reid et al. 
2001). In addition, actual recruitment in relation to the planned sample is better 
than in many other trials, which often achieve less than 75% (Chaiison & Horwitz 
1984).
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There is little evidence in the literature in relation to optimum strategies for 
recruitment to trials. In the main, what evidence there is relates to recruitment of 
patients. A recent report from the Health Teclmology Assessment programme on 
the factors limiting the quality and progi'ess of randomised controlled trials, 
outlines possible reasons for poor recruitment (Prescott et al. 1999). These 
include time constraints, lack o f availability of practice staff to support 
participation, rewards and recognition, impact on the doctor-patient relationship, 
concern for patients, perceived importance o f the trial, loss o f autonomy and 
incompatibility o f the study protocol with normal practice. Many o f these 
constraints were not relevant to the study reported in this thesis. There was no 
formal obligation on practitioners to change their practice, there was unlikely to 
be any impact on the doctor-patient relationship and there was also no research 
related clinical contact with patients which might cause concern. In addition, we 
attempted to minimise the level o f general practitioner involvement and all 
contact with a practice was generally made via the Practice Manager. However, 
whilst practices were randomly identified for contact, it is possible that there was 
some partiality in relation to those who agreed to participate. This selection bias 
may have favoured those who were interested in the topic, had the capacity to 
participate and did not wish financial incentive. As sueh, the results obtained may 
reflect this self selection, particularly in relation to practices in the Control group, 
who it could be argued, gained little from participation.
7.2.4 The patient population
The research described in the introduction (chapter 1) has demonstrated 
overwhelming evidence that treatment of hypertension produces significant 
reductions in cardiovascular risk and that those reductions are greater for older 
patients (section 1.2.4). Consequently, the numbers o f elderly hypertensive 
patients who need to receive antihypertensive treatment in order to prevent a 
cardiovascular event, such as stroke, is considerably lower than for younger 
people. However, the benefits demonstrated in the majority o f previously 
reported trials relate to patients aged 79 or less, since patients older than this have 
generally been excluded. The benefits o f treating patients aged 80 or over have 
not yet been established. Indeed, those studies which have included this subgroup
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of patients suggest that although treatment can reduce stroke, it may also have an 
adverse effect on overall CVD mortality (Gueyffier et al. 1999).
In 1994, the Hypertension in the Very Elderly Trial (HYVET) was established to 
assess the benefits o f antihypertensive treatment in those aged 80 and over. The 
trial is still ongoing, but results from the pilot, published in 2003, suggest that 
whilst the incidence o f stroke was reduced, estimated mortality suggests that there 
may be excess deaths with active treatment (Bulpitt et al. 2003). Wlien the study 
reported in this thesis was undertaken, the recommendations made in the British 
Hypertension Society guidelines related only to management o f patients aged up 
to 79 years. Thus, this study involved only older patients aged 65-79.
7.2.5 Population coverage
One o f the strengths o f this study relates to the extent o f its coverage in relation to 
the general practice population of Scotland. The 52 participating practices 
comprised 5% o f all Scottish general practices and encompassed eleven o f the 
twelve mainland health board areas. The population covered, over 260,000 
patients and around 5% o f the total population o f Scotland, was equivalent to two 
thirds that provided by the 72 practices participating in the national Continuous 
Morbidity Recording project (416,000; 7.9%; Table 6.3). However, this study 
included more than double the number o f practices from NHS Greater Glasgow 
and consequently more than double the coverage o f that area compared with CMR 
(number of practices 14 v 6; health board population 6.4% v 3.1%). NHS Greater 
Glasgow is the largest health board in Scotland. It also incorporates 80% of the 
most deprived postcode areas in Scotland. Not only are some parts of Glasgow 
the most deprived in the UK, but the inequalities in health that exist between the 
most affluent and the most deprived patients living there are greater than 
anywhere else in the country (Shaw, Dorling, Gordon, & Davey-Smith 1999). As 
such, this study provides greater representation o f practiees located in areas of 
higher deprivation.
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7.3 The rule of halves
7.3.1 Changes in identification, treatment and control
At the outset o f this study, most 65-79 year olds in each of the study groups had a 
blood pressure recorded on computer and just over one third o f those with a blood 
pressure o f >160 / >90 mm Hg were diagnosed as being hypertensive. More than 
80% of those patients were receiving antihypertensive treatment and around half 
were adequately controlled. Comparative analysis showed that by the end of the 
study, the numbers o f patients identified, treated and controlled had increased in 
all tln ee study groups. Between 40 and 50% of those whose blood pressure was 
>160 / >90 mm Hg had been diagnosed, more than 90% of those who were 
diagnosed were being treated and around 60% of those who were being treated 
were controlled (Tables 6.19-6.20).
The greatest improvements in treatment were observed in the Strategic group, 
which received not only audit feedback, but also a list prioritising patients in 
terms o f their absolute risk of death from stroke. The increase in the proportion of 
patients diagnosed and treated in that group was three times that of the Control 
group and twice that o f the Audit group. Wliilst the observed increase in the 
proportion o f patients with controlled blood pressure was not as great as in the 
Control group, results from the GEE cluster analysis model demonstrated that at 
the end o f the study, a significantly greater proportion o f patients were controlled 
in the Strategic group compared with both the Audit and Control groups (Table 
6.26). In addition, the lowest mean systolic pressure was observed in the Strategic 
group, although mixed model cluster analysis showed that the difference between 
the Strategic and Control groups was not significant (Table 6.28).
Given these results, it might appear inconsistent that one model demonstrated a 
significant difference in mean systolic pressure between the Strategic group and 
the Audit gi*oup only, whilst the other showed a significant difference in control 
between the Strategic group and both the Audit and Control gi'oups. However, 
this variance is feasible, since different statistical methods were used to ask 
different questions of the data. The significance levels demonstrated will depend 
on the models used and the tests carried out. In the analyses presented here, one
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model (mixed model for systolic blood pressure; Table 6.26) used a continuous 
outcome, whilst the other (GEE model for final blood pressure control; Table 
6.28) used a binary outcome. The first compared difference in means and the 
second relative risk; consequently, the significance levels are not directly 
comparable. Additionally, in the mixed model for final systolic blood pressure, 
significance levels were adjusted for multiple testing and as such, the p-values are 
more stringent than in the GEE model. That being the case, it is likely that the 
differences in control demonstrated did actually exist at that given threshold. Use 
o f a different threshold to denote controlled hypertension would change the 
results. Furthermore, if the direction o f the two sets o f results is considered, a 
feature which is also important, these are in fact similar. Results for both models 
are in the same direction, with the Strategic group being better than both the Audit 
and Control groups.
In clinical practice, stabilising hypertension differs for different patients. For 
some patients, starting treatment is enough to significantly lower their blood 
pressure and they require little in the way of follow up. Others may not respond 
well to medication, may suffer side effects and require several changes in 
prescription and intensive follow up. As such, the benefits o f treatment are not 
always immediately observed. At the outset of this study, the proportion of 
patients receiving treatment was greater in the Control group than in either of the 
other two groups. Conversely, the proportion of patients adequately controlled 
was greatest in the Strategic group. Comparative analyses showed that by the end 
o f the study, the greatest proportion of treated patients was seen in the Strategic 
group whilst the greatest increase in the proportion of controlled patients was 
obseiwed in the Control group. Given the time and effort that is likely to be 
involved in controlling blood pressure, it could be postulated that the Control 
group were seeing the benefits o f treatment initiated prior to this study, whilst the 
Strategic group, who demonstrated the greatest improvement in treatment during 
the study, would not see the benefits in the short term.
In this, as in other pragmatic trials in primary care, there are various factors which 
might have impacted on the results obseiwed, in addition to the time effect of the 
intervention. The potentially confounding nature o f training practice status has 
already been discussed (section 7.2.2) and it is possible that there were other,
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undetermined factors which occurred during the period under study and which 
acted as confounders, influencing either management or treatment of 
hypertension, or a practice’s engagement with and consequently its response to 
this research. Such confounders might have occurred at various levels, for 
example LHCC-wide hypertension audits, PCT prescribing initiatives and 
guidelines, or national progiammes such as the Scottish Programme for 
Improving Clinical Effectiveness in Primary Care (SPICE-PC), which was 
established in 1999 and which some practices may have participated in (SPICE- 
PC website; www.ceppc.org/spice). In this study, attempts were made to account 
for known confounding variables, both prior to recruitment and at the analysis 
phase. The cluster analysis models used took account o f training status as well as 
other practice and patient level factors. However, it may be the case that other, 
unidentified but relevant variables should also have been included and this may 
account for some o f the variation in significance demonstrated between the two 
models. Nonetheless, cluster analysis has considered the major factors likely to 
have impacted on management and as such, the results produced by the analyses 
can be accepted as valid.
7.3.2 Existence of a new rule
The comparative analyses carried out in this study have shed additional light on 
the rule o f halves. If the levels of identification, treatment and control stated in 
the rule o f halves are assumed, 50% of all those with hypertension will be 
diagnosed, 25% will be treated and 12.5% will be controlled. These results have 
shown that for the population studied, the rule o f halves no longer exists to the 
extent that it once did. Whilst the levels of identification found here are akin to 
those suggested by the rule, levels o f treatment and control are better. Three 
quarters of all hypertensive patients in this study, that is those patients who had a 
diagnosis of hypertension or had a blood pressure o f >160 / >90 mm Hg, were 
receiving antihypertensive treatment. Almost 40% of all patients were controlled. 
This study has shown significant improvements since previous work carried out in 
Scotland by Smith et al. in the 1980s, which found that 31% of all hypertensives 
were treated and only 17% were adequately controlled (Smith et al. 1990). It has 
also demonstrated an improvement on the more recent level of 33% controlled, 
found using data from the Scottish MONICA surveys (Chen et al. 2003).
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Such improvements in the rule of halves have also been shown in recent studies 
carried out elsewhere in the UlC. Fahey and Lancaster found that 51% of 
hypertensives in Northamptonshire were treated and around 30% were controlled 
(Fahey & Lancaster 1995). A study in Merseyside showed similar levels of 
improvement, with 64% of hypertensive patients on treatment and 28% controlled 
(Cranney, Barton, & Walley 1998). In London, an even greater improvement was 
shown. In an audit of electronic records in 22 practices. Hooker et al. found that 
67% of hypertensive patients were treated and 61% were controlled (Hooker et al.
1999). In a more recent study in which a random one in seven sample of the 
records o f patients aged 65-80 from 51 practices were audited, Duggan et al. 
found that 70% of hypertensive patients they identified were treated, whilst 20% 
were controlled (Duggan et al. 2001).
Thus, it would appear that in relation to treatment, the opposite of the rule is 
becoming the case, that 25% of all hypertensive patients will not be treated. Yet, 
whilst the levels o f control demonstrated by the study reported in this thesis are 
better than would perhaps be expected, 60% of all hypertensive patients and 40% 
of those who are being treated are not adequately controlled. Research using data 
from the Framingham study, has demonstrated that the rate o f use of 
antihypertensive medications in the United States increased from less than 4% in 
the 1950s to more than 26% in the 1980s (Mosterd et al. 1999). The authors 
conclude that this has been responsible for a reduction in the prevalence of 
hypertension over the same period from 24% to 8%. Given the period over which 
this change was achieved, it is likely to be some time before the increased rates of 
prescribing for hypertension shown in UK studies over the past decade result in 
even greater improvements in control. However, it is interesting to note that 
regardless o f group, diagnosed hypertensive patients in the current study were 
found to have a lower average blood pressure than the average for all 65-79 year 
olds (Tables 6.24-6.25), although it is not possible to determine whether this is a 
treatment effect or the result o f an atypical group o f patients.
7.3.3 Implications of improving on the rule of halves
Whilst adopting a strategic approach to target those at high risk of cardiovascular 
disease is less resource intensive than a mass screening approach (Marshall &
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Rouse 2002), there are consequences associated with making improvements in the 
proportion o f hypertensive patients identified, treated and controlled. Tudor Hart 
demonstrated the significant increase in staff time and consultation length that can 
arise from a more organised approach to disease management (Hart 1992). He 
estimated that actively trying to reduce the rule of halves would increase workload 
by at least 12%. This does not account for the time requirements involved in 
keeping up to date with recording or the increase in prescribing costs which would 
undoubtedly occur as a result o f higher levels of disease detection. Qualitative 
work on statin prescribing has shown that practitioners are aware o f these issues, 
which have the potential to act as barriers to the perfonnance o f disease 
prevention (Kedward & Dakin 2003).
Whilst cost and workload implications will vary depending on the blood pressure 
tlri'eshold used to denote hypertension and the level o f cardiovascular risk selected 
for intervention (Baker, Priest, & Jackson 2000), nonetheless, the prevalence of 
hypertension will continue to increase with an expanding elderly population. As 
such, so too will the volume o f work required to manage it.
7.3.4 Significance of the definition of hypertension
The British Hypertension Society guideline in use when this study was 
undertaken, and on which the thresholds applied here are based, recommended 
intervention for hypertension when systolic blood pressure was >160 mm Hg 
and/or diastolic pressure was >90 mm Hg (Sever et al. 1993). New guidelines 
published during the period covered by this research now regard hypertension as 
existing at a lower threshold o f >140 / >90 mm Hg (Scottish Intercollegiate 
Guideline Network 2001) (Ramsay et al. 1999) (Williams et al. 2004). hi their 
study on the rule o f halves in Merseyside, Cranney et al demonstrated the 
significance of the level of blood pressure used to denote hypertension (Cranney, 
Barton, & Walley 1998). Wlien control was assumed at the level of <160/90 mm 
Hg, they found that only 19% of the hypertensive population were adequately 
controlled. However, when it was assumed at the level o f <160 / <90, there was a 
9% increase in the proportion o f patients meeting the target. In their comparison 
of hypertension guidelines from the UIC, US, Canada, New Zealand and the 
World Health Organisation, Fahey and Peters found that the proportion of
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hypertensive patients controlled ranged from around 18% to 85%, depending on 
the criteria used (Fahey & Peters 1996). More recently, data from the 1998 
Health Survey for England was used to compare control of hypertension using the 
threshold that had been used in previous surveys, >160 / >95 mm Hg, with the 
new tlri'eshold o f >140 / >90 (Primatesta, Brookes, & Poulter 2001), This 
demonstrated that 39% of hypertensives were controlled using the old definition, 
but only 17% were controlled using the new definition.
Thus, it is extremely unlikely that use o f this lower level in the study reported in 
this thesis would have produced the scale o f improvements that were observed 
when using the higher threshold.
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7.4 The relevance of practice organisation
In his paper on prevention of cardiovascular disease, Geoffrey Rose likened the 
occurrence o f stroke in hypertension to the occurrence o f complications in 
pregnancy (Rose 1981). He suggested that an obstetrician confronted by a case of 
eclampsia would ask, “What went wrong? " He further suggested that a good 
general practitioner confronted by the occurrence of a stroke in an untreated or 
badly treated hypertensive patient would ask the same question. In relation to the 
prevention o f stroke he added,
“Wlien one occurs it suggests a possible failure ofpractice
organisation ”
7-4.1 The importance of practice size
One o f the findings of a study determining the effectiveness and cost of three 
different types o f feedback, was that smaller practices perfonned preventive care 
significantly better than larger practices (Szczepura et al. 1994). More recently, in 
a study from Netherlands, feedback combined with outreach visits by trained 
facilitators was implemented as a means of improving decision making for 
patients with cardiovascular disease, including those with hypertension (Frijling et 
al. 2003). As part o f the intervention, facilitators discussed barriers to change 
with practices and helped them select issues for improvement and methods for 
implementing change. Whilst the effects of the intervention were small, the 
researchers found that the practice characteristics which predicted success o f the 
intervention in relation to hypertension management were older GPs (mean age 
>45 years), single handed practice, non training practice and smaller list size 
(<2,500 patients per GP).
As described earlier in this chapter (section 7.2.2), training status requires a 
praetice to maintain a register of patients with chr onic diseases and ensure 
systematic call and recall of those patients. When the organisational 
characteristics of practices participating in this study were compared by practice 
size, 24% o f the small (1-2 GPs) and 28% of the medium sized (3-4 GPs) 
practices had training status, compared with 62% of the large practices (>5 GPs).
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However, the availability o f a hypertension register and recall system decreased as 
practice size increased, with less than half o f large practices operating a recall 
system compared with 94% of small practices (Table 6.6). This would suggest 
that larger practices, regardless o f their training status, are not selecting 
hypertension as one o f the clrronic diseases which they choose to manage more 
formally. Thirteen o f the practices participating in this study had five or more 
GPs. List size in those practices ranged from 5,456 to 18,335 patients, with an 
average list size of 8,400. If the level of prevalence shown in the recent UK 
health suiweys is assumed, a practice with a patient population o f 8,400 is likely to 
have around 2,000 adult hypertensive patients. If  the higher tlrreshold of 
>160/>95 mm Hg is used to denote hypertension, around 1,200 patients could be 
hypertensive. Thus, there are significant workload implications related to 
operating a recall system for hypertension in a large practice and it may be for that 
reason that fewer of the larger practices in this study were doing so.
7.4.2 The importance of practice structure
In a UK study on secondary prevention of coronary heart disease, audit with 
feedback was compared to the provision o f assistance in setting up a disease 
register and recall system, either for follow up by the GP or by the practice nurse 
(Moher et al. 2001). The researchers found that after 18 months, around 80% of 
patients in the nurse and GP recall groups had been adequately assessed compared 
with only 52% in the audit group. In addition, whilst the difference was not 
statistically significant, adequate assessment was higher in the nurse recall group 
than in the GP recall gi'oup.
The findings from this study would support the hypothesis that use o f a recall 
system can enhance disease management. Levels of identification, treatment and 
control observed in participating practices were compared by practice size (Table 
6.21) and whilst the proportion o f identified and treated patients increased as 
practice size increased, the proportion of controlled patients increased as practice 
size reduced. Twice as many o f the small practices operated a recall system and it 
could be postulated that this facilitated the achievement o f better control in that 
group. It may also be the case that whilst larger practices are as able as smaller 
practices to initiate treatment in the majority o f their identified hypertensives, the
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differing level o f workload related to having a larger patient population precludes 
the intensity o f follow up required to ensure adequate monitoring and subsequent 
control of those patients.
The method o f recall used may also be o f relevance in helping practices achieve 
better management o f hypertension. The majority o f practices in the Audit (70%) 
and Strategic (63%) gi'oups used a previously arranged appointment as their main 
method o f recall, compared with only 36% o f practices in the Control group. The 
predominant method used by practiees in that group was a reminder either by 
letter or by telephone and this may have contributed to the improvements which 
occurred in that group. Previous work evaluating the use o f different methods of 
recall for preventive care has demonstrated improvements with targeted patient 
reminders. Studies by McDowell et al. on reminders for blood pressure screening, 
cervical screening and immunisations found that computer generated letters and 
telephone calls to patients were consistently the most effective methods of recall 
(McDowell, Newell, & Rosser 1989a) (McDowell, Newell, & Rosser 1989b) 
(McDowell, Newell, & Rosser 1986). In addition, Coclnane reviews on cervical 
screening (Forbes, Jepson, & Martin-Flirsch 2004) and immunisations (Szilagyi et 
al. 2000) report benefits from written and telephone reminders.
When stmctural characteristics were compared by practice deprivation payment 
level, practices receiving higher levels o f payment were more likely to have a 
hypertension register, hypertension clinic and recall system (Table 6.7). These 
practices also tended to have larger proportions o f their hypertensive patients 
identified, treated and controlled (Table 6.22). Anecdotal evidence suggests that 
it is extremely difficult to recruit practices working in deprived areas to primary 
care research projects. Thirteen o f the practices taking part in this study (25%) 
were classed as being highly deprived, that is they received deprivation payments 
for more than 20% of their patient population. Their participation in itself may 
demonstrate that they are atypical of deprived practices in general. Flowever, 
more o f the deprived practices than the non deprived practices had a hypertension 
register and recall system. This was also true for the availability o f a practice 
nurse and although by no means conclusive, there is some evidence to suggest that 
nurse led management o f hypertension leads to improvements in levels of control 
(Oakeshott et al. 2003). Therefore, it may well be the case that better practice
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organisation, even in areas of high deprivation where levels of morbidity are 
higher and as a consequence workload greater, leads to better disease 
management.
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7.5 The feedback intervention
Results from the comparative analyses conducted in this study have shown that 
the greatest changes in blood pressure recording were observed in the Audit 
feedback group, which had the lowest preliminary blood pressure recording level, 
followed by the Strategic feedback group (Table 6.19). Improvements in 
identification were gi'eater in the Control and Audit groups than in the Strategic 
group, whilst the greatest change in the proportion of hypertensive patients treated 
was observed in the Strategic group. Both the Audit and Strategic groups 
increased the proportion of patients adequately controlled by almost 10%, 
although the largest increase was seen in the Control group (12%). Results from 
the cluster analysis, which incorporated adjustment for clustering, practice and 
patient effects demonstrated that a significantly greater proportion of patients 
were controlled in the Strategic gi'oup compared with the other two groups. Thus, 
the results demonstrate that providing practices with feedback developed from 
electronic patient records can have an impact on detection and management of 
hypertension in the elderly. However, the impact was relatively small and the 
Control group, which had not received feedback, also made improvements. 
Similarly, it is interesting to note that this group demonstrated greater 
improvements than the group which received audit only feedback. Previous 
sections in this chapter have discussed the methodological and organisational 
factors which are likely to have influenced the results obtained (sections 7.2.2,
7.3.1 and 7.4.1). However, it may also be the case that certain aspects o f the 
feedback itself precluded its uptake and therefore impacted on its ability to be of 
maximum use.
7.5.1 The composition of the feedback
When this study began, the versions of the GPASS system in use by participating 
practices did not store more than one blood pressure reading per patient and each 
new entry replaced the previous entry in a patient’s record. The feedback reports 
were therefore based on the most recent electronic blood pressure, regardless of 
when it had been recorded. Results from the data validation exercise 
demonstrated that only one third of the patients whose records were reviewed had 
their most recent blood pressure recorded in the electronic record; for most, it was
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recorded in the casenote and the electronic record had not been updated (62%; 
Table 6.12). Practices in the feedback groups may have been aware o f this 
discrepancy in their own practice and as such, been sceptical about the accuracy 
o f the feedback and as a consequence, sceptical about its usefulness. Feedback for 
practices in the Strategic gioup also contained the date o f the patient’s blood 
pressure reading and this may explain the significant difference observed in 
relation to the numbers o f patients in that group whose electronic blood pressure 
was updated during the course o f the study (Table 6.30).
Many significant trials in this field have been based on easual blood pressures, 
that is, a blood pressure which has been recorded on a single occasion. Previous 
research as part of the Framingham study has demonstrated that whilst the use of 
casual blood pressure does not enable a precise assessment o f an individual’s 
previous levels of blood pressure, it is highly predictive o f future cardiovascular 
disease (Vasan et al. 2002) (Gordon, Sorlie, & Kamiel 1976). Furthennore, a 
study from the Netherlands, in which the predictive value of repeated blood 
pressure measurements was assessed, concluded that casual blood pressure 
measurement leads to an underestimation of an individual’s long term risk of 
stroke (Keli, Bloemberg, & Ki'omhout 2004). Thus, the use o f a single blood 
pressure measurement in this study is likely to have underestimated rather than 
overestimated patient risk. However, whilst use o f a single measure may be 
valuable for research o f this type, guidelines recommend that treatment for 
hypertension should be initiated in patients whose have sustained high blood 
pressure. Those with a single reading of high blood pressure should be given non 
pharmacological advice and have their blood pressure monitored over a period of 
several months (Ramsay et al. 1999). As such, use o f casual blood pressure 
measurements is not recommended for the diagnosis and management of 
hypertension in clinical practice. That being the case, it may have influenced 
practice response to the feedback provided.
Practices in the feedback groups were provided with the average results for the 
other practices in their group, enabling them to make comparisons o f their 
performance. Few o f the studies which have used feedback as an intervention 
have compared feedback with and without peer comparison and indeed, the 
Cochrane review o f this area has not been able to determine whether or not there
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is an added effect (Jamtvedt, Young, Kaistoffersen, Thomson O'Brien, & Oxman 
2004). However, a meta-analysis combining trials which evaluated peer 
comparison feedback per se, found a statistically significant, but modest, effect on 
various clinical procedures including screening, prescribing and test ordering 
(Balas et al. 1996).
The additional feedback for practices in the Strategic group provided a prioritised 
list of patients according to their absolute risk of stroke. Whilst the report also 
contained data on the numbers of patients identified, treated and controlled, 
allowing the practice to immediately determine the likely level of workload 
involved in trying to improve on this, it may also have been o f value to have 
provided some measure o f the benefits o f intervening. Patients who did not have 
a record o f smoking status were allocated two risk scores, one on the basis o f their 
being a smoker, the other on the basis o f their being a non-smoker. It may have 
been useful to practices to have been provided with this sort o f multiple scoring 
for each patient on the list. Those patients who were untreated could have been 
allocated an additional score based on treatment being initiated, those whose 
blood pressure was >160 / >90 mm Hg could have been allocated a score based on 
blood pressure being controlled and those who were smokers could have been 
allocated a score based on stopping smoking.
However, whilst it would have been of interest and possibly o f value to have 
differed the content o f the feedback during the study in relation to the provision or 
otherwise o f peer comparisons and multiple scores, the number of practices 
involved and the complexity of processing and analysing data for feedback would 
have made this extremely difficult.
7.5.2 The recipient of the feedback
Whilst practices participating in this study were not obliged to alter their current 
behaviour, implicit within the study was the desire to change practice. The 
ultimate outcome of controlling hypertension is the prevention of stroke and other 
cardiovascular diseases. Whilst this is done at an individual patient level and 
requires the individual patient to adhere to treatment regimes and possibly modify 
lifestyle factors, it can only be achieved through activity on the part of 
practitioners. The methodology for the study was designed with a view to
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minimising the amount of active involvement required from practices prior to 
their receiving feedback. Inevitably, this also resulted in a ‘top down’ approach to 
the conduct o f the study. In such circumstances, it can be difficult to ensure 
participants’ sustained engagement with the research.
An alternative strategy might have been to have identified and recruited a group of 
participants who were interested in the methodology, since such a group might 
have been more likely to utilise the feedback and act upon it. Whilst the 
information provided in the feedback was designed to be used strategically to 
target those most at risk, so too the provision o f the feedback itself could have 
been used strategically, targeting those most inclined to change their behaviour. 
Whilst the study would have been open to criticisms o f bias and reduced 
generalisability, it may also have been a more accurate reflection of everyday 
practice, where those practices and practitioners who are interested are also the 
ones who adopt new initiatives, or indeed, utilise guidelines.
7.5.3 The timing of the feedback
Workload within practices varies, as do practice priorities. The nature of the 
study meant that it was not possible to accommodate the work cycles o f every 
practice and ensure that each received feedback at the most appropriate time. 
Whilst attempts were made to account for confounding structural factors, by 
stratifying practices prior to recmitment, it was neither possible nor feasible to 
incoiporate every possible one. During the period under study, amongst other 
organisational changes, three practices gained an additional partner, one practice 
lost a partner, nine had a change in partner, two gained a practice nurse, seven 
changed practice managers and two became training practices (Table 6.8). These 
changes were not distributed evenly across the study groups, and it is unlikely that 
such changes would be evenly spread, even given randomisation. The purpose of 
randomisation was to obviate the possibility o f systematic bias, by distributing 
those characteristics which might influence outcome randomly across the groups. 
In so doing, within the limits of chance variation, the intervention and control 
groups would be similar at the outset o f the study. Indeed, there were no 
significant differences between the groups at baseline (Tables 6.4-6.5). The 
practice changes outlined occurred after the study began and tliroughout its
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duration. In addition, they are more likely to have been related to personal 
circumstances and decisions made by individuals within individual practices than 
to any pre-determined organisational characteristics. As such, they occurred 
within the limits o f chance variation between study groups and it would not have 
been possible to have foreseen them or to have controlled for them.
The situations created by each o f these changes is likely to have involved a great 
deal o f time on the part o f the practice, whether in relation to recruitment of new 
team members, to those new members familiarising themselves with the practice 
and its population or in ensuring that the practice would be granted training status. 
Undoubtedly, the priorities o f a practice will change under such circumstances 
and the ability to participate in targeted patient care, or indeed in research, may 
well be affected. In addition, end o f year practice audits, staff absenteeism and 
changes in practice initiatives such as winter flu vaccinations, will undoubtedly 
have affected response to feedback. However, given these factors and given that 
elderly hypertensives are one o f several groups requiring care, the results o f the 
study are encouraging.
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7.6 Communication of risk
The communication o f risk is an area not without its challenges. Much o f the 
debate surrounds the public’s understanding of risk and the language used to 
communicate risk. Commentators have described the difficulties o f using 
standardised language since understanding and interpretation o f particular terms 
are likely to vary with each individual patient (Edwards, Elwyn, & Mulley 2002). 
Similarly, patients’ understanding o f particular conditions and of the 
consequences o f their lifestyle choices will also vary. Previous work on coronary 
heart disease has shown that those who perceive themselves to be more at risk are 
more likely to change their behaviour in order to reduce that risk (Van der Pligt
1998). However, research carried out in the West o f Scotland with children from 
the original Misdpan population, found that people are not always aware that they 
are at risk (Watt et al. 2000) and if they are aware, the extent o f that awareness 
varies by individual characteristics and knowledge (Hunt, Emslie, & Watt 2001). 
Such variations in understanding and resultant behaviour will also be present 
when risk information is communicated to practitioners.
7.6.1 Framing risk data
The study reported in this thesis used a risk equation to provide practices in the 
Strategic group with data on absolute risk o f stroke for individual patients. 
Assessment o f absolute risk is considered a more accurate way of determining the 
benefits of preventive action and also allows patients to be prioritised by need. 
However, as discussed earlier in this thesis (section 1.2.6), risk data can be also 
presented either as relative risk, or relative risk reduction, or as numbers needed to 
treat. One o f the most important factors determining practitioners’ responses to 
risk data is the way in which the data are presented, or framed.
Data presented as a relative risk reduction appear impressive. Indeed, presenting 
risk reduction in relative rather than absolute tenns is generally favoured by 
pharmaceutical companies since the effects appear more marked. However 
framing data in this way can be misleading, since full infonnatlon on the 
comparison group is necessary if the patient’s risk is to be set in the appropriate 
context (Gigerenzer & Edwards 2003). Despite this, there is some evidence to
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suggest that practitioners respond best to information on hypertension 
management when it is presented in this way. In one study, comparisons o f data 
presented as relative risk reduction, absolute risk reduction, differences in event 
free patients and numbers needed to treat were carried out with 73 GPs attending a 
continuing education course (Cranney & Walley 1996). Risk data were presented 
as part o f a clinical scenario and relative risk was found to be the only 
presentation which had a significant influence on practitioners’ decision to 
prescribe.
In a more recent study, cardiovascular risk presented as absolute risk or numbers 
needed to treat was compared as part of a randomised controlled trial evaluating 
the provision o f computerised decision support (Fahey, Montgomery, & Peters
2001). No difference was found between the two methods o f presentation in 
relation to reductions in cardiovascular risk at twelve months or in mean systolic 
and diastolic blood pressure. The study also found that eardiovascular risk in both 
groups increased over the study period. In the study presented here, both 
comparative and cluster analyses showed that the reduction in mean blood 
pressure was no greater in the gi'oup receiving absolute risk data than in the other 
two gi'oups (Tables 6.24-6.26). Risk o f stroke increased for 40-50%  of patients 
across the groups, with the largest proportion observed in the Strategic group 
(Table 6.29). Such increases are to be expeeted in an ageing hypertensive 
population. However, risk redueed for 10-20% of all patients, with the greatest 
reduction observed in the Strategic group. Most o f the patients in each group 
whose risk was reduced now had controlled blood pressure. In addition, a 
significantly greater number o f patients in the Strategic group were now recorded 
as being non-smokers or ex-smokers. This, in particular, is likely to have made a 
considerable contribution to the changes in risk observed in that group (Table 
6.32).
The complexities of this study and the derivation o f data for feedback would have 
made it extremely difficult to have presented data either as relative risk reduction 
or as number needed to treat. However, it could be postulated that feedback to the 
Strategic group might have had a greater impact if  relative risk reduction rather 
than level o f absolute risk had been used.
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7.6.2 Uncertainty In predicting risk
“Remember, then, that [scientific thought] is the guide o f action; that 
the truth at which it arrives is not that which we can ideally 
contemplate without error, but that which we may act upon without 
fea r  ’’(William Kingdon Clifford 1955)
Recent work in the UK has demonstrated that primary care practitioners are 
unable to accurately estimate cardiovascular risk in high risk groups, including 
elderly hypertensives, without the aid o f some sort o f risk prediction tool 
(McManus et al. 2002) (Montgomery et al. 2000a). Indeed, Montgomery et al. 
concluded that,
"... management o f hypertension in the community is unlikely to be 
based on realistic estimates o f either benefit or harm "
Whilst risk predictors can improve upon the estimation o f risk, they are not 
without their limitations. There are currently various risk prediction tools 
available, the majority based on equations developed from the Framingham Heart 
and Offspring studies (chapter 5). Such tools are widely used in the UK, despite 
increasing evidence that they do not accurately predict risk in European 
populations (Empana et al. 2003) (Brindle et al. 2003). Furthermore, Framingham 
equations were derived using data from a white, middle class population and as 
such may not accurately predict risk for those in lower socioeconomic or ethnic 
minority groups. However, whilst hypertension is a major risk factor for stroke, 
and for other eardiovascular diseases, it is by no means the only risk factor. 
Cholesterol, smoking status, co-morbidity, weight and lifestyle factors are also 
important (Padwal, Straus, & McAlister 2001). Targeting patients for preventive 
treatment based on estimation of their cardiovascular risk is more accurate than 
counting these risk factors or indeed targeting them individually.
In the study reported here, a new equation to predict risk was developed, the 
Hyper equation. At the outset o f the study, it was not possible to obtain 
cholesterol data from electronic patient records in the GPASS system and as such, 
it was not possible to use an existing predictor (section 5.4). Comparison of risk 
generated by this equation and by the widely used Joint British guidelines
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demonstrated that the Hyper equation was consistent in its estimations. 
Nonetheless, predicting absolute risk is not without error, and the tools used, 
including the equation used in this study, can only reach an approximation of the 
truth. However, general practice as a speciality is concerned with the 
management o f uncertainty. It is a diseipline in which intuition and experience 
are as important as scientific laiowledge. That being the case, and as suggested by 
the above extract from William Clifford, it does not appear unreasonable, nor 
indeed uncommon, to sacrifice some certainty in order to gain some clarity.
7.6.3 Primary and secondary prevention
The majority o f risk prediction tools are used to assess risk for primary 
prevention, that is, risk in people who have not already developed cardiovascular 
disease. Those with pre-existing disease were excluded from the Framingham 
study and as a result, the equations developed were not designed for use in this 
patient group. In addition, in relation to hypertension, most assume that the 
patient has been newly diagnosed and the prediction of risk is designed as a means 
o f informing the decision o f whether or not to initiate treatment. The Hyper 
equation used in this study can be applied to both primary and secondary 
prevention, since previous stroke is included as a variable in the regression model. 
In addition, it does not assume a new diagnosis, but predicts stroke risk based on 
whether the individual is cuiTently receiving antihypertensive medication. As 
such, it could be argued that it has the ability to provide risk prediction suited to 
the realities o f general practice.
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7.7 The importance of behaviour
As discussed earlier in this thesis, there is an extensive literature on the benefits of 
treating hypertension. The study reported here was concerned with the utilisation 
o f existing practice data to inform decision making in practice rather than with 
providing education on disease management. Although feedback was based on 
reeommendations from existing guidelines, practices were under no obligation to 
change their behaviour, nor were they provided with guideline based treatment or 
management recommendations for specific patients. The gap between the 
implementation o f best evidence in practice -  best practice -  and actual care is 
well recognised and there is an extensive literature on how this gap can be 
reduced, much of it related to the implementation o f guidelines. In the case of 
hypertension, there is considerable variation in the guidelines themselves, both in 
relation to their content and their recommendations. However, previous research 
in the area has coneluded that other factors contribute to these differences (Fahey 
& Peters 1997).
The feedback provided to practices participating in this study was an innovation 
designed to facilitate improved decision making. As such, its adoption, like that 
of guidelines, is dependent on a variety of factors. Its perceived usefulness and 
superiority over existing methods, whilst important, is only one such factor. 
Everett Rogers, an academic and researcher in communication, developed a 
theoretical model describing the adoption and diffusion o f innovations (Rogers 
2003). As part o f his theory, he suggests that adopters judge an innovation on its 
possession o f five attributes; it can be tested on a limited basis before adoption -  
trialability; it has visible results -  observability; it is more beneficial than other 
such innovations or the current situation -  relative advantage; it is not too 
complex -  complexity; it fits in with existing practices and values -  compatibility. 
One o f the most important factors affecting the use o f imiovations in general 
practice is compatibility. Inherent within this, is practitioner behaviour. There 
are various theories of human behaviour and researchers are now attempting to 
utilise these models as a means of enlrancing the use o f inteiwentions to improve 
clinical practice (Walker et al. 2003). Whilst studying behaviour was not part of 
the study reported here, it will undoubtedly have impacted upon the results. The 
following paragraphs consider some potential influences.
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7.7.1 Existing team culture
Some o f the organisational issues which may have had an impact on the 
improvements in hypertension management demonstrated in this study, both by 
practices which received feedback and by those which did not, have already been 
discussed (section 7.4). However, the relationship between practice structure and 
the provision of care is complex and there are likely to be many factors at play. A 
recent study carried out by researchers from the U K ’s National Primary Care 
Development Centre suggests that what is important is not the individual 
structural elements, but the interaction between these and the primary care team 
(Bower et al. 2003). Not only was the size of the practice, its level o f deprivation 
and its training status important, but also the ‘team climate’. This is a composite 
of information sharing, participation in decision making, support for innovation, 
reflexivity in relation to practice, clarity o f objectives and team working. Bower 
et al. found that higher team climate scores were associated with better care for 
some clmonic diseases. Practices rather than individual practitioners agreed to 
take part in this study and we did not determine whether each member o f the 
primary care team had been asked about or indeed had agi'eed to participation. 
Thus, if  the premise o f the study or the value of changing practice was not 
acceptable to the whole practice team, this will undoubtedly have lessened the 
impact o f the inteiwention.
7.7.2 Barriers to change
A recent supplement to the Medical Journal of Australia on Adopting Best 
Evidence in Practice, highlighted the need to identify and understand the barriers 
and incentives to changing practice (Sanson-Fisher, Grimshaw, & Eccles 2004) 
(Grimshaw & Eccles 2004) (Grol & Wensing 2004). Barriers which have 
previously been identified in relation to management o f hypertension in the 
elderly include time pressures, existing workload, poor team work, inadequate 
computing systems and the absence of peer support (Cranney, Barton, & Walley
1999). Similar obstacles have been demonstrated in relation secondary prevention 
o f coronary heart disease (Summerskill & Pope 2002). It is possible that the use 
or otheiivise o f feedback in this study could have been enlianced had potential 
barriers and facilitators to its utilisation been explored with each practice.
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Nonetheless, many o f the potential baniers are inlierent within general practice 
and the solutions out with the capability and scope of this research project. 
However, a project has now been funded by the European Commission, Research- 
based Education and Quality hnprovement (ReBEQI; www.rebeqi.org), which 
has the aim o f narrowing the gap between research and practice. Part of the 
project involves establishing a framework for the selection, implementation and 
evaluation o f interventions designed to improve quality o f care in practice. This is 
expected to include a suite o f tools which will enable researchers to identify 
barriers to change and thus select appropriate interventions.
7.7.3 The science of medicine versus the art of medicine
In the study reported here, the tlmeshold used to denote high blood pressure was 
>160 / >90 mm Hg. Tlmesholds for treatment o f hypertension in the elderly vary 
between guidelines. In addition, tlnesholds for treatment vary between practices. 
In 1993, around 500 of the praetices using the GPASS system were asked to 
indicate which values o f systolic and diastolic blood pressure they would classify 
as normal, borderline raised or raised and at what levels they would diagnose 
hypertension (Henderson et al. 1996). The results of this survey demonstrated 
wide variation in tlnesholds for treatment amongst general practitioners in 
Scotland. Only 61% would classify a systolic pressure o f 160 mm Hg as 
hypertensive and only 52% a diastolic of 90 mm Hg. It has also been shown that 
there is variation in the frequency of blood pressure measurement before treatment 
(Fahey & Silagy 1994). Whilst there is evidence to suggest that there is a 
discrepancy between actual activity and reported activity in the management of 
hypertension in the elderly (Eccles et al. 1999), it is possible that many of the 
practitioners participating in this study would not have intervened at the level used 
in the feedback, nor have acted on the basis of that single blood pressure reading.
It could be argued that some o f the discrepancies between best practice and actual 
practice relate to the pull between the science and the art o f medicine. In his book 
on medical automation, Payne described two different classes of data, one relating 
to variables that could be counted, the other to data too numerous to count (Payne 
1966). He classed the first as related to the science o f medicine and the second to 
the art of medicine. Assessment of risk, part of the science o f medicine, is not the
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only factor considered when managing hypertension. The practitioner is best 
placed to know his or her patient and may not recognise that patient in the 
guideline, or indeed the feedback presented. Best practice neither accounts for 
shared decision making nor the implications o f initiating treatment in individuals 
in their individual circumstances. It does not incorporate drug side effects, quality 
of life or the potential impact on the doetor-patient relationship. In short, it does 
not consider holistic care and leaves little room for intuition and experience.
7.7.4 Attitudes towards treatment
Whilst evidence from trials demonstrates the benefits o f treating hypertension in 
elderly patients, other studies suggest that praetitioners are reluctant to initiate 
treatment in this group and more inelined to treat younger patients (Dickerson & 
Brown 1995) (Ebrahim 1998). However, that was not found to be the case in the 
study reported here. Comparisons were made between patients aged 65-79 and 
those aged 45-64 as a means o f determining whether the study groups appeared to 
target effort at younger patients. No difference was found between the two age 
groups in relation to the proportions o f hypertensive patients identified, treated 
and controlled (Figure 6d). Furthermore, comparative analysis was conducted for 
observed blood pressure eontrol in patients with and without additional risk 
faetors in order to detennine possible bias in relation to patients’ clinical 
characteristics. Win 1st there were significant differences in levels o f control 
between the tlnee study groups, there were no systematic differences related to the 
presence o f additional risk factors (Table 6.34),
7.7.5 Current priorities
Two thirds o f the hypertensive patients included in this study had at least one 
other major clnonic disease in addition to their hypertension, some had as many as 
seven (Table 6.36). Almost one quarter of the patients already had cardiovascular 
disease, almost 20% had mental health problems and almost 10% had cancer. 
Many may also have had social or family problems. Whilst there is increasing 
awareness of the extent o f co-morbidity, particularly in deprived populations 
(Macleod et al. 2004), there is still little understanding of the implications of this 
for individuals. Even less is known about the impact on practice. It is possible, 
perhaps even likely, that patients will have problems which are o f greater concern
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to them, and indeed to their practitioner, than control o f a condition which often 
has no symptoms. Undoubtedly, the existence o f co-morbidity will have 
implications for best practice, not least in relation to the application of guidelines 
for individual conditions. It should be relatively easy to ensure that a patient with 
hypertension is started on the best treatment and has their blood pressure regularly 
monitored. However, if  that patient also has osteoarthritis, is housebound and 
depressed because of it, regular blood pressure measurement may not take 
priority. Previous research, has shown that practitioners are reluctant to initiate 
antihypertensive treatment in patients who are otherwise well (Duggan, Ford, & 
Eccles 1997). It has also shown their awareness o f the need to consider existing 
physical, emotional and social circumstances in those who are not (Summerskill 
& Pope 2002).
Patient choice and awareness of hypertension will also influence the decision to 
treat and indeed adherence to treatment. Patients will not always share 
practitioners’ opinions that treatment is worthwhile, indeed members of the public 
have been shown to require lower numbers needed to treat before they would 
agree to taking medication (Steel 2000). Previous qualitative work in the area has 
demonstrated that the decision to take antihypertensive medication is a balance 
between reservations about treatment and reasons for treatment (Benson & Britten
2002). Many patients adhere to their regime despite suffering side effects and this 
can be related to trust in their practitioner. The perceived lack o f such a 
relationship can have the opposite effect (Gascon et al. 2004). In addition, patient 
awareness of the disease is likely to be a major factor. A study in which patients 
were asked to comment on the problem summary o f their eleetronic record, found 
that 10% of hypertensive patients considered themselves cured, since medication 
had returned their blood pressure to normal (Lauteslager et al. 2002).
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7.8 Implications of utilising electronic patient data
This study was an exercise in Development as well as in Research and many of 
the learning points arose from this aspect o f the project, particularly in relation to 
using electronic patient data for strategic decision making. This required 
reflection on project methodology, with alterations having to be made to 
accommodate what was feasible. Wlrilst attempting to adhere to a rigorous 
project methodology added extra pressure to the Development, it also helped 
expedite it, which in turn added value to the Research, since methodological 
difficulties had to be overcome. Some o f these difficulties could be predicted, 
such as the technical problems inherent in generating data in this way, the variety 
o f GPASS system versions in use across the country and the difficulty in keeping 
practices engaged enough to consistently return data over a substantial period of 
time. Others could not have been so easily foreseen.
7.8.1 Patient identification
Perhaps the most important difficulty related to the contention between ensuring 
patient confidentiality and facilitating targeted patient inteiwention. Adherence to 
data protection regulations meant that it was not possible to extract patients’ 
Community Health Index. This number, which is allocated to each patient in 
Scotland and is unique to them, allows identification of patients in each NHS 
sector. It is a searchable field in the GPASS system and would have allowed 
practices to identify patients included in feedback. In the absence of this, the only 
identifier available was the patient’s GPASS ID, which is not searchable in 
practice. This problem was further compounded when existing GPASS identifiers 
were replaced as practices upgraded to newer versions o f the GPASS system. As 
such, linlcage o f patient data became extremely difficult.
The need to ensure appropriate access to and use o f patient data has led to 
increasing difficulties for the type o f study reported here. Fear of litigation has 
led to the production o f various pieces o f guidance, both for health professionals 
and for the research community, guidance which itself is often contentious, open 
to interpretation and not always the subject o f widespread consensus. It is
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debatable whether it benefits patients and it could be argued that valuable 
opportunities to improve patient care and outcomes could be missed because o f it.
The issue o f data protection notwithstanding, in Scotland at least, the actual 
process of accessing electronic patient data from primary care is getting easier.
The majority o f practices are now using New GPASS and extracting the sorts of 
data that were required for this study is now more straightforward and able to be 
done in practice. Use o f the Windows™ system allows data from patients’ 
clinical records to be exported to Microsoft Office packages such as Access and 
Excel. Expertise will still be required to linlc these individual pieces of data in a 
way which allows the prediction of risk for high risk gi'oups, but the overall 
procedures will be much quicker. In the extraction o f data for the present study, 
ensuring practice data returns took five months, data proeessing tlrree months and 
data analysis a further two to tlnee months. Thus, the benefits in terms o f time, of 
extracting data directly from practices in a ready to use format will be substantial.
7.8.2 The reliability of data
The quality of data held in electronie patient reeords can be measured in variety of 
ways including its completeness, accuracy and currency. In order to assess this, it 
is necessary to compare these data with some sort o f gold standard. In the case of 
this study, electronic data were compared against data held in patients’ casenotes 
to determine whether the items used to generate patient risk were reliable. Data 
from the survey on levels o f computerisation showed that 82% of practices used 
both paper and electronic records for recording clinical data (Table 6.18). Only 
half reported electronically recording diagnosis and measurement related data for 
all patients. Thus, validation of electronic data was necessary but not without its 
difficulties. The most important is that this process assumes that the written 
records themselves are accurate. Finding major diagnoses, particularly for 
conditions such as hypertension, was not easy without the use of the computer 
generated summary, usually stored at the fr ont o f the casenote. Whilst there may 
have been a series o f high blood pressures recorded in the patient’s clinical notes 
there was often no written reeord o f a diagnosis. In some cases, there was a 
record o f the patient being issued with a prescription for antihypertensive 
medication. However, many o f the drugs in this class are licensed for use in
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several conditions and it is possible that the drug in that case had been provided 
for a condition other than hypertension. In addition, the variation in the format 
and eontent o f casenotes between practices made maintaining consistency of data 
collection for research purposes difficult. Thus, validation o f patient records is 
becoming increasingly difficult without the use o f the computer, since in many 
ways, electronic and manual records are in fact shared.
The validation exercise showed that the reliability o f electronic data for diagnoses 
was high, as it was for antihypertensive treatment. Agreement between record 
formats for smoking status was slightly lower, whilst only one third o f patients 
had their most recent blood pressure recorded in their electronic record. For the 
majority this was recorded in the casenote, a factor which will undoubtedly have 
impacted on the accuracy and possibly the relevance of the feedback provided. 
Recent reviews o f the quality o f electronic records in primary care have 
demonstrated that whilst quality is relatively high, exceptionally so for some 
conditions, there is still room for improvement (Thiru, Flassey, & Sullivan 2003) 
(Jordan, Porcheret, & Croft 2004). That finding is reiterated in this study, 
although improvements over the course of the research were observed. The 
Strategic group, whose practices had been provided with the date o f the patient’s 
most recent blood pressure, updated the record o f more than 80% of patients. 
What is not known is whether that improvement in recording was translated into a 
change in patient care.
7.8.3 Variations in recording
Data from the survey on levels of computerisation showed that there were 
differences between practices in relation to the numbers o f GPs and practice 
nurses who had access to a computer during consultations (Table 6.18). Most 
likely as a consequence o f this, there was also variation in relation to whether 
these groups actually entered data. In addition, only 75% of practices reported 
eollecting a minimum dataset for each patient. Differences in the users and the 
uses o f computers in primary care will undoubtedly impact on the types, quantity 
and currency o f the data that are available in each practice. This in turn, has 
implications for the inteipretation o f those data. Indeed, this is even more 
pertinent when patients have two record formats. If a patient does not have a
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record of smoking status in his or her electronic record, it cannot be implied that 
they are a non-smoker, since it may be recorded elsewhere. Conversely, if a 
patient does not have a record of diabetes, in all probability, they are not diabetic, 
since electronic records are generally complete in relation to diagnoses.
The way in which electronic data are recorded also has implications for its use.
The clinical coding system produced by the Royal College o f General 
Practitioners in the late 1950s contained 500 rubrics, or terms (College of General 
Practitioners 1959). The Read classification used today contains 125,000 terms. 
The newest version. Clinical Terms Version 3, incorporates over 200,000 terms. 
The intricacies o f such systems mean that ensuring the identification of all 
relevant patients in a particular group is complex. There is no single term to 
denote each condition, nor is there a single term to denote particular states.
Whilst the tenn ‘smoker’ is used, it is qualified by ‘trivial’, ‘light’, ‘moderate’ etc. 
Even identifying non-smokers and ex-smokers requires the inclusion o f several 
tenns. In the study reported here, identification o f patients with hypertension 
required searching for 67 different Read codes, diabetes required 189 codes, 
stroke required 65 codes and smoking status required 52 codes. One hundred and 
sixty seven antihypertensive medications were used. Such a strategy may have 
mistakenly identified patients who had a relevant ‘history o f  or administrative 
code, but who should not have been included. In addition, there are likely to be 
differenees in the way in which the codes are used in practice with resultant 
inconsistencies between users coding the same thing. The number of codes 
contained in the hierarchy means that the majority are extremely specific. Others 
however, may not be specific enough. As such, a code may not accurately capture 
the meaning required by the practitioner entering the data, it may simply be the 
nearest to the meaning required (Brown et al. 2003). Whilst not necessarily 
important in a study such as the one reported here, this is likely to be of relevance 
in other research.
Attempts are being made, however, to deal with these issues and create 
standardisation in the use of clinieal coding. Scottish Clinical Information 
Management in Primary Care (SCIMP) has developed a set o f 800 codes as a 
means o f trying to ensure consistent recording of disease and its management 
across Scotland (Morris et al. 2002). In this system, practitioners are encouraged
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to use one single code to denote a specific condition, thereby creating more 
consistent recording across practices. At the end o f 2001, the core 300 codes were 
published and sent to every practice in Scotland and the full set o f 800 published 
on the SCIMP website. Undoubtedly, a move away from larger, more complex 
disease classifieations and towards the type first introdueed by the RCGP almost 
50 years ago will be o f major benefit, not only to practices, but also to researchers.
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7.9 Potential of the 2003 GMS contract
The study reported here was foiward looking in its foeus in relation to the use of 
routinely collected data, held on primary care computer systems, as a means of 
impacting on disease management at a population level. This had not been done 
in Scotland prior to the establislnnent o f this work. However, the political and 
financial implications of the new GMS contract are likely to ensure that these 
sorts o f methods are implemented in practice more rapidly than would occur 
through the dissemination o f research findings (British Medical Association
2003). Clearly, the data required for this study had a research focus, and it could 
be argued that practitioners have ready access to the data required for the care of 
individual patients, albeit held in more than one source. However, findings from 
the study, in relation to inadequate control of high blood pressure and the 
completeness and currency o f electronic data, have implications in tenns of the 
requirements o f the new contract.
Remuneration in the new contract is partly derived by the acquisition of points, 
which are allocated on the basis o f various organisational and clinical targets. 
These points are used as a proxy for quality. Quality indicators for hypertension 
comprise 19% of the clinical points available and 10% o f the overall total.
Whilst, as this study demonstrates, practices already collect vast amounts o f data 
relating to chronic disease management, formalisation o f indicators in this way is 
new. There is now increased pressure on practitioners to improve on data 
collection in order to reach set targets. In management of hypertension, more than 
half of the points available relate to adequate control o f blood pressure to the level 
of <150 / <90 mm Hg. Since achieving control can be a protracted process which 
is not always rewarding and which relies as much on the patient as on the 
practitioner, surely there is a perverse incentive not to improve on the 
identification aspect o f the rule of halves. Previous work in diabetes has shown 
that smaller practices may be likely to have greater variability in aehieved quality 
each year (Guthrie et al. 2003). However, the results of this study suggest that 
with a condition as prevalent as hypertension, larger practices may find it more 
difficult to reach targets.
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The 1990 GMS contract was primarily responsible for the widespread adoption of 
computer systems in primary care. Perhaps the legacy o f the 2003 GMS contract 
will be rapid improvement in the quality of the electronic records held in those 
systems. In the late 1960s, there was emerging unease about the impact that the 
use o f information technology might have on practitioner-patient relationships. In 
his article on computers in general practice, Marshall Marinlcer expressed concern 
that sueh systems demands,
".... that they [doctors] sum up a consultation with the title o f a
disease" (Marinker 1969)
Contractual obligations and other initiatives which encourage data recording are 
intended to improve patient care. Indeed, it is likely that they will do so for 
individual conditions. However, the danger is that holistic care will be lost if 
practitioners begin to treat the data rather than the patient.
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Chapter 8 
CONCLUSIONS
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The mie o f halves indicates that half of the hypertensive population are not 
known, half o f those known are not treated, and half o f those treated are not 
controlled. The study reported here has demonstrated, as have others in the field, 
that levels o f identification, treatment and control of hypertension have improved, 
to the extent that a new rule now exists. Sixty percent o f all hypertensive patients 
and 40% of treated hypertensives were not controlled at the end of this study. 
However, whilst the impact was small, the results show that providing practices 
with strategic feedback, developed from electronic patient data, can impact on 
identification and management of hypertension in the elderly and produce 
consequent increases in blood pressure control.
The relationship between organisational structure, practitioner behaviour and the 
provision of care is complex and there are likely to be many contributing factors. 
However, this study suggests that particular organisational features and practice 
characteristic facilitate improved control of hypertension. Smaller practices and 
practices with training practice status appeared more able to make improvements 
on the rule o f halves.
The study also demonstrated the utility of electronic primary care data and whilst 
a certain amount o f the research related to the development o f methods to enable 
retrieval and processing o f these data, the difficulties encountered have largely 
been addressed through advances in clinical record keeping systems. The 2003 
GMS contract for general practice is likely to make increasing demands on 
electronic data to support claims for reimbursement based on the quality o f care 
being provided to patients (British Medical Association 2003). This study 
demonstrates that improvements are already under way, but that utilisation of the 
unique methodology developed as part of this research can have an additional 
effect on an important quality indicator. This methodology, which utilises data 
linkage techniques to combine individual patient data, can provide strategic 
information to help practices identify at risk patients more readily. This could be 
applied to other conditions or aspects of care where quality improvement is 
necessary. Indeed, system advances mean that the method could now be adapted 
for use in primary care, allowing practitioners to generate lists o f priority patients 
at a suitable time and as frequently as required.
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This study has shown that improvements to the rule of halves can be made and 
that remote processing of primary care data can be used to facilitate those 
improvements. However, there are still questions to be answered. In particular, 
how would blood pressure control and risk o f stroke be affected by providing 
tailored risk data to patients, what will be the impact o f the new GMS contract on 
identification, treatment, control and risk and why do smaller practices appear to 
achieve better control o f hypertension than their larger contemporaries?
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Appendix 1 : Audit group feedback
Practice ID: «PractIcelD» HYPER Trial -  ‘turning data into knowledge’
Explanatory Information
These data relate only to:
• information recorded on your practice computer system
• patients registered as “Live” (de-registered and temporary patients are excluded)
• patients aged 65-79 years
• The threshold for high blood pressure being used in the HYPER trial study is a systolic 
pressure of ^160 or a diastolic pressure or >90
• Patients are taken as having a “Record of BP” if a measurement of systolic and diastolic 
blood pressure was recorded on their computer record. No time limit was applied.
.  Patients are taken as having hypertension if a diagnosis is recorded in their computer
record
• The presence of one or more of the following READ codes was taken as denoting a 
diagnosis of hypertension:
1. 14a2. (H/O: hypertension)
2. 6627. or 6628. (good/poor hypertension control)
3. 6629. (hypertension follow-up default)
4. 662F. or 662G. or 662H. (hypertensive treatm. started/changed/stopped)
5. 6620. (on treatment for hypertension)
6. 8826. (antihypertensive therapy)
7. 8HT5. (referral hypertension clinic)
8. 9N03. or 9N1y2 (seen in hypertension clinic)
9. 901.. (hypertension monitoring)
10. G20.. (essential hypertension)
11. G21-. or G22.. or G23.. (hypertensive heart/renal/heart+renal disease)
12. G24.. (secondary hypertension)
• When selecting data for this feedback report, priority was given to information recorded 
with dates over undated information. If no dated information was available, undated 
information was used.
• Percentages in Fig 1. and the Summary Table are based on the total number of patients 
aoed 65-79
• Percentages in Fig 2. are based on the number of hypertensive patients aged 65-79
Results for your practice are in dark  blue  text
Average results for all practices in the Strategic group are bracketed and in l ig h t  b l u e  text 
Due to the rounding process used, there may be some variation in percentages of +/- 0.1
Feedback from computerised data (Dec 2001 run) - Page 1
Practice ID: «PracticelD» HYPER Trial -  turning data into knowledge’
Fig 1. All registered patients aged 65-79
Patient records on computer
n=329 (n=686)
N.B. Percentages in Fig 1. 
and the Summary Table 
are based on the total 
number of registered 
patients aged 65-79
Male Female
n=171 (52.0%) n=158 (48.0%)
310 (45.2%) 376 (54.8%)
Recor
n*255
dofBP
(77.5%)
84.3%).........
No record of BP 
n-74 ta.5%)
108 r ts  j
BP <160/90 1 BP  ^160/90 I
! n=149 (45.3%) i n=106 (32.2%)J r r } y
Summary Table You Group ave.
Patients with no BP recorded: 22.5% (15.7%)
With recorded diagnosis of hypertension 3.0% (0.7%)
With recorded cardiovascular risk factors -1 0.0% (0.1%)
-2 0.0% (0.0%)
-3 0.0% (0.0%)
Patients with recorded BP of ^160/90: 32.2% (22.7%)
With recorded diagnosis of hypertension 10.9% (8.9%)
With recorded cardiovascular risk factors -1 3.6% (2.4%)
-2 0.0% (0.3%)
-3 0.0% (0.0%)
• Results for your practice are in da rk  blue  text
• Average results for all practices in the Stretegic group are bracketed and in l ig h t  b l u e  text
Feedback from computerised data (Dec 2001 run) - Page 2
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Appendix 2: Additional Strategic group feedback
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Appendix 3: Practice Structure Questionnaire
UNm ERSITY
of
GLASGOW à
HYPER Trial
‘Turning data into knowledge’ 
Practice Structure Questionnaire
GRASS User: XXX 
HYPER trial number; 01
Your practice is one of 52 Scottish practices which are participating in HYPER trial, a 
study looking at the usefulness of providing GPs with computerised feedback on 
management  of hypertension. As part of this we are trying to determine the resources 
which are available to practices so that  we can identify any changes which take place 
over the period of the study.
Some months ago we asked you to provide us with initial information about  this for 
your practice. We would be grateful if you would complete this 2"^ questionnaire and 
return it to us in the envelope provided as soon as possible. All of the information 
provided will be t reated in confidence. If you have any questions about  this 
questionnaire, please contact: -
Llz Mitchell
University of Glasgow Department  of General Practice 
4  Lancaster Crescent, Glasgow, G12 ORR 
r e / 0 1 4 1  211 1 6 6 6  F a x 0 1 4 1  211 1 6 6 7  
£-/77a/7edml a@clinmed.gla.ac.uk
For office me only 
PRACTICE ID
QUESTIONNAIRE B (% )  12 18 24
RETURN DATE /
1. Are the premises
Practice owned 
Health Board owned 
Privately rented 
Other
If OTHER, please specify
Tick one box only
2. Is the practice an approved tiaining practice?
Yes
No
Tick one box only
3a. Are the medical records summarised?
Yes
No
Partially
Tick one box only
3b. If YES, are they? 
Paper
Computerised
Both
Tick one box only
4. What is the total practice list size?
5. For what percentage of patients do you receive deprivation payments?
B4 payments 
B3 payments 
B2 payments 
B1 payments
%
%
%
%
6. How many of the following GPs work in the practice? (Wliole Time Equivalent)
Principals
Assistants
Trainees
Other
If OTHER, please specify _____________________________________ _
7. How many of the following nurses work in or from the practice? (WTE)
Practice nurses 
Health visitors 
District nurses
Others ~ for example, CPN, Liaison
If OTHER, please specify ______________________________________
Please go to the next page now
8. How many other staff work in the practice? (WTE)
Practice Manager 
Receptionists 
Secretaries 
Clerical staff 
Other
If OTHER, please specify _____________________
9. Does the practice have an appointment system?
Yes, for all surgeries 
Yes, for some surgeries 
No
10a. Approximately how many consultations per week are there...,? 
Per GP (WTE)
Per Practice Nurse (if applicable)
Tick one box only
10b. What is the average consultation time....?
For GP consultations
For Practice Nurse consultations (if applicable)
11. Does the practice hold a hypertension register?
Yes
No
Minutes
Minutes
Tick one box only
12a. Does the practice hold a hypertension clinic?
Yes
No
If NO go to Question 13
12b. If YES, how often is this held?
Tick one box only
12c. Who normally conducts the clinic? 
GP only
Practice nurse only
GP and practice nurse
Mainly practice nurse but GP available
12d. How many patients are usually seen at the clinic?
Tick one box only
Please go to the next page now
12e. Which patients do you see in the clinic?
All patients with hypertension 
Specific gi'oups of hypertensive patients 
Others
If GROUPS or OTHER, please specify 
12f. How long does a clinic usually last?
Tick one box only
Hours Minutes
13a. Does the practice have a recall system for hypertensive patients?
Yes
No
Tick one box only
13b. If YES, is it?
By letter 
By telephone
Appointment arranged at previous visit 
Other
If OTHER, please specify _________
Tick one box only
13c. How often are hypertensive patients recalled?
Please give the date when this questionnaire was completed / /
Thank you for your help
Appendix 4: Computerisation questionnaire
14. In what year did your practice first acquire a computing system for collecting 
patient information e.g. registration details, diagnoses?
15. Aie there computers/terminals in the consulting rooms used by the doctors in your 
your practice?
All of the consulting rooms 
Some of the consulting rooms 
None of the consulting rooms
16. Are there computers/tenninals in the rooms used by the nurses in your practice?
All of the rooms 
Some of the rooms 
None of the rooms
17a. Is there a designated person or group of people in the practice with responsibility 
for computer related issues e.g. breakdowns, hardware/software purchasing etc.?
Yes
No
17b. If YES, is this (please tick all that apply)
GP
Nurse
Practice Manager
Computer operator/Data input clerk
Receptionist
Other
If OTHER, please specify ____________
18a. Who in the practice enters data onto the computer (please tick all that apply)
GP(s)
Nurse(s)
Practice Manager
Computer operator/Data input clerk 
Receptionist(s)
Other
If OTHER, please specify __________________________________________
18b. Has the practice allocated computer entry of specific types of information to a 
particular person or group of people e.g. registration data to receptionists?
Yes
No
18c. If YES, is this (please tick all that apply)
GP
Nurse
Practice Manager
Computer operator/Data input clerk
Receptionist
Other
If OTHER, please specify ____________
18d. How long ago was data entry organised in this way?
Years Months
19a. Is there a designated person with responsibility for IT related training?
Yes
No
19b. If YES, is this person 
GP
Nurse
Practice Manager
Computer operator/Data input clerk
Receptionist
Other
If OTHER, please specify ____
20a. Does your practice have a branch surgery?
Yes
No
20b. If YES, is there access to the computerised patient record system there?
Yes
No
21. In your practice, what record system is currently used for each of the following tasks
Totally/largely Both computerised Totally/largely
Paper-based and paper-based Computerised
a. Patient registration 1 2 3
b. Appointments 1 2 3
c. Disease registers 1 2 3
d. Clinical records 1 2 3
e. Referral letters 1 2 3
f. Acute prescribing 1 2 3
g- Repeat prescribing 1 2 3
h. Call and recall 1 2 3
i. Highlighting future tasks (e.g. record BP) 1 2 3
j- Guidelines / protocols 1 2 3
22a. Does the computer record for the majority of patients in your practice date from 
The patient’s birth
The patient’s registration with the practice 
Installation of the computer system
22b. If REGISTRATION or INSTALLATION OF THE COMPUTER SYSTEM, has the 
practice decided to retrospectively enter some or all data recorded before this date?
Yes 
No
23a. Has the practice agreed on a minimum set of data which should be collected for 
each patient?
Yes
No
Don’t laiow
23b. If YES, is this data collected for 
All patients
Specific gi'oups of patients
24a. Is there any patient infoimation which the practice has decided not to record? 
All patients
Specific groups of patients
24b. If YES, please give details?
25. What patient information is routinely recorded on computer?
Not entered Entered for some
Administration:
a. Registration details
b. Family histoiy
c. Past medical history
d. Routine prevention (e.g. immunisations)
e. Recall infoimation (e.g. smears)
f. Details of fees
Consultation:
g. Presenting complaint/symptom(s)
h. Clinical findings on examination
i. Measurements (e.g. BP, peak flow) 
j. Diagnosis
k. Drugs prescribed
1. Acute problems
m. Ongoing problems
Entered for all
3
3
3
3
3
3
3
3
3
3
3
3
3
n. Drug side-effects 1 2 3
0. Drug contra-indications 1 2 3
Referrals:
P Referrals to other primary care (e.g. chiropody) 1 2 3
q- Referrals to secondary care 1 2 3
r. Other refeiTals 1 2 3
s. Investigations 1 2 3
t. Results of investigations 1 2 3
u. Secondary care management 1 2 3
26a. How many GPs in your practice usually record data onto the computer during or 
directly after consultations?
26b. How many nurses in your practice usually record data onto the computer during 
or directly after consultations?
27. How stTongly do you agree or disagree with the following statement: “computerisation 
of patient data been well received by the practice team as a whole”?
Strongly agree Agree Neither agree 
nor disagree
Disagree Strongly disagree
Position held by person completing questionnaire: Date completed:
Thank you very much for your help
Appendix 5; Casenote review proforma
DATE OF DOWNLOAD: 
Practice ID 
HYPER ID
Patient ID 
D o B 
Gender Male Female
Diagnosis of Yes 1 1 No | 1 Visits in Practice
hypertension period (GP)(PN / HV) i
Drug treatment Yes I  | No | I Hospital 1
Number BP records In | f  1 1 / i ..- | No record 1
12-month period
S D Date PRACT HOSP
Blood pressure 1 / ' ......1readings 2 ....... ! / 1............3 ......... 1 /1  ■ ! ■
Smoking status Current 1 | E x | 1 Non 1 I No record |
Total HDL
Cholesterol
Co-morbidity
Hypertension
ECO
LVH
Yes
Yes
No
No
Diabetes Stroke
NOTES
Appendix 6: Data release form
UNIVERSITY
ofGLASGOW „
-SnÎTÎS
HYPER trial -  'turning data into knowie dge'
Data Release Consent Form
The data on this disk may be used for two purposes and we would like to confirm your 
consent for:
♦ HYPER Triai
and that you will release anonymised practice data for, 
♦ EQ
as previously described to you by personnel from that project.
Please complete: 
Name:
For: (practice name) 
GPASS user number: 
Signed:
Date:
HYPER Trial. University of Glasgow, Dept, of General Practice 
4 Lancaster Crescent Glasgow G12 0RR 
Tel: 0141 211 1666 Fax: 0141 211 1667 email: edm1a@ clinmed.gla.ac.uk
Appendix 7: Hypertension Read codes
Read codes used to indicate diagnosed hypertension (n=67)
READ CODE DESCRIPTOR
14A2. H/O: hypertension
6627. Good hypertension control
6628. Poor hypertension control
6629. Hypertension: follow-up default
662F. Hypertension treatment started
662G. Hypertensive treatment changed
662H. Hypertension treatment stopped
6620. On treatment for hypertension
8B26. Antihypertensive therapy
8HT5. Referral hypertension clinic
9N03. Seen in hypertension clinic
9N1y2 Seen in hypertension clinic
901.. Hypertension monitoring admin.
9011. Attends hypertension monitor.
9012. Refuses hypertension monitor.
9013. Hypertension monitor offer default
9014. Hypertension monitor 1st letter
9015. Hypertension monitor 2nd letter
9016. Hypertension monitor 3rd letter
9017. Hypertension monitor verbal invite
9018. Hypertension monitor phone invite
9019. Hypertension monitor deleted
901A. Hypertension monitor check done
90IZ. Hypertension monitoring admin NOS
G20.. Essential hypertension
G200. Malignant essential hypertension
G201. Benign essential hypertension
G202. Systolic hypertension
G20z. Essential hypertension NOS
G21.. Hypertensive heart disease
G210. Malignant hypertensive heart disease
G2100 Malignant hypertensive heart disease - no COP
G2101 Malignant hypertensive heart disease + CCF
G21ÛZ Malignant hypertensive heart disease NOS
G211. Benign hypertensive heart disease
G2110 Benign hypertensive heart disease - no CCF
G2111 Benign hypertensive heart disease + CCF
G211 z Benign hypertensive heart disease NOS
G21z. Hypertensive heart disease NOS
G21z0 Hypertensive heart disease NOS - no CCF
G21z1 Hypertensive heart disease NOS + CCF
G21zz Hypertensive heart disease NOS
G22.. Hypertensive renal disease
G220. Malignant hypertensive renal disease
G221. Benign hypertensive renal disease
G222. Hypertensive renal disease + renal failure
G22z. Hypertensive renal disease NOS
G23,. Hypertensive heart + renal disease
G230. Malignant hypertensive heart + renal disease
G231. Benign hypertensive heart + renal disease
G232. Hypertensive heart & renal disease + (congestive) heart failure
G233. Hypertensive heart & renal disease + renal failure
G234. Hypertensive heart & renal disease + both (congestive) heart & renal failure
G23z. Hypertensive heart + renal disease NOS
G24.. Secondary hypertension
G240. Secondary malignant hypertension
READ CODE DESCRIPTOR
G2400 Secondary malignant renovascular hypertension
G240z Secondary malignant hypertension NOS
G241. Secondary benign hypertension
G2410 Secondary benign renovascular hypertension
G241z Secondary benign hypertension NOS
G244. Hypertension 2ndry endocrine disorder
G24z. Secondary hypertension NOS
G24z0 Secondary renovascular hypertension NOS
G24zz Secondary hypertension NOS
Gyu20 [X] Other secondary hypertension
Gyu21 [X] Hypertension, 2ndary other renal disease
Appendix 8: Diabetes Read codes
Read codes used to indicate diagnosed diabetes (n=189)
READ CODE DESCRIPTOR
13B1. Diabetic diet
1434. H/O: diabetes mellitus
14P3. H/O: insulin therapy
2G5A. O/E-Right diabetic foot at risk
2G5B. 0/E-Left diabetic foot at risk
42W.. Hb. A1C - diabetic control
42W1. Hb. A1C < 7% - good control
42W2. Hb. A1C 7-10% - borderline
42W3. Hb. A1C > 10% - bad control
42WZ. Hb. A1C - diabetic control NOS
44UZ. Blood glucose 14+mmol/L
44Uz. Blood glucose raised NOS
44V3. Glucose tolerance test diabetic
66A.. Diabetic monitoring
66A1. Initial diabetic assessm ent
66A2. Follow-up diabetic assessm ent
66A3. Diabetic on diet only
66A4. Diabetic on oral treatment
66A5. Diabetic on insulin
66A8. Has seen dietician - diabetes
66A9. Understands diet - diabetes
66AD. Fundoscopy - diabetic check
66AG. Diabetic drug side effects
66AH. Diabetic treatment changed
66AH0 Conversion to insulin
66AI. Diabetic - good control
66AJ. Diabetic - poor control
66AJ0 Chronic hyperglycaemia
66AJ1 Brittle diabetes
66AJ2 Loss of hypoglycaemic warning
66AJz Diabetic - poor control NOS
66AK. Diabetic - cooperative patient
66AL. Diabetic - uncooperative patient
66AM. Diabetic - follow-up default
66AN. Date diabetic treatment start
66AO. Date diabetic treatment stopped
66AP. Diabetes: practice programme
66AQ. Diabetes: shared care program
66AR. Diabetes management plan given
66AS. Diabetic annual review
66AZ. Diabetic monitoring NOS
8A12. Diabetic crisis monitoring
8A13. Diabetic stabilisation
8A17. Self monitoring blood glucose
8A18. Self monitoring urine glucose
8A19. Self monitoring blood + urine glucose
8CA41 Patient advised re diabetic diet
8H2J. Admit diabetic emergency
8H30. Non-urgent diabetic admission
8H4F. Referral to diabetologist
8H7C. Refer, diabetic liaison nurse
8HKE. Diabetology D.V. requested
8HLE. Diabetology D.V. done
8HME. Listed for Diabetology admission
8HVU. Private referral diabetologist
9N1Q. Seen in diabetic clinic
90L.. Diabetes monitoring admin.
90L1. Attends diabetes monitoring
90L2. Refuses diabetes monitoring
READ CODE DESCRIPTOR
90L3. Diabetes monitoring default
90L4. Diabetes monitoring 1st letter
90L5. Diabetes monitoring 2nd letter
90L6. Diabetes monitoring 3rd letter
90L7. Diabetes monitoring verbal invite
90L8. Diabetes monitoring phone Invite
90L9. Diabetes monitoring deleted
90LA. Diabetes monitor, check done
90LZ. Diabetes monitoring admin NOS
CIO.. Diabetes mellitus
0100. Diabetes mellitus - no complications
01000 Diabetes mellitus no complications - juvenile
01001 Diabetes mellitus no complications - adult
0100z Diabetes mellitus no complications - onset NOS
0101. Diabetes mellitus with ketoacidosis
01010 Diabetes mellitus + ketoacidosis - juvenile
01011 Diabetes mellitus + ketoacidosis - adult
0101 y Other specified Diabetes mellitus + ketoacidosis
O101z Diabetes mellitus + ketoacidosis - onset NOS
0102. Diabetes mellitus + hyperosmolar coma
01020 Diabetes mellitus + hyperosmolar coma - juvenile
01021 Diabetes mellitus + hyperosmolar coma - adult
O102z Diabetes + hyperosmolar coma NOS
0103. Diabetes mellitus. + ketoacidotic coma
01030 Diabetes mellitus.+ ketoacidotic coma - juvenile
01031 Diabetes mellitus.+ ketoacidotic coma - adult
O103y Other specified diabetes mellitus with coma
O103z Diabetes mellitus + ketoacidotic coma NOS
0104. Diabetes mellitus with nephropathy
01040 Diabetes mellitus + nephropathy - juvenile
01041 Diabetes mellitus + nephropathy - adult
O104y Other specified diabetes mellitus + renal complications
O104z Diabetes mellitus + nephropathy NOS
0105. Diabetes mellitus+ eye manifestation
01050 Diabetes mellitus + eye manifestation - juvenile
01051 Diabetes mellitus + eye manifestation - adult
0105y Other specified diabetes mellitus + ophthalmic complications
O105z Diabetes mellitus + eye manifestation NOS
0106. Diabetes mellitus. with neuropathy
01060 Diabetes mellitus + neuropathy - juvenile
01061 Diabetes mellitus + neuropathy - adult
O106y Other specified diabetes mellitus + neuropathic complications
O106z Diabetes mellitus + neuropathy NOS
0107. Diabetes mellitus + peripheral circulatory disease
01070 Diabetes + peripheral circulatory disease - juvenile
01071 Diabetes + peripheral circulatory disease - adult
01072 Diabetic gangrene - adult
01073 IDDM peripheral circulatory disorder
01074 NIDDM peripheral circulatory disorder
O107y Other specified diabetes mellitus + peripheral circulatory comps.
O107z Diabetes + peripheral circulatory disease NOS
0108. Insulin dependent diabetes mellitus
01080 Insulin dependent diabetes mellitus + renal complications
01081 Insulin dependent diabetes mellitus + ophthalmic complications
01082 Insulin dependent diabetes mellitus + neuropathic complications
01083 Insulin dependent diabetes mellitus + multi complications
01084 Unstable insulin dependent diabetes mellitus
01085 Insulin dependent diabetes mellitus + ulcer
01086 Insulin dependent diabetes mellitus + gangrene
01087 Insulin dependent diabetes mellitus + retinopathy
01088 Insulin dependent diabetes mellitus - poor control
READ CODE DESCRIPTOR
0 1 0 8 9  
O 1 0 8 y  
O 1 0 8 Z  
0 1 0 9 .
0 1 0 9 0
0 1 0 9 1
0 1 0 9 2
0 1 0 9 3
0 1 0 9 4
0 1 0 9 5
0 1 0 9 6
01097 
01OA. 
O10A0 
O10A1 
O10A2 
O10A3 
010A4 
O10A5 
O10A6 
O10A7 
O10AW 
O10AX 
01 OB. 
O10B0 
01 Oy. 
OlOyO 
OlOyl 
OlOyy 
OlOyz 
010z. 
OlOzO 
OlOzI 
OlOzy 
OlOzz 
011yO 
Oyu2. 
Oyu20 
Oyu21 
Oyu22 
Oyu23 
F1711 
F3450 
F35z0 
F372. 
F3720 
F3721 
F3722 
F3813 
F3y0. 
F420. 
F4200 
F4201 
F4202 
F4203 
F420Z 
F4407 
F4640 
G73y0 
KOIxl 
Kyu03
Insulin dependent diabetes adult onset
Other specified diabetes mellitus + multiple complications
Unspecified diabetes mellitus + multiple complications
Non-insulin dependent diabetes mellitus
Non-insulin dependent diabetes mellitus + renal complications
Non-insulin dependent diabetes mellitus + ophthalmic comps.
Non-insulin dependent diabetes mellitus + neuropathic comps.
Non-insulin dependent diabetes mellitus + multi complications
Non-Insulin dependent diabetes mellitus + ulcer
Non-insulin dependent diabetes mellitus + gangrene
Non-insulin dependent diabetes mellitus + retinopathy
Non-insulin dependent diabetes mellitus - poor control
Malnutrition-related diabetes mellitus
Malnutrition-related diabetes mellitus + coma
Malnutrition-related diabetes mellitus + ketoacidosis
Malnutrition-related diabetes mellitus + renal complications
Malnutrition-related diabetes mellitus + ophthalmic complications
Malnutrition-related diabetes mellitus + neuropathic complications
Malnutrition-related diabetes mellitus + periph. circulatory comp
Malnutrition-related diabetes mellitus + multiple complications
Malnutrition-related diabetes mellitus without complications
Malnutrition-related diabetes mellitus + unspecified complications
Malnutrition-related diabetes mellitus + other specified comps.
Diabetes mellitus induced by steroids
Steroid induced diabetes mellitus without complications
Diabetes mellitus + other manifestation
Diabetes mellitus + other manifestation - juvenile
Diabetes mellitus + other manifestation - adult
Other specified diabetes mellitus + other specified complications
Diabetes mellitus + other manifest NOS
Diabetes mellitus + unspecified complications
Diabetes mellitus + comp NOS - juvenile
Diabetes mellitus + comp NOS - adult
Other specified diabetes mellitus + unspecified complications
Diabetes mellitus + unspecified complications NOS
Steroid induced diabetes
[X]Diabetes mellitus[xjother specified diabetes mellitus
[XjMalnutritlon-related diabetes mellitus +other specified comps. 
[XjMalnutrition-related diabetes mellitus + unspecified comps.
[X]Unspecified diabetes mellitus + renal complications
Autonomic neuropathy - diabetes
Diabetic mononeuritis multiplex
Diabetic mononeuritis NOS
Polyneuropathy in diabetes
Acute painful diabetic neuropathy
Chronic painful diabetic neuropathy
Asymptomatic diabetic neuropathy
Myasthenic syndrome + diabetes
Diabetic mononeuropathy
Diabetic retinopathy
Background diabetic retinopathy
Proliferative diabetic retinopathy
Preproliferative diabetic ret
Advanced diabetic maculopathy
Diabetic retinopathy NOS
Diabetic iritis
Diabetic cataract
Diabetic peripheral angiopathy
Nephrotic syndrome + diabetes mellitus
[XjGlomerular disorders / diabetes mellitus
READ CODE DESCRIPTOR
M0372 Cellulitis in diabetic foot
M2710 Ischaemic ulcer diabetic foot
M2711 Neuropathic diabetic ulcer - foot
M2712 Mixed diabetic ulcer - foot
N0300 Diabetic cheiroarthropathy
N0301 Diabetic Charcot arthropathy
R0542 [DjGangrene of toe in diabetic
R0543 [DjWidespread diabetic foot gangrene
Appendix 9: Stroke Read codes
Read codes used to indicate previous stroke (n=65)
READ CODE DESCRIPTOR
14A7.
14AK.
662M.
G61..
G610.
G611.
G612.
G613.
G614.
G615.
G616.
G617.
G618.
G61X.
G61X0
G61X1
G61z.
G62z.
G63..
G630.
G631.
G632.
G633.
G63y.
G63y0
G63y1
G63z.
G64..
G640.
G6400
G641.
G6410
G64z.
G64z0
G64z1
G64z2
G64z3
G66..
G660.
G661.
G662.
G663.
G664.
G665.
G666.
G667.
G668.
G6760
G677.
G6770
G6771
G6772
G6773
G6774
G681.
G683.
G68X.
G6W..
G6X..
H/O: GVA/stroke
H/0: Stroke in last year
Stroke monitoring
Intracerebral haemorrhage
Cortical haemorrhage
Internal capsule haemorrhage
Basal nucleus haemorrhage
Cerebellar haemorrhage
Pontine haemorrhage
Bulbar haemorrhage
External capsule haemorrhage
Intracerebral haemorrhage intraventricular
Intracerebral haemorrhage multiple local
Intracerebral haemorrhage hemisphere unspecified
Left side intracerebral haemorrhage unspecified
Right side intracerebral haemorrhage unspecified
Intracerebral haemorrhage NOS
Intracranial haemorrhage NOS
Precerebral arterial occlusion
Basilar artery occlusion
Carotid artery occlusion
Vertebral artery occlusion
Multiple / bilateral precerebral arterial occlusion
Other precerebral artery occlusion
Cerebral infarctlon/thrombosis/precerebral artery
Cerebral infarction /embolism/precerebral artery
Precerebral artery occlusion NOS
Cerebral arterial occlusion
Cerebral thrombosis
Cerebral infarctlon/thrombosis/cerebral artery 
Cerebral embolism
Cerebral infarction/embolism/cerebral artery
Cerebral infarction NOS
Brainstem infarction
Wallenberg syndrome
Left sided cerebral infarction
Right sided cerebral infarct
Stroke/CVA unspecified
Middle cerebral artery syndrome
Anterior cerebral artery syndrome
Posterior cerebral artery syndrome
Brain stem stroke syndrome
Cerebellar stroke syndrome
Pure motor lacunar syndrome
Pure sensory lacunar syndrome
Left sided CVA
Right sided CVA
Cerebral infarction /cerebral vein thrombosis, non pyo 
Occlusion/stenosis cerebral artery, n rsit cer inft 
Occlusion + stenosis/midI cerebral artery 
Occlusion + stenosis/anterior cerebral artery 
Occlusion + stenosis/post cerebral artery 
Occlusion + stenosis/cerebellar artery 
Occlusion/stenosis/multiple + bilateral cerebral artery 
Sequelae/intracerebral haemorrhage 
Sequelae/cerebral infarction
Sequelae/stroke, n specified/haemorrhage, infarction
Cerebral infarction, unspecified occlusion/stenosis precerebral artery
Cerebral infarction /unspecified occlusion, stenosis/cerebral artery
READ CODE DESCRIPTOR
Gyu62 [X]Other intracerebral haemorrhage
Gyu63 [xjcerebral infarction/unspecified occlusion, stenosis/cerebral artery
Gyu64 [XjOther cerebral infarction
Gyu65 [xjocclusion + stenosis/other precerebral artery
Gyu66 [XJOcclusion + stenosis/other cerebral arteries
Gyu6C [xjsequelae/stroke, n spc/haemorrhage, infarction
Appendix 10; Smoking status Read codes
Read codes used to indicate smoking status (n=52)
READ CODE DESCRIPTOR
137.. Tobacco consumption
1371. Never smoked tobacco
1372. Trivial smoker - < 1 cig/day
1373. Light smoker -1 -9 cigs/day
1374. Moderate smoker -10-19 cigs/d
1375. Heavy smoker - 20-39 cigs/day
1376. Very heavy smoker - 40+cigs/d
1377. Ex-trivial smoker {
1378. Ex-light smoker (1 -9/day)
1379. Ex-moderate smoker (10-19/day)
137A. Ex-heavy smoker (20-39/day)
137B. Ex-very heavy smoker (40+/day)
1370. Keeps trying to stop smoking
137D. Admitted tobacco cons untrue?
137E. Tobacco consumption unknown
137F. Ex-smoker - amount unknown
137G. Trying to give up smoking
137H. Pipe smoker
1371. Passive smoker
137J. Cigar smoker
137K. Stopped smoking
137L. Current non-smoker
137M. Rolls own cigarettes
137N. Ex pipe smoker
1370. Ex cigar smoker
137P. Cigarette smoker
137Q. Smoking started
137R. Current smoker
137S. Ex smoker
137Z. Tobacco consumption NOS
9 0 0 .. Anti-smoking monitoring admin.
9001 . Attends stop smoking monitor
9002 . Refuses stop smoking monitor
9003 . Stop smoking monitor default
9004 . Stop smoking monitor 1st letter
9005 . Stop smoking monitor 2nd letter
9006 . Stop smoking monitor 3rd letter
9007 . Stop smoking monitor verbal invite
9008 . Stop smoking monitor phone inv
9009 . Stop smoking monitoring delete
900A. Stop smoking monitor check done
900Z . Stop smoking monitor admin. NOS
E251. Tobacco dependence
E2510 Tobacco dependence-unspecified
E2511 Tobacco dependence-continuous
E2512 Tobacco dependence-episodic
E2513 Tobacco dependence-in remission
E251z Tobacco dependence NOS
Eu171 [XjHarmful use of tobacco
Eu 172 [XjTobacco dependence syndrome
ZV4K0 jV]Tobacco use
ZV6D8 [V]Tobacco abuse counselling
Appendix 11: Antihypertensive drugs
Drug names indicating antihypertensive medication (n=167)
BNF CHAPTER I CLASS NON-PROPRIETORY (PROPRIETORY)
2.2.1 Thiazides and related diuretics
2.2.2 Loop diuretics
2.4 Beta-adrenoceptor blocking drugs
2.5.1 Vasodilator antihypertensive drugs
2.5.2 Centrally acting antihypertensive 
drugs
2.5.4 Alpha-adrenoceptor blocking drugs
Bendrofiuazide 
Chlorothiazide (Saluric)
Cyclopenthiazide (N avid rex)
Indapamide (Natrillix)
Mefruside (Baycaron)
Metolazone (Metenix)
Xipamide (Diurexan)
Bumetanide (Burinex)
Frusemide (Lasix)
Acebutolol (Secadrex, Sectral)
Atenolol (Beta-Adalat, Co-tenidone, Kalten, 
Tenben, Ten if, Tenoret, Tenoretic, 
Tenormin)
Betaxolol (Kerlone)
Timolol Maieate (Betim, Blocadren) 
Bisoprolol Fumarate (Emcor, Monocor, 
Monozide)
Carvedilol (Eucardic)
Celiprolol Hydrochloride (Celectol)
Esmolol Hydrochloride (Brevlbloc) 
Propranolol (Inderal, Inderetic, Inderex) 
Labetalol Hydrochloride (Trandate) 
Metoprolol Tartrate (Betaloc, Lopresor) 
Nebivolol (Nebilet)
Nadolol (Corgard, Corgaretic)
Oxprenolol Hydrochloride (Trasicor, 
Trasidrex)
Pindolol (Viskaldix, Visken)
Sotalol Hydrochloride (Beta-Cardone, 
Sotacor)
Hydralazine Hydrochloride (Apresoline) 
Minoxidil (Loniten)
Clonidine Hydrochloride (Catapres, Dixarit) 
Methyldopa (Aldomet)
Doxazosin (Cardura)
Indoramin (Baratol, Doralese)
Prazosin Hydrochloride (Hypovase) 
Terazosin (Hytrin)
2.5,5.1 ACE inhibitors Captopril (Capoten, Capozide) 
Cilazapril (Vascace)
Enalapril Maieate (Innovace, Innozide) 
Fosinopril (Staril)
Lisinopril (Carace, Zestril, Zestoretic) 
Moexipril Hydrochloride (Perdix) 
Perindopril (Coversyl)
Quinapril (Accupro, Accuretic)
Ramipril (Tritace)
Trandolapril (Gopten, Odrik, Tarka)
BNF CHAPTER I  CLASS
2.5.5 2 Angiotensin-ll receptor inhibitors
NON-PROPRIETORY (PROPRIETORY)
Candesartan Citexetil (Amias) 
Irbesartan (Aprovel)
Losartan Potassium (Cozaar) 
Valsartan (Diovan)
2.6,2 Calcium channel blockers Amlodlpine Besylate (istin)Diltiazem Hydrochloride (Adizem, Angitil, 
Calcicard, Dllcardia, Dilzem, Slozem,
Tildiem, Viazem, Zemtard)
Felodipine (Plendil)
Isradipine (Prescal)
Lacidipine (Motens)
Lercanidipine Hydrochloride (Zanidip) 
Nicardipine Hydrochloride (Gardens) 
Nifedipine (Adalat, Adipine, Angiopine, 
Cardilate, Coracten, Coroday, Fortipine, 
Hypolar, Nefidipress, Nifedotard, Nifelease, 
NIfensar, Nivaten, Slofedipine, Tenstplne, 
Unipine)
Nisoldipine (Syscor)
Verapamil Hydrochloride (Cordilox, Securon, 
Unlver, Verapress, Vertab)
Appendix 12: Audit traii for the deveiopment of 
search queries
Audit trail for generation of feedback data ^
Copied tables C lin ical e v e n ts ,  M e a s u r e m e n ts , P a tie n ts  and P re sc r ip tio n s  to a new database 
called “Analyse HYPER data”.
Created a new table called MORBIDITY MASTER, which contains Practice ID, Patient ID, Read 
code. Diagnosis date and Update date. Update date contains information on when data records 
were Imported to the table.
Created an append query called BRING IN EVENTS which links P a tie n ts  and C linical e v e n ts .  
This query adds records containing Patient ID, Practice ID, Read code. Diagnosis date and 
Update date to MORBIDITY MASTER. Records selected are limited by age criteria [>044 and 
<080] and patient registration status [live = L]. All variables are grouped in ascending order and 
only the most recently dated Read code is Imported [last]. Discovered on testing that grouping 
by ‘last’ for Diagnosis date did not import the most recent Read code. Changed to ‘Max’ and 
tested again. Using ‘Max’ selects a dated Read code over an undated Read code if both are 
available.
Test complete 26.2.00
Created a delete query called WIPE MORBIDITY MASTER. This query deletes all information 
held in MORBIDITY MASTER.
Tested 13.2,00/26.2.00
Created a macro called IMPORT NEW DATA. This macro runs the WIPE MORBIDITY 
MASTER query followed by the BRING IN EVENTS query. This allows the same tables and 
queries to be used each time a new dataset is obtained. Previous data will be archived before 
this query is run.
Tested 13.2.00/26.2.00
Created a find duplicates query called FIND DUPLICATES FOR MORBIDITY MASTER. 
Running this query ensures that there are no duplicates in the table.
Created a select query called VERIFY MORBIDITY AGAINST EVENTS. This query links P a tien ts , MORBIDITY MASTER and C linical e v e n ts .  It is run to ensure that there are no 
relevant records in the C linical e v e n ts  source data which have not been transferred to 
MORBIDITY MASTER.
Created a select query called SORTED MEASUREMENTS. This query is run on M e a s u r e m e n ts  
and contains Practice ID, Patient ID, Measurement date. Systolic, Diastolic, Height, Weight, 
Parity and Gravida. Records selected are limited to those where Systolic and Diastolic have a 
BP reading [is not null, is not -1 , is not 0]. Practice ID, Patient ID and Measurement are 
grouped and sorted in ascending order.
Tested 28.2.00
Created a select query called PATIENT DATA. This query links P a tie n ts  and SORTED 
MEASUREMENTS and contains Practice ID, Patient ID, Age-band, Sex, Registration status, 
Depcat score. Measurement date. Systolic and Diastolic. All variables are grouped and only the 
most recent record for each patient is imported [last]. All patients are included even if they have 
no Systolic and / or Diastolic reading.
Test complete 29.02.99; Re-test complete 20.3.00 ^
 ^ All processes were developed using ‘HYPER data’ as the sample. This contains baseline data 
from three practices. These practices were chosen as they are New GRASS practices which 
have the smallest {1,999}, largest {16,400} and average {5,217} numbers of patients. Process 
began 10.2.00, completed 24.5.00.
 ^ After linking “Analyse Hyper data” with tables held in “Hyper extract 1”, PATIENT DATA, 
CHECK BP RECORDED, HYPERTENSIVES AND MORBIDIY VERBOSE were subsequently 
tested using three different practices; {1 New Gpass-4,547}, {1 UNIX-6,859} and {1 DOS-767}.
Created a select query called EXTRACT STUDY AGE GROUP. This query extracts data from P a tie n ts  for all relevant patients [>44 and <80 and of live status]. It also contains one created 
variable: Age Group. This inserts either ‘45-64’ or ‘65-79’ for each patient depending on their 
age band.
Test complete 28.2.00 I 29.2.00
Created a crosstab query called AGE AND SEX BY PRACTICE. This query is run on EXTRACT 
STUDY AGE GROUP and plots Practice ID and Age Group against total patient count, total 
count for females and total count for males.
Test complete 28.2.00 1 29.2.00
Created a select query called CHECK BP RECORDING. This query links P a tie n ts  and 
PATIENT DATA and contains Patient ID, Practice ID, Sex, Age-band, Registration status, 
LastOfSystolic and LastOfDiastolic. It also contains three created variables; Age Group, BP 
Recorded and Hypertensive Reading. BP Recorded inserts ‘No’ or ‘Yes’ depending on whether 
the patient has an entry for diastolic and systolic pressure. Hypertensive Reading inserts 
‘Missing’, ‘Normal BP’ or ‘Query HBP’ depending on whether their BP is 0, -1 or null, <160/90 or 
>160/90.
Test complete 1.3.00
Created a crosstab query called AGE & BP RECORDING BY PRACTICE. This query is run on 
CHECK BP RECORDING and plots Practice ID and Age Group against total patient count, total 
count for BP recorded and total count for BP not recorded.
Test complete 1.3.00
Created a crosstab query called AGE & BP LEVEL BY PRACTICE. This query is run on CHECK 
BP RECORDING and plots Practice ID and Age Group against total patient count, total count for 
‘Missing’, total count for ‘Normal BP’ and total count for ‘Query HBP’.
Test complete 1.3.00
Created a crosstab query called BP LEVEL BY PATIENT. This query is run on CHECK BP 
RECORDING and plots Practice ID and Patient ID against Hypertensive Reading to give one 
variable per patient; either ‘Missing’, ‘Normal BP’ or ‘Query HBP’.
Test complete 1.3.00
Created a select query called HYPERTENSIVES. This query links PATIENT DATA and 
MORBIDITY MASTER and contains Practice ID, Patient ID, Sex, Systolic, Diastolic and 
Measurement date. It also contains the created variables Hypertensive Reading and Age 
Group. Records selected are limited by our age criteria [>044 and <080] and relevant 
hypertension READ codes.
Test complete 10.3.00; Re-test complete 21.3.00
Created a crosstab query called HYPERTENSIVE BY LEVEL BY PRACTICE. This query is run 
on HYPERTENSIVES and plots Practice ID and Age Group against total hypertensive patient 
count, total count for ‘Missing’, total count for ‘Normal BP’ and total count for ‘Query HBP'.
Test complete 10.3.00
Created a select query called SORTED DIABETES. This query links MORBIDITY MASTER and 
READFILE and contains Practice ID, Patient ID, Read code. Diagnosis date and rubric. 
Records selected are limited by our criteria [relevant diabetes READ codes]. All variables are 
group and Practice ID and Patient ID are sorted in ascending order.
Tested 11.3.00
Created a select query called MORBIDITY DIABETES. This query is run on SORTED 
DIABETES and contains Practice ID, Patient ID, Read code. Diagnosis date and rubric. All 
variables are grouped and only the most recently dated READ code is Imported [last].
Test complete 11.3.00
• Created a select query called SORTED STROKE. This query links MORBIDITY MASTER and
READFILE and contains Practice ID, Patient ID, Read code, Diagnosis date and rubric.
Records selected are limited by our criteria [relevant stroke READ codes]. All variables are 
group and Practice ID and Patient ID are sorted in ascending order.
Tested 11.3.00
• Created a select query called MORBIDITY STROKE. This query is run on SORTED STROKE 
and contains Practice ID, Patient ID, Read code. Diagnosis date and rubric. All variables are 
grouped and only the most recently dated READ code is imported [last].
Test complete 11.3.00
• Created a select query called SORTED SMOKING. This query links MORBIDITY MASTER and
READFILE and contains Practice ID, Patient ID, Read code. Diagnosis date and rubric.
Records selected are limited by our criteria [relevant smoking READ codes]. All variables are 
grouped and Practice ID and Patient ID are sorted in ascending order.
Tested 11.3.00
• Created a select query called MORBIDITY SMOKING. This query is run on SORTED
SMOKING and contains Practice ID, Patient ID, Read code. Diagnosis date and rubric. All
variables are grouped and only the most recently dated READ code is imported [last].
Test complete 11.3.00
• Created a group of select queries called DRUGS 1-5. These queries are run on Prescriptions 
and contain Practice ID, Patient ID, Drug name and Start date. Records selected are limited by 
our criteria [5 batches of relevant anti-hypertensive drugs].
• Created a union query called ALL DRUGS. This query contains Practice ID, Patient ID, Drug
name and Start date and combines the results of DRUGS 1, DRUGS 2, DRUGS 3, DRUGS 4
and DRUGS 5. Only unique records are included [Script type was excluded from this set of 
queries as it resulted in duplicate Drug name and Start date data if one script was acute and the 
other repeat].
Test complete 12.3.00
• Created a select query called DRUG THERAPY. This query is run on ALL DRUGS and contains 
Practice ID, Patient ID and Start date. All variables are grouped and only the most recently 
dated script is imported [max] [Drug name] was excluded as this resulted in duplicate entries if 
the date was identical].
Test complete 13.3.00
• Created a select query called MORBIDITY VERBOSE. This query links HYPERTENSIVES, 
MORBIDITY DIABETES, MORBIDITY SMOKING, MORBIDITY STROKE and DRUG 
THERAPY. It contains Practice ID, Patient ID, Sex, LastOfSystolic, LastOfDiastolic, 
LastOfMeasurement date, Hypertensive Reading, Age Group, Smoking: Read code, Stroke: 
Read code. Diabetes: Read code and Therapy: MaxOfStartDate. This query gives a record in 
each category for every hypertensive.
Test complete 13.3.00; Re-test complete (excluding drugs)
• Added "Age-band” to the HYPERTENSIVES select query.
• Added “Age-band” to the MORBIDITY VERBOSE select query.
Test complete 31.3.00
• Created a select query called BP 160/90+. This query is run on PATIENT DATA and contains 
Practice ID, Patient ID, Age-band, Sex, Systolic, Diastolic and Measurement date. It also 
contains the created variables Hypertensive Reading and Age Group. Records selected are 
limited by our age criteria [>044 and <080].
Tested 5.4.00
Created a select query called POSSIBLE HYPERTENSIVES. This query links 
HYPERTENSIVES and BP 160/90+. It contains Practice ID, Patient ID, Age-band, Sex, Systolic, 
Diastolic, Measurement date. Hypertensive Reading and Age Group. It also contains a created 
variable called Diagnosed HTN which inserts ‘Undiagnosed’ for each patient in the query. 
Records selected are limited to those which are included in BP 160/90+ and are not in 
HYPERTENSIVES i.e. patients with a high blood pressure and no diagnosis of hypertension.
Test complete 23.5.00
Created a variable in HYPERTENSIVES called Diagnosed HTN. This inserts ‘Diagnosed’ for 
each patient in the HYPERTENSIVES query.
Tested 5.4.00
Added "Diagnosed HTN” to the MORBIDITY VERBOSE select query.
Test complete 5.4.00
Created a select query called MORBIDITY POSSIBLE. This query links POSSIBLE 
HYPERTENSIVES, MORBIDITY DIABETES, MORBIDITY SMOKING, MORBIDITY STROKE 
and DRUG THERAPY. It contains Practice ID, Patient ID, Age-band, Sex, LastOfSystolic, 
LastOfDiastolic, LastOfMeasurement date. Diagnosed HTN, Hypertensive Reading, Age Group, 
Diagnosed HTN, Smoking: Read code. Stroke: Read code, Diabetes: Read c o d e  and Therapy; 
MaxOfStartDate. This query gives a record in each of these categories for every possible 
hypertensive patient.
Test complete 23.5.00
Created a union query called COMPLETE MORBIDITY. This query combines the results of 
MORBIDITY VERBOSE and POSSIBLE HYPERTENSIVES MORBIDITY and contains Practice 
ID, Patient ID, Age-band, Sex, LastOfSystolic, LastOfDiastolic, LastOfMeasurement date. 
Diagnosed HTN, Hypertensive Reading, Age Group, Diagnosed HTN, Smoking: Read code. 
Stroke: Read code. Diabetes: Read code and Therapy: MaxOfStartDate. This query gives a 
record in each of these categories for every hypertensive or possible hypertensive patient.
Test complete 24.5.00
V
